FIDELITY REVERE STREET TRUST Form N-CSR Filed 2025-07-23

N-CSR false 0001022695 N-1A Fidelity Revere Street Trust 0001022695fmr:C000019656Member2024-05-312025-05-310001022695fmr:C000019656Member2025-05-310001022695fmr:C000019656Memberfmr:EMD0Member2025-05-310001022695fmr:C000019656Memberfmr:EMD1Member2025-05-310001022695fmr:C000019656Memberfmr:EMD2Member2025-05-310001022695fmr:C000019656Memberfmr:AARepurchaseAgreementsMember2025-05-310001022695fmr:C000019656Memberfmr:AAUSTreasuryObligationsMember2025-05-310001022695fmr:C000019656Memberfmr:AANonNegotiableTimeDepositMember2025-05-310001022695fmr:C000019656Memberfmr:AANetOtherAssetsLiabilitiesMember2025-05-310001022695fmr:C000019655Member2024-05-312025-05-310001022695fmr:C000019655Member2025-05-310001022695fmr:C000019655Memberfmr:EMD0Member2025-05-310001022695fmr:C000019655Memberfmr:AAVariableRateDemandNotesVRDNsMember2025-05-310001022695fmr:C000019655Memberfmr:AATenderOptionBondMember2025-05-310001022695fmr:C000019655Memberfmr:AANetOtherAssetsLiabilitiesMember2025-05-310001022695fmr:C000019654Member2024-05-312025-05-310001022695fmr:C000019654Member2025-05-310001022695fmr:C000019654Memberfmr:EMD0Member2025-05-310001022695fmr:C000019654Memberfmr:EMD1Member2025-05-310001022695fmr:C000019654Memberfmr:EMD2Member2025-05-310001022695fmr:C000019654Memberfmr:EMD3Member2025-05-310001022695fmr:C000019654Memberfmr:AARepurchaseAgreementsMember2025-05-310001022695fmr:C000019654Memberfmr:AAUSTreasuryObligationsMember2025-05-310001022695fmr:C000019654Memberfmr:AANonNegotiableTimeDepositMember2025-05-310001022695fmr:C000019654Memberfmr:AANetOtherAssetsLiabilitiesMember2025-05-310001022695fmr:C000019657Member2024-05-312025-05-310001022695fmr:C000019657Member2025-05-310001022695fmr:C000019657Memberfmr:EMD0Member2025-05-310001022695fmr:C000019657Memberfmr:AAVariableRateDemandNotesVRDNsMember2025-05-310001022695fmr:C000019657Memberfmr:AATenderOptionBondMember2025-05-310001022695fmr:C000019657Memberfmr:AANetOtherAssetsLiabilitiesMember2025-05-3100010226952024-05-312025-05-31 iso4217:USD xbrli:pure xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-07807

Fidelity Revere Street Trust

(Exact name of registrant as specified in charter)

245 Summer St., Boston, Massachusetts 02210

(Address of principal executive offices) (Zip code)

Nicole Macarchuk, Secretary

245 Summer St.

Boston, Massachusetts 02210

(Name and address of agent for service)

Registrant's telephone number, including area code:

617-563-7000


Date of fiscal year end:	May 31

Date of reporting period:	May 31, 2025

Item 1.

Reports to Stockholders


	ANNUAL SHAREHOLDER REPORT \| AS OF MAY 31, 2025	This report describes changes to the Fund that occurred during the reporting period.
	Fidelity® Securities Lending Cash Central Fund Fidelity® Securities Lending Cash Central Fund true

This annual shareholder report contains information about Fidelity® Securities Lending Cash Central Fund for the period June 1, 2024 to May 31, 2025. You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

What were your Fund costs for the last year?

(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Fidelity® Securities Lending Cash Central Fund	$ 0 A	0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Key Fund Statistics

(as of May 31, 2025)

KEY FACTS
Fund Size	$31,287,008,376
Number of Holdings	16
Total Advisory Fee	$0

What did the Fund invest in?
(as of May 31, 2025)

EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets)
Days
1-7	82.9
8-30	7.7
31-60	7.7

ASSET ALLOCATION (% of Fund's net assets)

	Repurchase Agreements - 78.6
	U.S. Treasury Obligations - 18.0
	Non-Negotiable Time Deposit - 1.7
	Net Other Assets (Liabilities) - 1.7

How has the Fund changed?

This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
		For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec 1.9913316.101 761-TSRA-0725


	ANNUAL SHAREHOLDER REPORT \| AS OF MAY 31, 2025	This report describes changes to the Fund that occurred during the reporting period.
	Fidelity® Municipal Cash Central Fund Fidelity® Municipal Cash Central Fund true

This annual shareholder report contains information about Fidelity® Municipal Cash Central Fund for the period June 1, 2024 to May 31, 2025. You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

What were your Fund costs for the last year?

(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Fidelity® Municipal Cash Central Fund	$ 0 A	0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Key Fund Statistics

(as of May 31, 2025)

KEY FACTS
Fund Size	$4,205,639,702
Number of Holdings	450
Total Advisory Fee	$0

What did the Fund invest in?
(as of May 31, 2025)

EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets)
Days
1-7	98.1

ASSET ALLOCATION (% of Fund's net assets)

	Variable Rate Demand Notes (VRDNs) - 69.2
	Tender Option Bond - 28.9
	Net Other Assets (Liabilities) - 1.9

How has the Fund changed?

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
		For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec 1.9913315.101 698-TSRA-0725


	ANNUAL SHAREHOLDER REPORT \| AS OF MAY 31, 2025	This report describes changes to the Fund that occurred during the reporting period.
	Fidelity® Cash Central Fund Fidelity® Cash Central Fund true

This annual shareholder report contains information about Fidelity® Cash Central Fund for the period June 1, 2024 to May 31, 2025. You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

What were your Fund costs for the last year?

(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Fidelity® Cash Central Fund	$ 0 A	0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Key Fund Statistics

(as of May 31, 2025)

KEY FACTS
Fund Size	$55,069,730,076
Number of Holdings	17
Total Advisory Fee	$0

What did the Fund invest in?
(as of May 31, 2025)

EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets)
Days
1-7	82.8
8-30	8.3
31-60	7.3
61-90	0.1

ASSET ALLOCATION (% of Fund's net assets)

	Repurchase Agreements - 78.2
	U.S. Treasury Obligations - 18.6
	Non-Negotiable Time Deposit - 1.7
	Net Other Assets (Liabilities) - 1.5

How has the Fund changed?

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
		For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec 1.9913314.101 693-TSRA-0725


	ANNUAL SHAREHOLDER REPORT \| AS OF MAY 31, 2025	This report describes changes to the Fund that occurred during the reporting period.
	Fidelity® Tax-Free Cash Central Fund Fidelity® Tax-Free Cash Central Fund true

This annual shareholder report contains information about Fidelity® Tax-Free Cash Central Fund for the period June 1, 2024 to May 31, 2025. You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

What were your Fund costs for the last year?

(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

	Costs of a $10,000 investment	Costs paid as a percentage of a $10,000 investment
Fidelity® Tax-Free Cash Central Fund	$ 0 A	0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Key Fund Statistics

(as of May 31, 2025)

KEY FACTS
Fund Size	$2,412,130,368
Number of Holdings	336
Total Advisory Fee	$0

What did the Fund invest in?
(as of May 31, 2025)

EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets)
Days
1-7	96.5

ASSET ALLOCATION (% of Fund's net assets)

	Variable Rate Demand Notes (VRDNs) - 69.1
	Tender Option Bond - 27.4
	Net Other Assets (Liabilities) - 3.5

How has the Fund changed?

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2025 FMR LLC. All rights reserved.
		For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec 1.9913317.101 1335-TSRA-0725

Item 2.

Code of Ethics

As of the end of the period, May 31, 2025, Fidelity Revere Street Trust (the trust) has adopted a code of ethics, as defined in Item 2 of Form N-CSR, that applies to its President and Treasurer and its Chief Financial Officer. A copy of the code of ethics is filed as an exhibit to this Form N-CSR.

Item 3.

Audit Committee Financial Expert

The Board of Trustees of the trust has determined that Laura M. Bishop is an audit committee financial expert, as defined in Item 3 of Form N-CSR. Ms. Bishop is independent for purposes of Item 3 of Form N-CSR.

Item 4.

Principal Accountant Fees and Services

Fees and Services

The following table presents fees billed by Deloitte & Touche LLP, the member firms of Deloitte Touche Tohmatsu, and their respective affiliates (collectively, “Deloitte Entities”) in each of the last two fiscal years for services rendered to Fidelity Tax-Free Cash Central Fund (the “Fund”):

Services Billed by Deloitte Entities

May 31, 2025 Fees^A


	Audit Fees	Audit-Related Fees	Tax Fees	All Other Fees
Fidelity Tax-Free Cash Central Fund	$31,800	$-	$5,800	$600

May 31, 2024 Fees^A


	Audit Fees	Audit-Related Fees	Tax Fees	All Other Fees
Fidelity Tax-Free Cash Central Fund	$30,300	$-	$5,600	$700

^AAmounts may reflect rounding.

The following table presents fees billed by PricewaterhouseCoopers LLP (“PwC”) in each of the last two fiscal years for services rendered to Fidelity Cash Central Fund,

Fidelity Municipal Cash Central Fund, and Fidelity Securities Lending Cash Central Fund (the “Funds”):

Services Billed by PwC

May 31, 2025 Fees^A


	Audit Fees	Audit-Related Fees	Tax Fees	All Other Fees
Fidelity Cash Central Fund	$40,700	$2,900	$2,200	$1,200
Fidelity Municipal Cash Central Fund	$31,900	$2,400	$2,200	$1,000
Fidelity Securities Lending Cash Central Fund	$39,800	$2,900	$2,200	$1,200

May 31, 2024 Fees^A


	Audit Fees	Audit-Related Fees	Tax Fees	All Other Fees
Fidelity Cash Central Fund	$39,700	$2,900	$2,100	$1,200
Fidelity Municipal Cash Central Fund	$31,100	$2,400	$2,100	$1,000
Fidelity Securities Lending Cash Central Fund	$39,000	$2,900	$2,100	$1,200

^AAmounts may reflect rounding.

The following table(s) present(s) fees billed by Deloitte Entities and PwC that were required to be approved by the Audit Committee for services that relate directly to the operations and financial reporting of the Fund(s) and that are rendered on behalf of Fidelity Management & Research Company LLC ("FMR") and entities controlling, controlled by, or under common control with FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund(s) (“Fund Service Providers”):

Services Billed by Deloitte Entities


	May 31, 2025^A	May 31, 2024^A
Audit-Related Fees	$125,000	$200,000
Tax Fees	$-	$-
All Other Fees	$3,964,900	$935,000

^A Amounts may reflect rounding.

Services Billed by PwC


	May 31, 2025^A	May 31, 2024^A
Audit-Related Fees	$9,845,100	$9,367,800
Tax Fees	$1,000	$61,000
All Other Fees	$35,000	$-

^A Amounts may reflect rounding.

“Audit-Related Fees” represent fees billed for assurance and related services that are reasonably related to the performance of the fund audit or the review of the fund's financial statements and that are not reported under Audit Fees.

“Tax Fees” represent fees billed for tax compliance, tax advice or tax planning that relate directly to the operations and financial reporting of the fund.

“All Other Fees” represent fees billed for services provided to the fund or Fund Service Provider, a significant portion of which are assurance related, that relate directly to the operations and financial reporting of the fund, excluding those services that are reported under Audit Fees, Audit-Related Fees or Tax Fees.

Assurance services must be performed by an independent public accountant.

* * *

The aggregate non-audit fees billed by Deloitte Entities and PwC for services rendered to the Fund(s), FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any Fund Service Provider for each of the last two fiscal years of the Fund(s) are as follows:


Billed By	May 31, 2025^A	May 31, 2024^A
Deloitte Entities	$4,477,600	$5,165,800
PwC	$14,895,800	$14,881,300

^A Amounts may reflect rounding.

The trust's Audit Committee has considered non-audit services that were not pre-approved that were provided by Deloitte Entities and PwC to Fund Service Providers to

be compatible with maintaining the independence of Deloitte Entities and PwC in its(their) audit of the Fund(s), taking into account representations from Deloitte Entities and PwC, in accordance with Public Company Accounting Oversight Board rules, regarding its independence from the Fund(s) and its(their) related entities and FMR’s review of the appropriateness and permissibility under applicable law of such non-audit services prior to their provision to the Fund(s) Service Providers.

Audit Committee Pre-Approval Policies and Procedures

The trust’s Audit Committee must pre-approve all audit and non-audit services provided by a fund’s independent registered public accounting firm relating to the operations or financial reporting of the fund. Prior to the commencement of any audit or non-audit services to a fund, the Audit Committee reviews the services to determine whether they are appropriate and permissible under applicable law.

The Audit Committee has adopted policies and procedures to, among other purposes, provide a framework for the Committee’s consideration of non-audit services by the audit firms that audit the Fidelity funds. The policies and procedures require that any non-audit service provided by a fund audit firm to a Fidelity fund and any non-audit service provided by a fund auditor to a Fund Service Provider that relates directly to the operations and financial reporting of a Fidelity fund (“Covered Service”) are subject to approval by the Audit Committee before such service is provided.

All Covered Services must be approved in advance of provision of the service either: (i) by formal resolution of the Audit Committee, or (ii) by oral or written approval of the service by the Chair of the Audit Committee (or if the Chair is unavailable, such other member of the Audit Committee as may be designated by the Chair to act in the Chair’s absence). The approval contemplated by (ii) above is permitted where the Treasurer determines that action on such an engagement is necessary before the next meeting of the Audit Committee.

Non-audit services provided by a fund audit firm to a Fund Service Provider that do not relate directly to the operations and financial reporting of a Fidelity fund are reported to the Audit Committee periodically.

Non-Audit Services Approved Pursuant to Rule 2-01(c)(7)(i)(C) and (ii) of Regulation S-X (“De Minimis Exception”)

There were no non-audit services approved or required to be approved by the Audit Committee pursuant to the De Minimis Exception during the Fund’s(s’) last two fiscal years relating to services provided to (i) the Fund(s) or (ii) any Fund Service Provider that relate directly to the operations and financial reporting of the Fund(s).

The Registrant has not retained, for the preparation of the audit report on the financial statements included in the Form N-CSR, a registered public accounting firm that has a branch or office that is located in a foreign jurisdiction and that the Public Company

Accounting Oversight Board (the “PCAOB”) has determined that the PCAOB is unable to inspect or investigate completely because of a position taken by an authority in the foreign jurisdiction.

The Registrant is not a “foreign issuer,” as defined in 17 CFR 240.3b-4.

Item 5.

Audit Committee of Listed Registrants

Not applicable.

Item 6.

Investments

(a)

Not applicable.

(b)

Not applicable.

Item 7.

Financial Statements and Financial Highlights for Open-End Management Investment Companies

Fidelity® Tax-Free Cash Central Fund

Annual Report

May 31, 2025

Contents

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Tax-Free Cash Central Fund

Notes to Financial Statements

Report of Independent Registered Public Accounting Firm

Distributions

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

Item 9: Proxy Disclosures for Open-End Management Investment Companies

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SEC's web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SEC's Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Tax-Free Cash Central Fund

Schedule of Investments May 31, 2025

Showing Percentage of Net Assets

Tender Option Bond - 27.4%
	Principal Amount (a)	Value ($)
Alabama - 0.6%
Alabama Infirmary Health Rev Participating VRDN Series 5065, 2% 2/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	5,700,000	5,700,000
Black Belt Energy Gas District Participating VRDN Series 2023 XM1127, 3.15% 6/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,800,000	2,800,000
Black Belt Energy Gas District Participating VRDN Series 2024 XM1190, 2.02% 5/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	300,000	300,000
Black Belt Energy Gas District Participating VRDN Series 2025 XM1233, 2.02% 3/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	300,000	300,000
East Alabama Health Care Auth Participating VRDN Series 2025 BAML5061, 3.14% 9/1/2054 (Liquidity Facility Bank of America, N.A.) (b)(c)	2,800,000	2,800,000
Southeast Alabama Gas Supply District Participating VRDN Series 2023 ZL0521, 2.02% 1/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,500,000	2,500,000
TOTAL ALABAMA		14,400,000
Alabama,Arizona - 0.0%
Jefferson County AL Board Ed Participating VRDN Series 2023 YX1319, 2.01% 2/1/2046 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,025,000	2,025,000
Arizona - 0.3%
Arizona Health Facilities Auth Rev Participating VRDN Series 2022 MIZ9101, 2.17% 3/1/2029 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	200,000	200,000
Arizona Health Facs Auth Rev Participating VRDN Series 3384, 2% 1/1/2037 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	2,100,000	2,100,000
Arizona Indl Dev Auth Hosp Rev Participating VRDN Series 2022 XM1013, 3.17% 2/1/2050 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,460,000	4,460,000
Mesa AZ Util Sys Rev Participating VRDN 2.02% 7/1/2046 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	700,000	700,000
TOTAL ARIZONA		7,460,000
Colorado - 0.2%
Colorado Health Facilities Authority Participating VRDN Series 2023 XG0491, 2% 11/15/2050 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,730,000	1,730,000
Regional Transn Dist CO Sales Participating VRDN Series 2025 CF7024, 2% 11/1/2033 (Liquidity Facility Citibank NA) (b)(c)	1,900,000	1,900,000
TOTAL COLORADO		3,630,000
Connecticut - 0.4%
Connecticut Gen. Oblig. Participating VRDN Series 2017 016, 2.01% 6/1/2037 (Liquidity Facility Barclays Bank PLC) (b)(c)	5,400,000	5,400,000
Connecticut Gen. Oblig. Participating VRDN Series 2017 014, 2.01% 6/1/2037 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,840,000	4,840,000
TOTAL CONNECTICUT		10,240,000
District Of Columbia - 0.4%
District Columbia Gen. Oblig. Participating VRDN 3.05% 1/1/2048 (Liquidity Facility UBS AG) (b)(c)	3,200,000	3,200,000
District Columbia Income Tax Rev Participating VRDN Series 2025 ZF3380, 2% 6/1/2050 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	4,660,000	4,660,000
Metropolitan Washington Arpts Auth Dulles Toll Road Rev Participating VRDN Series 2019 XG0267, 2.02% 10/1/2053 (Liquidity Facility Bank of America, N.A.) (b)(c)	25,000	25,000
Metropolitan Washington Arpts Auth Dulles Toll Road Rev Participating VRDN Series 2019 XF0853, 2.01% 10/1/2044 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	835,000	835,000
TOTAL DISTRICT OF COLUMBIA		8,720,000
Florida - 2.5%
Broward Cnty Fla Convention Ctr Hotel Rev Participating VRDN 3.17% 1/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	5,500,000	5,500,000
Broward Cnty Fla Convention Ctr Hotel Rev Participating VRDN Series 2023 XF1641, 2.07% 1/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,300,000	2,300,000
County of Broward FL Tourist Development Tax Revenue Participating VRDN Series 2023 XL0429, 2.08% 9/1/2051 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	460,000	460,000
Florida Dev Fin Corp Healthcare Facility Rev Participating VRDN 3.08% 2/1/2045 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,600,000	1,600,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN 2% 11/15/2054 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	3,330,000	3,330,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN 2% 11/15/2054 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,200,000	1,200,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN Series 2025 XM1229, 2% 11/15/2054 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,200,000	1,200,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN Series 2025 XM1246, 2% 11/15/2049 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,000,000	1,000,000
Jacksonville Fla Spl Rev Participating VRDN Series 2025 XL0618, 3.1% 10/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,800,000	2,800,000
JEA FL Wtr & Swr Sys Rev Participating VRDN Series 2025 XF1845, 3.1% 10/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,555,000	2,555,000
JEA FL Wtr & Swr Sys Rev Participating VRDN Series 2025 XM1219, 3.1% 10/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,750,000	3,750,000
Miami-Dade Cnty FL Sch Dist Participating VRDN Series 2025 CF7023, 2.02% 3/15/2047 (Liquidity Facility Citibank NA) (b)(c)	2,100,000	2,100,000
Miami-Dade Cnty FL Wtr & Swr Rev Participating VRDN Series 2023 XF3122, 2% 10/1/2049 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,280,000	4,280,000
Miami-Dade County Expressway Auth Participating VRDN Series 2019 XG0252, 2.02% 7/1/2034 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,300,000	1,300,000
Miami-Dade FL The Villages Apts Participating VRDN Series 2024 MIZ9196, 3.17% 5/14/2036 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	6,890,000	6,890,000
Palm Beach Cnty Fla Health Facs Auth Hosp Rev Participating VRDN Series 2022 XG0370, 2.07% 8/15/2049 (Liquidity Facility Bank of America, N.A.) (b)(c)	400,000	400,000
Pasco County FL Hosp Rev Participating VRDN Series 2023 XM1155, 2% 7/1/2030 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,000,000	1,000,000
South Miami FL Hlth Fcs Hsp Rv Participating VRDN 2.04% 8/15/2036 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,400,000	2,400,000
South Miami FL Hlth Fcs Hsp Rv Participating VRDN Series 2018 XG0173, 2.07% 8/15/2047 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	900,000	900,000
Tampa FL Hosp Rev Participating VRDN Series 2025 XG0613, 2% 8/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	900,000	900,000
Tampa Fla Wtr & Wastewtr Sys Participating VRDN Series 2023 ZL0485, 2% 10/1/2052 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	1,665,000	1,665,000
Volusia County FL Deltona Med Center Participating VRDN Series 5078, 3.1% 12/15/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	13,820,000	13,820,000
TOTAL FLORIDA		61,350,000
Georgia - 0.7%
Brookhaven Development Authority Participating VRDN Series 2023 XF1503, 3.1% 7/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	9,400,000	9,400,000
Burke County Indl Dev Auth Poll Cont Rev Participating VRDN 2.01% 11/1/2045 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,000,000	1,000,000
Georgia Muni Elec Auth Pwr Rev Participating VRDN Series 2023 XF1554, 2.01% 1/1/2059 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	300,000	300,000
Georgia Muni Elec Auth Pwr Rev Participating VRDN Series 2023 XG0470, 2.02% 1/1/2059 (Liquidity Facility Bank of America, N.A.) (b)(c)	500,000	500,000
Georgia Muni Elec Auth Pwr Rev Participating VRDN Series 2023 XG0472, 2.01% 1/1/2063 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	2,500,000	2,500,000
Main Street Natural Gas Inc Participating VRDN Series 2023 XF1601, 2% 12/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,000,000	1,000,000
Main Street Natural Gas Inc Participating VRDN Series 2023 XG0489, 2% 12/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,710,000	2,710,000
Main Street Natural Gas Inc Participating VRDN Series 2024 XM1187, 2.02% 6/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	300,000	300,000
Muni Elec Auth of Georgia Participating VRDN Series 2019 XG0254, 2.02% 1/1/2063 (Liquidity Facility Bank of America, N.A.) (b)(c)	250,000	250,000
TOTAL GEORGIA		17,960,000
Hawaii - 0.0%
Hawaii Dpt Bg & Fin Spl Pur Rev Participating VRDN Series 2025 XM1242, 2.05% 7/1/2052 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,290,000	1,290,000
Illinois - 1.4%
Chicago IL Gen. Oblig. Participating VRDN 2.01% 11/27/2028 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	7,875,000	7,875,000
Chicago Transit Auth Participating VRDN Series 2023 XG0487, 2% 12/1/2051 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,660,000	3,660,000
IL Met Pier & Exp Auth Participating VRDN Series 2025 XF1905, 2.01% 6/15/2050 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	2,825,000	2,825,000
Illinois Fin Auth Participating VRDN 2% 5/15/2050 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,500,000	1,500,000
Illinois Gen. Oblig. Participating VRDN 2.02% 11/1/2029 (Liquidity Facility Bank of America, N.A.) (b)(c)	250,000	250,000
Illinois Gen. Oblig. Participating VRDN 2.02% 5/1/2039 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,800,000	1,800,000
Illinois Gen. Oblig. Participating VRDN Series 2019 XM0759, 2.02% 11/1/2025 (Liquidity Facility Bank of America, N.A.) (b)(c)	390,000	390,000
Illinois Gen. Oblig. Participating VRDN Series 2022 XL0260, 2% 3/1/2047 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,200,000	1,200,000
Illinois St Toll Hwy Auth Hwy Rev Participating VRDN 2% 1/1/2045 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,600,000	1,600,000
Illinois St Toll Hwy Auth Hwy Rev Participating VRDN Series 2023 XF1533, 2.03% 1/1/2044 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,330,000	1,330,000
Illinois St Toll Hwy Auth Hwy Rev Participating VRDN Series 2023 ZF3156, 2% 1/1/2041 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	2,165,000	2,165,000
Metropolitan Pier & Exposition Participating VRDN Series 2015 XF1045, 2.01% 6/15/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)	400,000	400,000
Pittsburg WTSW Participating VRDN 3.13% 11/15/2046 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	7,900,000	7,900,000
TOTAL ILLINOIS		32,895,000
Indiana - 0.3%
Indian Fin Auth Univ Hlth Participating VRDN Series E 161, 2% 10/1/2064 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	6,100,000	6,100,000
Iowa - 0.0%
State of Iowa Board of Regents Participating VRDN 2% 9/1/2050 (Liquidity Facility Bank of America, N.A.) (b)(c)	500,000	500,000
Kansas - 0.1%
Wyandotte County KS Uni Sch Dist Participating VRDN Series 2025 ZF1821, 2% 9/1/2050 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,850,000	2,850,000
Kentucky - 0.3%
CommonSpirit Health Participating VRDN Series 2020 MIZ9021, 2.07% 5/1/2029 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	600,000	600,000
Kentucky Inc Pub Energy Participating VRDN Series 2024 XM1189, 2.02% 8/1/2052 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	300,000	300,000
Kentucky Inc Pub Energy Participating VRDN Series 2024 XM1188, 2.02% 5/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	300,000	300,000
Kentucky Property & Buildings Commission Rev Participating VRDN Series 2017 XG0113, 2.01% 4/1/2032 (Liquidity Facility Barclays Bank PLC) (b)(c)	5,600,000	5,600,000
Louisville & Jefferson KY Swr Sys Rev Participating VRDN 2% 5/15/2049 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	800,000	800,000
TOTAL KENTUCKY		7,600,000
Louisiana - 2.0%
Louisiana Pub Facilities Auth Hosp Rev Participating VRDN Series 2023 BAML5041, 3.08% 12/1/2052 (Liquidity Facility Bank of America, N.A.) (b)(c)	47,700,000	47,700,000
Massachusetts - 0.2%
Massachusetts St Gen. Oblig. Participating VRDN Series 2025 XM1251, 3.05% 1/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,420,000	4,420,000
Michigan - 5.0%
Bronson MI Hlth Rev Participating VRDN Series 2025 XL0615, 2% 5/15/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,625,000	2,625,000
Eastern Michigan Univ Revs Participating VRDN 3.08% 3/1/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)	41,800,000	41,800,000
Michigan Fin Auth Rev Participating VRDN Series 2019 XF0782, 2% 2/15/2050 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	585,000	585,000
Michigan Fin Auth Rev Participating VRDN Series 2023 XF1667, 2% 11/15/2048 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,250,000	2,250,000
Michigan Hsg Dev Auth Rent Hsg Rev Participating VRDN 3.08% 12/1/2045 (Liquidity Facility Barclays Bank PLC) (b)(c)	18,290,000	18,290,000
Michigan St Hosp Fin Auth Rev Participating VRDN 2% 11/15/2047 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	2,500,000	2,500,000
Pittsburg WTSW Participating VRDN 3.13% 5/15/2046 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	52,000,000	52,000,000
TOTAL MICHIGAN		120,050,000
Minnesota - 0.2%
Duluth Econ Dev Auth Health Care Facs Rev Participating VRDN Series 2023 XG0523, 2.01% 2/15/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,685,000	4,685,000
Missouri - 0.8%
Missouri Health & Edl Facilities Auth Participating VRDN Series 2023 XF1611, 2.01% 11/15/2045 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	3,750,000	3,750,000
Missouri Health & Edl Facilities Auth Rev Participating VRDN Series C 16, 2.02% 3/1/2045 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	7,800,000	7,800,000
Missouri Health & Edl Facs Rev Participating VRDN Series C 23, 2.01% 6/1/2045 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,200,000	3,200,000
Missouri Hlth & Edl Facs Rev Participating VRDN Series 2025 XF1841, 2% 4/1/2045 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,670,000	2,670,000
Missouri St Hsg Dev Commn Single Family Mtg Rev Participating VRDN Series 2025 XF1885, 2% 11/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	1,250,000	1,250,000
Montana Hlth Facs Auth Rev Participating VRDN 2% 11/15/2043 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	600,000	600,000
TOTAL MISSOURI		19,270,000
Nebraska - 0.2%
Central Plains Energy Proj Rev Participating VRDN Series 2022 ZL0301, 2.02% 5/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	145,000	145,000
Nebraska Invt Fin Auth Sfh Rev Participating VRDN Series 2024 XF1774, 2% 9/1/2051 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,450,000	2,450,000
Nebraska Invt Fin Auth Sfh Rev Participating VRDN Series 2024 YX1335, 2% 9/1/2054 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,910,000	1,910,000
TOTAL NEBRASKA		4,505,000
New Jersey - 0.3%
New Jersey Econ Dev Auth Participating VRDN Series 2018 XF2538, 2% 6/15/2040 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,810,000	2,810,000
New Jersey Trans Trust Fund Auth Participating VRDN 2% 6/15/2046 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,100,000	1,100,000
New Jersey Trans Trust Fund Auth Participating VRDN Series 2023 XF1557, 2% 6/15/2050 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	2,000,000	2,000,000
New Jersey Turnpike Authority Participating VRDN 2.02% 1/1/2052 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,200,000	1,200,000
TOTAL NEW JERSEY		7,110,000
New York - 0.9%
City of New York NY Gen. Oblig. Participating VRDN Series 2025 XL0612, 3.1% 2/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,100,000	2,100,000
New York City Gen. Oblig. Participating VRDN 2% 9/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,950,000	2,950,000
New York City Transitional Finance Authority Participating VRDN 3% 5/1/2054 (Liquidity Facility UBS AG) (b)(c)	1,330,000	1,330,000
New York City Transitional Finance Authority Participating VRDN Series 2023 XF1660, 3.1% 5/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,750,000	3,750,000
New York NY Cty Muni Wtr Fin Auth Participating VRDN Series 2025 XF1891, 3.1% 6/15/2051 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,250,000	2,250,000
NY St Dorm Auth Revs Non St Supported Debt Participating VRDN Series 2025 XF1892, 3.1% 7/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,625,000	3,625,000
Triborough Brdg & Tunl NY Revs Participating VRDN Series 2022 009, 3.05% 11/15/2042 (Liquidity Facility Barclays Bank PLC) (b)(c)	5,600,000	5,600,000
TOTAL NEW YORK		21,605,000
Ohio - 0.8%
Middletown Hosp Facilities Rev Participating VRDN Series 2024 BAML5056, 3.08% 11/15/2054 (Liquidity Facility Bank of America, N.A.) (b)(c)	13,300,000	13,300,000
Montgomery County Hosp Rev Participating VRDN 2.01% 11/15/2045 (Liquidity Facility Barclays Bank PLC) (b)(c)	800,000	800,000
Ohio Hosp Rev Participating VRDN Series C 18, 2.01% 1/15/2041 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	300,000	300,000
Ohio Housing Finance Agency Participating VRDN Series 2024 XF1762, 2% 9/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	965,000	965,000
Ohio St Hsg Fin Agy Residential Mtg Rev Participating VRDN Series 2024 XL0540, 2% 9/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,490,000	3,490,000
TOTAL OHIO		18,855,000
Oregon - 0.2%
Clackamas Cnty OR Sch Dist No 62 Participating VRDN Series 2023 XG0533, 2.01% 6/15/2049 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	3,905,000	3,905,000
Multinomah OR Adventist Health Participating VRDN 2% 3/1/2040 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	900,000	900,000
TOTAL OREGON		4,805,000
Pennsylvania - 2.1%
Allegheny County Arpt Auth Rev Participating VRDN Series 2018 XX1094, 2.01% 4/1/2047 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,260,000	2,260,000
Allegheny County Arpt Auth Rev Participating VRDN Series 2024 XF1685, 2% 1/1/2056 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	6,015,000	6,015,000
Geisinger Auth PA Hlth Sys Rev Participating VRDN Series 2025 XF3344, 2% 2/15/2045 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	2,000,000	2,000,000
Lehigh County Gen Purp Hosp Rev Participating VRDN 3.08% 7/1/2033 (Liquidity Facility Bank of America, N.A.) (b)(c)	2,475,000	2,475,000
Montgomery County Higher Ed & Health Auth Rev Participating VRDN Series 2023 XG0528, 2.01% 9/1/2048 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	900,000	900,000
Pennsylvania Hsg Fin Agcy Multi Fam Hsg Dev Rev Participating VRDN 3.17% 9/19/2027 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	2,600,000	2,600,000
Philadelphia PA Auth For Indl Dev Hosp Rev Participating VRDN Series 2025 XF1898, 3.1% 7/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	7,700,000	7,700,000
Philadelphia PA Auth For Indl Dev Hosp Rev Participating VRDN Series 2025 XL0621, 3.1% 7/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,700,000	3,700,000
Philadelphia PA Auth For Indl Dev Hosp Rev Participating VRDN Series 2025 XX1395, 3.08% 7/1/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,345,000	4,345,000
Philadelphia School District Participating VRDN Series 2023 XG0536, 2% 9/1/2048 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,500,000	2,500,000
Southeastern PA Transn Auth Rev Participating VRDN 2% 6/1/2052 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	4,000,000	4,000,000
Thomas Jefferson University Participating VRDN Series 2024 XF1769, 2% 11/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	900,000	900,000
Thomas Jefferson University Participating VRDN Series 5077, 2% 11/1/2064 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	9,400,000	9,400,000
Westmoreland Cnty PA Participating VRDN Series 2017 YX1075, 2.01% 8/15/2036 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,700,000	1,700,000
TOTAL PENNSYLVANIA		50,495,000
South Carolina - 0.5%
Patriots Energy Group Fing Agcy Participating VRDN Series 2023 XG0539, 2% 2/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,750,000	3,750,000
Prism Health SC Participating VRDN 2% 5/1/2048 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	5,800,000	5,800,000
South Carolina Pub Svc Auth Rev Participating VRDN Series 2023 XF1548, 2% 12/1/2047 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,000,000	3,000,000
TOTAL SOUTH CAROLINA		12,550,000
Tennessee - 2.5%
Chattanooga YN Commonspirit Health Participating VRDN Series 2025 XG0611, 2% 8/1/2049 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,970,000	1,970,000
Metropolitan Govt Nashville & Davidson Cnty TN Gen. Oblig. Participating VRDN Series 2025 CF7031, 2% 1/1/2042 (Liquidity Facility Citibank NA) (b)(c)	1,400,000	1,400,000
Sullivan County Health Ed and Hsg Board Participating VRDN 3.08% 9/1/2036 (Liquidity Facility Bank of America, N.A.) (b)(c)	55,935,000	55,935,000
TOTAL TENNESSEE		59,305,000
Texas - 2.3%
Greenwood Tex Indpt Sch Dist Participating VRDN 3.1% 2/15/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,000,000	4,000,000
Harris Cnty TX Cultural Ed Facs Fin Corp Rev Participating VRDN Series 2023 XF3203, 2.12% 7/1/2052 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	600,000	600,000
Harris Cnty TX Flood Ctl Dist Gen. Oblig. Participating VRDN 2% 10/1/2046 (Liquidity Facility Citibank NA) (b)(c)	1,300,000	1,300,000
Harris Cnty TX Gen. Oblig. Participating VRDN 2% 9/15/2048 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	2,160,000	2,160,000
Harris County Children's Hosp Participating VRDN Series E 149, 2% 10/1/2041 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,700,000	1,700,000
Lamar TX Isd Participating VRDN 2.02% 2/15/2058 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,800,000	1,800,000
Lamar TX Isd Participating VRDN Series 2023 XM1103, 3.1% 2/15/2058 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,500,000	2,500,000
Lamar TX Isd Participating VRDN Series 2025 XX1391, 2% 2/15/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)	900,000	900,000
Lamar TX Isd Participating VRDN Series 2025 ZF3318, 2.02% 2/15/2058 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,100,000	1,100,000
Las Varas TX Multi Fam Hsg Auth Participating VRDN Series 2024 MIZ9171, 3.17% 9/26/2027 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	7,475,000	7,475,000
Los Angeles CA Multi Fam Mtg Rev Participating VRDN Series 2024 MIZ9195, 2.07% 7/1/2063 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	3,400,000	3,400,000
North Ft Bend Wtr Auth Tex Wtrsys Rev Participating VRDN Series 2023 XL0422, 2.08% 12/15/2058 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	215,000	215,000
Princeton TX Indpt Sch Dist Participating VRDN Series 2023 XF3192, 1.99% 2/15/2053 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	3,125,000	3,125,000
Royse City TX Indpt Sch Dist Participating VRDN 2% 2/15/2053 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,670,000	1,670,000
San Antonio TX Elec & Gas Rev Participating VRDN 3.1% 2/1/2046 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,100,000	2,100,000
Tarrant Cnty TX Cultural Ed Facs Fin Corp Hosp Rev Participating VRDN 2.02% 11/15/2051 (Liquidity Facility Bank of America, N.A.) (b)(c)	755,000	755,000
Tarrant County Cultural Ed Facilities Fin Corp Rev Participating VRDN Series 2022 XG0399, 2% 7/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,750,000	3,750,000
Texas Wtr Dev Brd Participating VRDN Series 2023 XF1528, 2.01% 4/15/2049 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	2,855,000	2,855,000
Texas Wtr Dev Brd Participating VRDN Series 2023 XF3154, 2% 10/15/2051 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	2,000,000	2,000,000
Texas Wtr Dev Brd Participating VRDN Series 2023 ZF1678, 2% 10/15/2052 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,420,000	3,420,000
Travis TX Hog Eye Apts Participating VRDN Series 2024 MIZ9197, 3.17% 2/1/2068 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	2,900,000	2,900,000
Tuloso Midway TX Indpt Sch Dst Participating VRDN 3.1% 8/15/2050 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,830,000	2,830,000
Waller TX Indpt Sch Dist Participating VRDN Series 2025 XG0596, 2% 2/15/2048 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,405,000	3,405,000
TOTAL TEXAS		55,960,000
Virginia - 0.6%
Norfolk Econ Dev Health Care Facs Participating VRDN 2.01% 11/1/2043 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,000,000	3,000,000
Suffolk Econ Dev Auth Hosp Facs Rev Participating VRDN Series 2020 MIZ9025, 2.07% 11/1/2035 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	8,100,000	8,100,000
Virginia Small Business Fing Auth Healthcare Facs Rev Participating VRDN 3.15% 12/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,500,000	3,500,000
TOTAL VIRGINIA		14,600,000
Washington - 0.5%
Multicare Health Sys Participating VRDN Series E 153, 2% 8/15/2044 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,600,000	3,600,000
Seattle WA Mun Lt & Pwr Rev Participating VRDN Series 2023 XL0482, 3.1% 7/1/2052 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	6,670,000	6,670,000
Washington Health Care Facs Auth Rev Participating VRDN Series 2023 XF1514, 2.01% 10/1/2044 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	2,025,000	2,025,000
TOTAL WASHINGTON		12,295,000
West Virginia - 0.2%
West Virginia Hosp Fin Auth Hosp Rev Participating VRDN Series 2023 XF1537, 2.01% 6/1/2053 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	5,520,000	5,520,000
Wisconsin - 0.9%
Wisconsin Health & Edl Facilities Auth Rev Participating VRDN 3.14% 2/15/2040 (Liquidity Facility Bank of America, N.A.) (b)(c)	21,100,000	21,100,000
TOTAL TENDER OPTION BOND (Cost $661,850,000)		661,850,000

Variable Rate Demand Note - 69.1%
	Principal Amount (a)	Value ($)
Alabama - 1.8%
Columbia AL Indl Dev Brd Pcr (Alabama Power & Light Proj.) Series 2014A, 3% 12/1/2037 VRDN (b)	12,665,000	12,665,000
Columbia AL Indl Dev Brd Pcr (Alabama Power & Light Proj.) Series 2014B, 3% 12/1/2037 VRDN (b)	23,900,000	23,900,000
Eutaw AL Idl Dev Bd Pln Ctl Rv (Alabama Power & Light Proj.) 3% 6/1/2028 VRDN (b)	1,600,000	1,600,000
Mobile AL Indl Dev Board Poll Cont Rev (Alabama Power & Light Proj.) 3% 6/1/2034 VRDN (b)	4,400,000	4,400,000
TOTAL ALABAMA		42,565,000
Alaska - 1.0%
Valdez Alaska Marine Term Rev (Conocophillips Company Proj.) 1.93% 5/1/2031 (ConocoPhillips Guaranteed) VRDN (b)	900,000	900,000
Valdez Alaska Marine Term Rev (Conocophillips Company Proj.) 2.03% 3/1/2035 (ConocoPhillips Guaranteed) VRDN (b)	9,400,000	9,400,000
Valdez Alaska Marine Term Rev (Conocophillips Company Proj.) 2.03% 5/1/2031 (ConocoPhillips Guaranteed) VRDN (b)	15,000,000	15,000,000
TOTAL ALASKA		25,300,000
Arizona - 0.7%
Arizona Brd Regents AZ St Univ Sys Rev (Arizona St Univ Revs Proj.) Series 2025C, 2.12% 7/1/2055 VRDN (b)	4,700,000	4,700,000
Arizona Indl Dev Auth Hosp Rev (Phoenix Childrens Hospital Proj.) Series 2019 A, 3% 2/1/2048, LOC TD Bank NA VRDN (b)	6,820,000	6,820,000
Maricopa Cnty AZ Pollution Ctl (Arizona Public Service Co Proj.) 2.2% 5/1/2029 VRDN (b)	6,300,000	6,300,000
Maricopa Cnty AZ Pollution Ctl (Arizona Public Service Co Proj.) 2.25% 5/1/2029 VRDN (b)	200,000	200,000
TOTAL ARIZONA		18,020,000
Colorado - 1.9%
Colorado Health Facilities Authority (Childrens Hospital Assoc, Co Proj.) Series 2020A, 3% 12/1/2052, LOC TD Bank NA VRDN (b)	2,675,000	2,675,000
Colorado Health Facilities Authority (Ihc Health Services Inc Proj.) 3% 5/15/2064 VRDN (b)	15,500,000	15,500,000
University of Colorado Hospital Authority Series 2018 A, 1.75% 11/15/2030 VRDN (b)	16,750,000	16,750,000
University of Colorado Hospital Authority Series 2018B, 3% 11/15/2035 VRDN (b)	11,235,000	11,235,000
TOTAL COLORADO		46,160,000
Connecticut - 0.4%
Conn St Hsg Fin Auth (Ct Hsg Mortgage Proj.) 1.95% 11/15/2048 (Liquidity Facility TD Bank NA) VRDN (b)	1,200,000	1,200,000
Conn St Hsg Fin Auth (Ct Hsg Mortgage Proj.) Series 2018 B 3, 1.95% 11/15/2048 (Liquidity Facility Royal Bank of Canada) VRDN (b)	1,025,000	1,025,000
Connecticut St Health & Edl Facs Auth Revenue (Yale-New Haven Hospital Inc Proj.) Series 2024C 1, 1.85% 7/1/2060 VRDN (b)	8,200,000	8,200,000
TOTAL CONNECTICUT		10,425,000
Delaware - 0.0%
Delaware St Econ Dev Auth Rev (Delmarva Power & Light Proj.) 2.2% 10/1/2028 VRDN (b)	800,000	800,000
District Of Columbia - 0.1%
District Columbia Hsg Fin Mult (Park 7 Gp Llc Proj.) Series 2012, 1.98% 2/1/2046, LOC Freddie Mac Non Gold Pool VRDN (b)	2,040,000	2,040,000
Florida - 1.5%
Escambia Cnty FL Solid Wste (Florida Pwr & Lt Co Proj.) Series 2ND, 1.9% 4/1/2039 VRDN (b)	3,300,000	3,300,000
Escambia Cnty FL Solid Wste (Florida Pwr & Lt Co Proj.) Series FIRST 2009, 2.4% 4/1/2039 VRDN (b)	3,800,000	3,800,000
FL Pcr Power And Light (Florida Pwr & Lt Co Proj.) 2.45% 5/1/2029 VRDN (b)	2,500,000	2,500,000
Gainesville FL Utils Sys Rev Series 2019C, 3.03% 10/1/2047, LOC Bank of America NA VRDN (b)	14,300,000	14,300,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev (Baycare Health System Proj.) 3% 11/15/2054 (Liquidity Facility Royal Bank of Canada/New York NY) VRDN (b)	9,615,000	9,615,000
Palm Beach Cnty FL Rev (Raymond F Kravis Center For The Performing Arts Inc Proj.) 2% 7/1/2032, LOC Northern Trust CO Chicago VRDN (b)	3,110,000	3,110,000
TOTAL FLORIDA		36,625,000
Georgia - 2.3%
Burke Cnty GA Dev Auth Pcr (Georgia Power Co Proj.) 3.1% 7/1/2049 VRDN (b)	23,240,000	23,240,000
Burke Cnty GA Dev Auth Pcr (Georgia Power Co Proj.) Series 2018, 3.05% 11/1/2052 VRDN (b)	3,800,000	3,800,000
Coweta Cnty GA Dev Au Poll Ctl (Georgia Power Co Proj.) 3.2% 6/1/2032 VRDN (b)	1,000,000	1,000,000
Heard Cnty GA Dev Auth Poll Cont Rev (Georgia Power Co Proj.) 3.05% 9/1/2029 VRDN (b)	22,000,000	22,000,000
Monroe Cnty GA Dev Auth Pcr (Florida Pwr & Lt Co Proj.) Series 2010 1, 2.25% 6/1/2049 VRDN (b)	500,000	500,000
Monroe Cnty GA Dev Auth Pcr (Florida Pwr & Lt Co Proj.) Series FIRST 2002, 2.12% 9/1/2037 VRDN (b)	1,900,000	1,900,000
Monroe Cnty GA Dev Auth Pcr (Georgia Power Co Proj.) 3.2% 4/1/2032 VRDN (b)	4,000,000	4,000,000
TOTAL GEORGIA		56,440,000
Illinois - 2.4%
Illinois Dev Fin Auth Rev (Glenwood School For Boys, Il Proj.) 2.17% 2/1/2033, LOC Northern Trust CO Chicago VRDN (b)	700,000	700,000
Illinois Fin Auth Rev (University Of Chicago Hosps,Il Proj.) 2.85% 8/1/2043, LOC TD Bank NA VRDN (b)	7,650,000	7,650,000
Illinois Fin Auth Rev (University Of Chicago Hosps,Il Proj.) 2.85% 8/1/2044, LOC TD Bank NA VRDN (b)	7,130,000	7,130,000
Illinois Finance Authority Rev (Northwestern Memorial Hosp,Il Proj.) Series 2021D, 1.85% 7/15/2055 VRDN (b)	43,600,000	43,600,000
TOTAL ILLINOIS		59,080,000
Indiana - 2.1%
Indiana Fin Auth Health Sys Rev (Franciscan Alliance Proj.) 1.9% 9/1/2048, LOC Barclays Bank PLC VRDN (b)	3,700,000	3,700,000
Indiana Fin Auth Health Sys Rev (Franciscan Alliance Proj.) 3.05% 11/1/2037, LOC Barclays Bank PLC VRDN (b)	7,300,000	7,300,000
Indiana Fin Auth Health Sys Rev (Franciscan Alliance Proj.) 3.05% 11/1/2037, LOC Barclays Bank PLC VRDN (b)	3,070,000	3,070,000
Indiana Fin Auth Hosp Rev (Parkview Health System Proj.) 3% 11/1/2039, LOC TD Bank NA VRDN (b)	15,385,000	15,385,000
Indiana Mun Pwr Agy Pwr Supply Series 2019 B, 3% 1/1/2042, LOC Truist Bank VRDN (b)	8,100,000	8,100,000
Indiana St Fin Auth Environmental Rev (Arcelormittal Sa Luxembourg Proj.) 2.05% 6/1/2035, LOC Cooperatieve Rabobank UA/NY VRDN (b)	1,500,000	1,500,000
Indiana St Fin Auth Rev (Ascension Health Credit Group Proj.) 1.85% 11/15/2036 VRDN (b)	1,300,000	1,300,000
Indiana St Fin Auth Rev (Ascension Health Credit Group Proj.) 2.03% 11/15/2033 VRDN (b)	10,725,000	10,725,000
TOTAL INDIANA		51,080,000
Iowa - 1.3%
Iowa Fin Auth Health Facs Rev (Unitypoint Health Proj.) Series 2013B 2, 2.8% 2/15/2039, LOC TD Bank NA VRDN (b)	10,400,000	10,400,000
Iowa Fin Auth Pollutn Ctl Fac Rev (Midamerican Energy Co Proj.) Series 2016A, 2.1% 9/1/2036 VRDN (b)	7,600,000	7,600,000
Iowa Fin Auth Rev (Unitypoint Health Proj.) Series 2018 F, 2.8% 7/1/2041, LOC TD Bank NA VRDN (b)	14,510,000	14,510,000
TOTAL IOWA		32,510,000
Kansas - 1.8%
Burlington Kans Envr Imprv Rev (Evergy Kansas Metro Proj.) 2.4% 9/1/2035 VRDN (b)	4,200,000	4,200,000
Burlington Kans Envr Imprv Rev (Evergy Kansas Metro Proj.) 2.4% 9/1/2035 VRDN (b)	2,650,000	2,650,000
LA Cygne KS Pollution Ctl Rev (Evergy Kansas South Proj.) 2.5% 4/15/2027 VRDN (b)	3,040,000	3,040,000
St Marys Kans Pollutn Ctl Rev (Evergy Kansas Central Proj.) 2.5% 4/15/2032 VRDN (b)	11,600,000	11,600,000
St Marys Kans Pollutn Ctl Rev (Evergy Kansas South Proj.) 2.5% 4/15/2032 VRDN (b)	900,000	900,000
University Kansas Hosp Auth Hlth Fac Rev 3% 9/1/2034, LOC US Bank NA/Cincinnati OH VRDN (b)	15,885,000	15,885,000
Wamego Kansas Pcr (Evergy Kansas Central Proj.) 2.5% 4/15/2032 VRDN (b)	4,100,000	4,100,000
Wamego Kansas Pcr (Evergy Kansas South Proj.) 2.5% 4/15/2032 VRDN (b)	1,600,000	1,600,000
TOTAL KANSAS		43,975,000
Kentucky - 1.9%
Kentucky Bond Development Corp (Baptist Health Obligated Group Proj.) Series 2025 B, 3.1% 8/15/2055, LOC Truist Bank VRDN (b)	19,380,000	19,380,000
Louisville & Jefferson Cnty KY Metro Govt Health Sys Rev (Norton Healthcare Inc Proj.) Series 2023D, 3.1% 10/1/2053, LOC Truist Bank VRDN (b)	27,000,000	27,000,000
TOTAL KENTUCKY		46,380,000
Louisiana - 6.8%
East Baton Rouge Parish LA Inc Indl Dev Brd Rev (Exxon Capital Ventures Inc Proj.) 2.97% 8/1/2035 (Exxon Mobil Corp Guaranteed) VRDN (b)	59,260,000	59,260,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 1.9% 8/1/2050 VRDN (b)	10,400,000	10,400,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 2.03% 12/1/2039 VRDN (b)	24,850,000	24,850,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 2.97% 8/1/2043 VRDN (b)	30,000,000	30,000,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 3% 12/1/2043 VRDN (b)	20,100,000	20,100,000
Louisiana St Gas & Fuel Tax Rv 3% 5/1/2043, LOC Toronto-Dominion Bank/NY VRDN (b)	11,300,000	11,300,000
Louisiana St Gas & Fuel Tax Rv 3% 5/1/2043, LOC Toronto-Dominion Bank/NY VRDN (b)	2,500,000	2,500,000
St James Parish LA Rev (Nucor Corp Proj.) 2.18% 11/1/2040 VRDN (b)	1,075,000	1,075,000
St James Parish LA Rev (Nucor Corp Proj.) 2.3% 11/1/2040 VRDN (b)	3,200,000	3,200,000
TOTAL LOUISIANA		162,685,000
Maryland - 1.1%
Maryland Health & Higher Educational Facilities Authority (Johns Hopkins Health Sys Corp Proj.) 2.95% 6/1/2048, LOC TD Bank NA VRDN (b)	15,355,000	15,355,000
Maryland Health & Higher Educational Facilities Authority (Johns Hopkins Health Sys Corp Proj.) 2.95% 6/1/2048, LOC TD Bank NA VRDN (b)	7,875,000	7,875,000
Montgomery Cnty MD Hsg Oppt Rv 1.97% 1/1/2049, LOC TD Bank NA VRDN (b)	4,350,000	4,350,000
TOTAL MARYLAND		27,580,000
Massachusetts - 0.1%
Massachusetts Housing Finance Agency (Single Family Housing Proj.) Series 196, 1.95% 12/1/2048 (Liquidity Facility TD Bank NA) VRDN (b)	3,125,000	3,125,000
Michigan - 1.5%
Grand Traverse Cnty MI Hosp (Munson Healthcare Proj.) Series 2019C, 3% 7/1/2041, LOC PNC Bank NA VRDN (b)	5,800,000	5,800,000
Michigan St Strategic Fd Ltd Oblig Rev (Air Products & Chemicals Inc Proj.) 2.97% 12/1/2042 VRDN (b)	29,250,000	29,250,000
Michigan St Strategic Fd Ltd Oblig Rev (Kroger Co Proj.) 2.01% 1/1/2026, LOC Bank of Nova Scotia NY Brh VRDN (b)	700,000	700,000
TOTAL MICHIGAN		35,750,000
Minnesota - 0.5%
Minneapolis MN Health Care Sys Rev (Fairview Hsp & Hltcare Srv Sys Proj.) Series 2018 C, 3% 11/15/2048, LOC Bank of America NA VRDN (b)	12,100,000	12,100,000
Mississippi - 0.8%
Mississippi Business Fin Corp Miss Gulf Opportunity Zone Indl Dev Rev (Chevron Corp New Proj.) 3% 11/1/2035 VRDN (b)	1,475,000	1,475,000
Mississippi Business Fin Corp Miss Gulf Opportunity Zone Indl Dev Rev (Chevron Usa Inc Proj.) 2.95% 12/1/2030 (Chevron Corp Guaranteed) VRDN (b)	16,400,000	16,400,000
Mississippi Business Fin Corp Miss Gulf Opportunity Zone Indl Dev Rev (Chevron Usa Inc Proj.) 3% 12/1/2030 (Chevron Corp Guaranteed) VRDN (b)	1,320,000	1,320,000
TOTAL MISSISSIPPI		19,195,000
Nebraska - 0.5%
Nebraska Invt Fin Auth Sfh Rev (Ne Single Family Hsg Proj.) 1.8% 3/1/2049 (Liquidity Facility Federal Home Loan Bank of Topeka) VRDN (b)	3,165,000	3,165,000
Nebraska Invt Fin Auth Sfh Rev (Ne Single Family Hsg Proj.) Series 2019 C, 1.8% 9/1/2049 (Liquidity Facility Federal Home Loan Bank of Topeka) VRDN (b)	8,400,000	8,400,000
TOTAL NEBRASKA		11,565,000
New Hampshire - 0.3%
National Fin Auth NH Health Care Facs Rev (Novant Health Inc Proj.) Series 2024 B, 3% 11/1/2064, LOC Truist Bank VRDN (b)	4,600,000	4,600,000
National Fin Auth NH Health Care Facs Rev (Novant Health Inc Proj.) Series 2024 C, 2.07% 11/1/2064, LOC Truist Bank VRDN (b)	2,600,000	2,600,000
TOTAL NEW HAMPSHIRE		7,200,000
New York - 15.8%
City of New York NY Gen. Oblig. 3% 4/1/2036 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	16,505,000	16,505,000
City of New York NY Gen. Oblig. Series 2013 SUB A 2, 3% 10/1/2038 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (b)	8,925,000	8,925,000
City of New York NY Gen. Oblig. Series 2014 D 4, 3% 8/1/2040, LOC TD Bank NA VRDN (b)	3,950,000	3,950,000
City of New York NY Gen. Oblig. Series 2014 I 2, 3% 3/1/2040 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	8,900,000	8,900,000
City of New York NY Gen. Oblig. Series 2015 F 5, 3.05% 6/1/2044 (Liquidity Facility Barclays Bank PLC) VRDN (b)	6,830,000	6,830,000
City of New York NY Gen. Oblig. Series 2015 F6, 3% 6/1/2044 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	19,325,000	19,325,000
City of New York NY Gen. Oblig. Series 2017 A 7, 2.97% 8/1/2044 (Liquidity Facility BMO Bank NA) VRDN (b)	2,655,000	2,655,000
City of New York NY Gen. Oblig. Series B 4, 3.05% 10/1/2046 (Liquidity Facility Barclays Bank PLC) VRDN (b)	2,110,000	2,110,000
City of New York NY Gen. Oblig. Series B 5, 3.05% 10/1/2046 (Liquidity Facility Barclays Bank PLC) VRDN (b)	2,255,000	2,255,000
City of New York NY Gen. Oblig. Series FISCAL 2019 D 4, 3.05% 12/1/2047 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	15,345,000	15,345,000
City of New York NY Gen. Oblig. Series FISCAL 2023A SUB A 3, 3% 9/1/2049 (Liquidity Facility Bank of Montreal/Chicago IL) VRDN (b)	6,100,000	6,100,000
City of New York NY Gen. Oblig. Series FISCAL 2023A SUB A 4, 3% 9/1/2049 (Liquidity Facility Toronto Dominion Bank) VRDN (b)	1,600,000	1,600,000
City of New York NY Gen. Oblig. Series G 3, 3% 2/1/2055 (Liquidity Facility TD Bank NA) VRDN (b)	13,000,000	13,000,000
City of New York NY Series FISCAL 2017A SUB A4, 3% 8/1/2044 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	8,150,000	8,150,000
Metropolitan Transn Auth NY Rv Series 2005 E 1, 1.9% 11/15/2035, LOC Barclays Bank PLC VRDN (b)	1,225,000	1,225,000
Metropolitan Transn Auth NY Rv Series 2015 E 1, 3.05% 11/15/2045, LOC Barclays Bank PLC VRDN (b)	11,115,000	11,115,000
Metropolitan Transn Auth NY Rv Series SUB 2002D 2A 1, 3% 11/1/2032, LOC Truist Bank VRDN (b)	5,800,000	5,800,000
Metropolitan Transn Auth NY Rv Series SUB 2005D 1, 3% 11/1/2035, LOC Truist Bank VRDN (b)	2,900,000	2,900,000
Metropolitan Transn Auth NY Rv Series SUB 2012G 3, 3% 11/1/2031, LOC Royal Bank of Canada/New York NY VRDN (b)	17,555,000	17,555,000
New York NY City Transitional Fin Auth Rev 3% 8/1/2045 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	4,375,000	4,375,000
New York NY City Transitional Fin Auth Rev Series 2011 A 4, 3.05% 8/1/2039 (Liquidity Facility Barclays Bank PLC) VRDN (b)	6,115,000	6,115,000
New York NY City Transitional Fin Auth Rev Series 2013C 4, 3% 11/1/2036 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	9,000,000	9,000,000
New York NY City Transitional Fin Auth Rev Series 2014 B 3, 3.05% 11/1/2042 (Liquidity Facility Barclays Bank PLC) VRDN (b)	1,000,000	1,000,000
New York NY City Transitional Fin Auth Rev Series 2015 E 3, 3% 2/1/2045 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	21,555,000	21,555,000
New York NY City Transitional Fin Auth Rev Series 2015 E 4, 2.95% 2/1/2045 (Liquidity Facility Bank of America NA) VRDN (b)	6,700,000	6,700,000
New York NY City Transitional Fin Auth Rev Series 2016 E 4, 3% 2/1/2045 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	18,680,000	18,680,000
New York NY City Transitional Fin Auth Rev Series A 4, 3% 8/1/2043 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (b)	850,000	850,000
New York NY City Transitional Fin Auth Rev Series A-3, 2.96% 8/1/2043 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (b)	9,655,000	9,655,000
New York NY City Transitional Fin Auth Rev Series FISCAL 2019 C 4, 3.05% 11/1/2044 (Liquidity Facility Barclays Bank PLC) VRDN (b)	1,455,000	1,455,000
New York NY Cty Muni Wtr Fin Auth 3% 6/15/2043 (Liquidity Facility TD Bank NA) VRDN (b)	1,720,000	1,720,000
New York NY Cty Muni Wtr Fin Auth 3% 6/15/2044 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	9,400,000	9,400,000
New York NY Cty Muni Wtr Fin Auth Series 2014 AA 3, 3% 6/15/2049 (Liquidity Facility TD Bank NA) VRDN (b)	3,475,000	3,475,000
New York NY Cty Muni Wtr Fin Auth Series 2015 BB 2, 3.02% 6/15/2049 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (b)	15,800,000	15,800,000
New York NY Cty Muni Wtr Fin Auth Series AA 1, 3% 6/15/2050 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	10,965,000	10,965,000
New York NY Cty Muni Wtr Fin Auth Series AA 5, 3% 6/15/2048 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (b)	13,750,000	13,750,000
New York NY Cty Muni Wtr Fin Auth Series BB 1A, 3% 6/15/2049 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	19,485,000	19,485,000
New York NY Cty Muni Wtr Fin Auth Series BB 1B, 3% 6/15/2049 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	13,715,000	13,715,000
New York NY Cty Muni Wtr Fin Auth Series DD 2, 3% 6/15/2043 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (b)	3,335,000	3,335,000
New York NY Cty Muni Wtr Fin Auth Series FISCAL 2023 CC, 3.05% 6/15/2053 (Liquidity Facility Barclays Bank PLC) VRDN (b)	2,200,000	2,200,000
New York St Hsg Fin Agy Rev (Various Capital Projects) Series 2013A, 3% 11/1/2046, LOC Landesbank Hess-Thurngn (Ungtd) NY Br VRDN (b)	32,355,000	32,355,000
New York St Hsg Fin Agy Rev (Various Capital Projects) Series 2014A, 3% 11/1/2046, LOC Landesbank Hess-Thurngn (Ungtd) NY Br VRDN (b)	3,600,000	3,600,000
NY Mta Dedicated Tax Fund Series 2008A 1, 3% 11/1/2031, LOC TD Bank NA VRDN (b)	7,035,000	7,035,000
Triborough Brdg & Tunl NY Revs Series 2005 A, 1.9% 11/1/2041, LOC Barclays Bank PLC VRDN (b)	3,795,000	3,795,000
Triborough Brdg & Tunl NY Revs Series 2005B 4A, 3% 1/1/2032, LOC TD Bank NA VRDN (b)	3,700,000	3,700,000
TOTAL NEW YORK		377,960,000
North Carolina - 2.5%
Atrium Health (Carolinas Healthcare System Proj.) 3% 1/15/2044, LOC TD Bank NA VRDN (b)	30,830,000	30,830,000
Lower Cape Fear N C Wtr & Swr Auth Spl Fac Rev (Smithfield Foods Proj.) 2.06% 12/1/2034, LOC Cooperatieve Rabobank UA/NY VRDN (b)	1,100,000	1,100,000
North Carolina Housing Finance Agency (Nc Homeownership Proj.) Series 55 B, 3% 1/1/2050 (Liquidity Facility TD Bank NA) VRDN (b)	7,700,000	7,700,000
North Carolina Med Care Commn Health Care Facs Rev (Firsthealth Of Carolinas Proj.) Series 2017C, 3.1% 10/1/2039, LOC Truist Bank VRDN (b)	20,000,000	20,000,000
TOTAL NORTH CAROLINA		59,630,000
Ohio - 3.4%
Allen Cnty OH Hosp Facs Rev (Mercy Healthcare System Proj.) 3.05% 6/1/2034, LOC Truist Bank VRDN (b)	1,700,000	1,700,000
Cuyahoga Cnty OH Hlth Care Fac (The A.M. Mcgregor Home Proj.) Series 2014, 2.01% 5/1/2049, LOC Northern Trust CO Chicago VRDN (b)	1,765,000	1,765,000
Franklin Cnty OH Hosp Facs Rev (Ohiohealth Corporation Proj.) Series 2018 C, 1.85% 5/15/2053 VRDN (b)	9,875,000	9,875,000
Montgomery Cnty OH Hosp Rev (Premier Health Partners Proj.) Series 2019 C, 3.05% 11/15/2045, LOC PNC Bank NA VRDN (b)	19,835,000	19,835,000
Ohio St Higher Ed Fac Comm (Cleveland Clinic Foundtn (The) Proj.) 3% 1/1/2043 (Liquidity Facility Barclays Bank PLC) VRDN (b)	13,500,000	13,500,000
Ohio St Hosp Rev (University Hosp Hlth Sys, Oh Proj.) 3% 1/15/2046, LOC PNC Bank NA VRDN (b)	17,300,000	17,300,000
Ohio St Hsg Fin Agy Res Mtg Rev (Cleveland Clinic Foundtn (The) Proj.) Series 2019 D 1, 1.85% 1/1/2052 VRDN (b)	2,320,000	2,320,000
Ohio St Spl Oblig (Ohio St Proj.) Series 2022 B, 1.95% 12/1/2041 VRDN (b)	1,375,000	1,375,000
Ohio St Univ Gen Rcpts Series 2023 D1, 2.02% 12/1/2035 VRDN (b)	14,900,000	14,900,000
TOTAL OHIO		82,570,000
Oregon - 0.2%
Oregon St Facs Auth Rev (Peacehealth (Hlth Sys),Wa Proj.) Series 2018 B, 2.9% 8/1/2034, LOC TD Bank NA VRDN (b)	5,900,000	5,900,000
Pennsylvania - 3.8%
Lancaster PA Indl Dev Auth Rev (Willow Valley Retirement Communities Proj.) 2.05% 12/1/2039, LOC PNC Bank NA VRDN (b)	1,500,000	1,500,000
Montgomery Co PA Rdv Ath Mlfml (Kbf Associates Proj.) 2% 8/15/2031, LOC Fannie Mae VRDN (b)	700,000	700,000
Pennsylvania Higher Educational Facilities Authority (Thomas Jefferson Univ-Abiington Proj.) 3% 11/1/2061, LOC Truist Bank VRDN (b)	50,025,000	50,025,000
Pennsylvania Higher Educational Facilities Authority (Thomas Jefferson Univ-Abiington Proj.) Series 2024 D3, 3% 11/1/2061, LOC Truist Bank VRDN (b)	30,825,000	30,825,000
Philadelphia PA Au Ind Dev Revs (Franklin Institute (The) Proj.) 2.04% 6/1/2026, LOC Bank of America NA VRDN (b)	1,155,000	1,155,000
Philadelphia PA Gen. Oblig. 2.07% 8/1/2031, LOC Truist Bank VRDN (b)	5,000,000	5,000,000
TOTAL PENNSYLVANIA		89,205,000
South Carolina - 0.5%
South Carolina Jobs-Economic Dev Auth Hosp Rev (Prisma Health Proj.) Series 2018B, 3% 5/1/2048, LOC TD Bank NA VRDN (b)	1,000,000	1,000,000
South Carolina Jobs-Economic Dev Auth Hosp Rev (Prisma Health Proj.) Series 2018C, 3% 5/1/2048, LOC TD Bank NA VRDN (b)	12,055,000	12,055,000
TOTAL SOUTH CAROLINA		13,055,000
Tennessee - 0.5%
Clarksville TN Public Bldg Ath (Tennessee Muni Bond Fund Proj.) 3.03% 1/1/2033, LOC Bank of America NA VRDN (b)	120,000	120,000
Clarksville TN Public Bldg Ath (Tennessee Muni Bond Fund Proj.) 3.03% 11/1/2035, LOC Bank of America NA VRDN (b)	4,800,000	4,800,000
Clarksville TN Public Bldg Ath (Tennessee Muni Bond Fund Proj.) 3.03% 2/1/2038, LOC Bank of America NA VRDN (b)	6,275,000	6,275,000
Montgomery Cnty TN Pub Bldg Au 3% 4/1/2032, LOC Bank of America NA VRDN (b)	100,000	100,000
TOTAL TENNESSEE		11,295,000
Texas - 7.6%
Harris Cnty TX Cultural Ed Facs Fin Corp Rev (Methodist Healthcare Sys, Tx Proj.) Series 2020B, 3% 12/1/2059 VRDN (b)	31,715,000	31,715,000
Harris Cnty TX Health Facs Rev (Methodist Healthcare Sys, Tx Proj.) 3% 12/1/2041 VRDN (b)	7,760,000	7,760,000
Harris Cnty TX Health Facs Rev (Methodist Healthcare Sys, Tx Proj.) 3% 12/1/2041 VRDN (b)	7,605,000	7,605,000
Harris Cnty TX Hosp Dist Rev 2.02% 2/15/2042, LOC JPMorgan Chase Bank NA VRDN (b)	5,500,000	5,500,000
Houston TX Util Sys Rev 2% 5/15/2034, LOC Royal Bank of Canada/New York NY VRDN (b)	33,100,000	33,100,000
Lower Nchs Vly Ath TX Idcrp Re (Exxon Capital Ventures Inc Proj.) 3% 11/1/2029 (Exxon Mobil Corp Guaranteed) VRDN (b)	7,010,000	7,010,000
Lower Neches Valley Auth Tex (Exxon Capital Ventures Inc Proj.) 3% 11/1/2038 (Exxon Mobil Corp Guaranteed) VRDN (b)	9,660,000	9,660,000
Lower Neches Valley Auth Tex (Exxon Capital Ventures Inc Proj.) 3% 11/1/2051 (Exxon Mobil Corp Guaranteed) VRDN (b)	17,570,000	17,570,000
Lower Neches Valley Auth Tex (Exxon Capital Ventures Inc Proj.) 3% 5/1/2046 (Exxon Mobil Corp Guaranteed) VRDN (b)	22,485,000	22,485,000
Port Arthur TX Navigation District (Air Products Lp Proj.) 2.97% 5/1/2040 (Air Products and Chemicals Inc Guaranteed) VRDN (b)	4,000,000	4,000,000
Port Arthur TX Navigation District (Total Petrochemicals &Refining Sa/Nv Proj.) 1.8% 3/1/2042 (TotalEnergies SE Guaranteed) VRDN (b)	4,300,000	4,300,000
Tarrant Cnty TX Cultural Ed Facs Fin Corp Hosp Rev (Methodist Hospitals Of Dallas Proj.) 2.95% 10/1/2041, LOC TD Bank NA VRDN (b)	23,865,000	23,865,000
Texas State Gen. Oblig. 2.25% 6/1/2043 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	2,500,000	2,500,000
Texas State Gen. Oblig. 2.25% 6/1/2044 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	2,925,000	2,925,000
Texas State Gen. Oblig. 2.25% 6/1/2045 (Liquidity Facility State Street Bank & Trust Co) VRDN (b)	1,900,000	1,900,000
TOTAL TEXAS		181,895,000
Virginia - 3.5%
Roanoke VA Economic Dev Auth Hosp Rev (Carilion Health System Proj.) Series 2020C, 2.9% 7/1/2052, LOC TD Bank NA VRDN (b)	11,795,000	11,795,000
VA Small Business Fing Auth Hosp Rev (Carilion Health System Proj.) Series 2008 A, 3% 7/1/2042, LOC Truist Bank VRDN (b)	17,150,000	17,150,000
VA Small Business Fing Auth Hosp Rev (Carilion Health System Proj.) Series 2008 B, 3% 7/1/2042, LOC TD Bank NA VRDN (b)	5,915,000	5,915,000
Winchester VA Economic Dev Auth Rev (Valley Health Proj.) Series 2024B 1, 3.1% 1/1/2054, LOC Truist Bank VRDN (b)	11,500,000	11,500,000
Winchester VA Economic Dev Auth Rev (Valley Health Proj.) Series 2024B 2, 3.1% 1/1/2054, LOC Truist Bank VRDN (b)	36,715,000	36,715,000
TOTAL VIRGINIA		83,075,000
Washington - 0.1%
Washington St Hsg Fin Commn Multifamily Hsg Rev (Bitter Lake Village Associates Lp Proj.) 2% 12/15/2044, LOC Fannie Mae VRDN (b)	1,685,000	1,685,000
Washington St Hsg Fin Commn Multifamily Hsg Rev (Interurban Senior Living Associates Lp Proj.) 2.6% 7/1/2052, LOC Freddie Mac Non Gold Pool VRDN (b)	300,000	300,000
TOTAL WASHINGTON		1,985,000
West Virginia - 0.1%
West Virginia St Hosp Fin Auth Hosp Rev (Cabell-Huntington Hsp, Wv Proj.) 2.25% 1/1/2034, LOC Truist Bank VRDN (b)	1,890,000	1,890,000
Wisconsin - 0.3%
Wisconsin Health & Educational Facilities Authority (Marshfield Clinic Proj.) Series 2018 A, 3.05% 2/15/2050, LOC Barclays Bank PLC VRDN (b)	7,815,000	7,815,000
TOTAL VARIABLE RATE DEMAND NOTE (Cost $1,666,875,000)		1,666,875,000

TOTAL INVESTMENT IN SECURITIES - 96.5% (Cost $2,328,725,000)	2,328,725,000
NET OTHER ASSETS (LIABILITIES) - 3.5%	83,405,368
NET ASSETS - 100.0%	2,412,130,368

Security Type Abbreviations

VRDN

VARIABLE RATE DEMAND NOTE (A debt instrument that is payable upon demand, either daily, weekly or monthly)

The date shown for securities represents the date when principal payments must be paid, taking into account any call options exercised by the issuer and any permissible maturity shortening features other than interest rate resets.

Legend

(a)	Amount is stated in United States dollars unless otherwise noted.

(b)	Coupon rates for floating and adjustable rate securities reflect the rates in effect at period end.

(c)	Provides evidence of ownership in one or more underlying municipal bonds. Coupon rates are determined by re-marketing agents based on current market conditions.

Investment Valuation

The following is a summary of the inputs used, as of May 31, 2025, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Tender Option Bond	661,850,000	-	661,850,000	-

Variable Rate Demand Note	1,666,875,000	-	1,666,875,000	-
Total Investments in Securities:	2,328,725,000	-	2,328,725,000	-

Financial Statements

Statement of Assets and Liabilities
As of May 31, 2025
Assets
Investment in securities, at value - See accompanying schedule: Unaffiliated issuers (cost $2,328,725,000)			$	2,328,725,000
Cash				543
Receivable for investments sold				81,175,000
Interest receivable				7,770,192
Other receivables				8,780
Total assets				2,417,679,515
Liabilities
Payable for investments purchased	$	360,000
Distributions payable		5,180,814
Other payables and accrued expenses		8,333
Total liabilities				5,549,147
Net Assets			$	2,412,130,368
Net Assets consist of:
Paid in capital			$	2,412,124,355
Total accumulated earnings (loss)				6,013
Net Assets			$	2,412,130,368
Net Asset Value, offering price and redemption price per share ($2,412,130,368 ÷ 2,411,162,740 shares)			$	1.0004

Statement of Operations
Year ended May 31, 2025
Investment Income
Interest			$	51,033,447
Expenses
Custodian fees and expenses	$	24,117
Independent trustees' fees and expenses		4,462
Miscellaneous		2,212
Total expenses before reductions		30,791
Expense reductions		(13,990)
Total expenses after reductions				16,801
Net Investment income (loss)				51,016,646
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		20,930
Total net realized gain (loss)				20,930
Net increase in net assets resulting from operations			$	51,037,576

Statement of Changes in Net Assets

		Year ended May 31, 2025		Year ended May 31, 2024
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	51,016,646	$	51,425,760
Net realized gain (loss)		20,930		28,914
Change in net unrealized appreciation (depreciation)		-		(240)
Net increase in net assets resulting from operations		51,037,576		51,454,434
Distributions to shareholders		(51,016,329)		(51,451,691)

Affiliated share transactions
Proceeds from sales of shares		10,240,038,127		8,059,064,133
Cost of shares redeemed		(9,279,348,100)		(7,671,895,201)

Net increase (decrease) in net assets and shares resulting from share transactions		960,690,027		387,168,932
Total increase (decrease) in net assets		960,711,274		387,171,675

Net Assets
Beginning of period		1,451,419,094		1,064,247,419
End of period	$	2,412,130,368	$	1,451,419,094

Other Information
Shares
Sold		10,235,943,750		8,055,841,796
Redeemed		(9,275,637,845)		(7,668,827,670)
Net increase (decrease)		960,305,905		387,014,126

Financial Highlights

Fidelity® Tax-Free Cash Central Fund

Years ended May 31,		2025		2024		2023		2022		2021
Selected Per-Share Data
Net asset value, beginning of period	$	1.0004	$	1.0004	$	1.0003	$	1.0003	$	1.0002
Income from Investment Operations
Net investment income (loss) A		.0299		.0343		.0214		.0016		.0009
Net realized and unrealized gain (loss)		- B		- B		.0001		- B		.0002
Total from investment operations		.0299		.0343		.0215		.0016		.0011
Distributions from net investment income		(.0299)		(.0343)		(.0214)		(.0016)		(.0009)
Distributions from net realized gain		-		- B		- B		- B		- B
Total distributions		(.0299)		(.0343)		(.0214)		(.0016)		(.0010) C
Net asset value, end of period	$	1.0004	$	1.0004	$	1.0004	$	1.0003	$	1.0003
Total Return D		3.03 %		3.48%		2.17%		.16%		.10%
Ratios to Average Net Assets A,E,F
Expenses before reductions G		-%		-%		-%		-%		-%
Expenses net of fee waivers, if any G		- %		-%		-%		-%		-%
Expenses net of all reductions, if any G		-%		-%		-%		-%		-%
Net investment income (loss)		2.94%		3.40%		1.78%		.18%		.10%
Supplemental Data
Net assets, end of period (000 omitted)	$	2,412,130	$	1,451,419	$	1,064,247	$	2,017,931	$	1,145,228

ANet investment income (loss) is affected by the timing of the declaration of dividends by any underlying mutual funds or exchange-traded funds (ETFs). Net investment income (loss) of any mutual funds or ETFs is not included in the Fund's net investment income (loss) ratio.

BAmount represents less than $.00005 per share.

CTotal distributions per share do not sum due to rounding.

DTotal returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

EFees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses.

FExpense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

GAmount represents less than .005%.

Notes to Financial Statements

For the period ended May 31, 2025

1. Organization.

Fidelity Tax-Free Cash Central Fund (the Fund) is a fund of Fidelity Revere Street Trust (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Delaware statutory trust. Shares of the Fund are only offered to other investment companies and accounts (the Investing Funds) managed by Fidelity Management & Research Company LLC (FMR), or its affiliates. The Fund has been designated an institutional money market fund, and the value of the Fund's shares are calculated to four decimal places that fluctuates based upon changes in the value of the Fund's investments.

2. Significant Accounting Policies.

The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies. The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. The Fund operates as a single operating segment. The Fund's income, expenses, assets, and performance are regularly monitored and assessed as a whole by the investment adviser and other individuals responsible for oversight functions of the Trust, using the information presented in the financial statements and financial highlights. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The Fund's Schedule of Investments lists any underlying mutual funds or exchange-traded funds but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of the Fund:

Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Other short-term securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Securities held by a money market fund are generally high quality and liquid; however, they are reflected as Level 2 because the inputs used to determine fair value are not quoted prices in an active market.

The aggregate value of investments by input level as of May 31, 2025 is included at the end of the Fund's Schedule of Investments.

Investment Transactions and Income. Security transactions are accounted for as of trade date. Gains and losses on securities sold are determined on the basis of identified cost. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable.

Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of May 31, 2025, the Fund did not have any unrecognized tax benefits in the financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction.

Distributions are declared and recorded daily and paid monthly from net investment income. Distributions from realized gains, if any, are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, the Fund claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.

The Fund purchases municipal securities whose interest, in the opinion of the issuer, is free from federal income tax. There is no assurance that the IRS will agree with this opinion. In the event the IRS determines that the issuer does not comply with relevant tax requirements, interest payments from a security could become federally taxable, possibly retroactively to the date the security was issued.

As of period end, the cost and unrealized appreciation (depreciation) in securities for federal income tax purposes were as follows:

Gross unrealized appreciation	$-
Gross unrealized depreciation	-
Net unrealized appreciation (depreciation)	$-
Tax Cost	$2,328,725,000

The tax-based components of distributable earnings as of period end were as follows:

Undistributed tax-exempt income	$2,439
Undistributed ordinary income	$-
Undistributed long-term capital gain	$3,573
Net unrealized appreciation (depreciation) on securities and other investments	$-

The tax character of distributions paid was as follows:

	May 31, 2025	May 31, 2024
Tax-exempt Income	$51,016,329	$51,426,191
Long-term Capital Gains	-	25,500
Total	$51,016,329	$51,451,691

New Rule Issuance. In July 2023, the Securities and Exchange Commission issued a Final Rule relative to Money Market Reform. Among other things, the Final Rule includes amendments for: (1) Removal of redemption gates except for liquidations; (2) Required liquidity fees for institutional prime and institutional tax-exempt money market funds; (3) Discretionary liquidity fees for non-government money market funds; (4) Higher liquidity requirements; and (5) Changes to reporting requirements for Form N-MFP and Form N-CR. The Final Rule imposes different implementation dates for the amendments through October 2, 2024. The amendments have been implemented to date, and management has concluded that there are no material impacts to the Fund's financial statements and related disclosures.

New Accounting Pronouncements. FASB Accounting Standards Update (ASU) 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures became effective in this reporting period. ASU 2023-07 enhances segment information disclosure in the notes to financial statements.

In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures. Effective for annual periods beginning after December 15, 2024, the amendments require greater disaggregation of disclosures related to income taxes paid. The ASU allows for early adoption and amendments should be applied on a prospective basis. Management is currently evaluating the impact of the ASU but does not expect this guidance to materially impact the financial statements.

3. Fees and Other Transactions with Affiliates.

Management Fee and Expense Contract. Fidelity Management & Research Company LLC (the investment adviser) provides the Fund with investment management services. The Fund does not pay any fees for these services. Pursuant to the Fund's expense contract, the investment adviser also pays all other expenses of the Fund, excluding custody fees, the compensation of the independent Trustees, and certain miscellaneous expenses such as proxy and shareholder meeting expenses.

Interfund Trades. Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board of Trustees. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Interfund trades during the period are noted in the table below.

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Fidelity Tax-Free Cash Central Fund	1,107,988,000	978,245,000	-

4. Expense Reductions.

Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $13,990.

5. Other.

A fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the fund. In the normal course of business, a fund may also enter into contracts that provide general indemnifications. A fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against a fund. The risk of material loss from such claims is considered remote.

At the end of the period, mutual funds and accounts managed by the investment adviser or its affiliates were the owners of record of all of the outstanding shares of the Fund.

6. Risk and Uncertainties.

Many factors affect a fund's performance. Developments that disrupt global economies and financial markets, such as pandemics, epidemics, outbreaks of infectious diseases, war, terrorism, and environmental disasters, may significantly affect a fund's investment performance. The effects of these developments to a fund will be impacted by the types of securities in which a fund invests, the financial condition, industry, economic sector, and geographic location of an issuer, and a fund's level of investment in the securities of that issuer. Significant concentrations in security types, issuers, industries, sectors, and geographic locations may magnify the factors that affect a fund's performance.

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity Revere Street Trust and the Shareholders of Fidelity Tax-Free Cash Central Fund:

Opinion on the Financial Statements and Financial Highlights

We have audited the accompanying statement of assets and liabilities of Fidelity Tax-Free Cash Central Fund (the "Fund"), a fund of Fidelity Revere Street Trust, including the schedule of investments, as of May 31, 2025, the related statement of operations for the year then ended, the statement of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of May 31, 2025, and the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of May 31, 2025, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

July 16, 2025

We have served as the auditor of one or more of the Fidelity investment companies since 1999.

Distributions

(Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

The fund hereby designates as a capital gain dividend with respect to the taxable year ended May 31, 2025, $10,696 or, if subsequently determined to be different, the net capital gain of such year.

During fiscal year ended 2025, 100% of the fund's income dividends was free from federal income tax, and 0% of the fund's income dividends was subject to the federal alternative minimum tax.

The fund will notify shareholders in January 2026 of amounts for use in preparing 2025 income tax returns.

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 9: Proxy Disclosures for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

(Unaudited)

Note: This information is disclosed as part of the financial statements for each Fund as part of Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

(Unaudited)

Note: This is not applicable for any fund included in this document.

1.795174.121

TFC-ANN-0725

Fidelity® Securities Lending Cash Central Fund

Annual Report

May 31, 2025

Contents

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Securities Lending Cash Central Fund

Notes to Financial Statements

Report of Independent Registered Public Accounting Firm

Distributions

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

Item 9: Proxy Disclosures for Open-End Management Investment Companies

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Securities Lending Cash Central Fund

Schedule of Investments May 31, 2025

Showing Percentage of Net Assets

Repurchase Agreements - 78.6%
	Maturity Amount ($)	Value ($)
Repurchase Agreements* (Cost $24,585,000,000)	24,593,707,187	24,585,000,000

Time Deposits - 1.7%
	Yield (%) (b)	Principal Amount (a)	Value ($)
Canadian Imperial Bank of Commerce 4.33% 6/2/2025	4.33	115,000,000	115,000,000
Credit Agricole CIB 4.33% 6/2/2025	4.33	54,000,000	54,000,000
Mizuho Bank Ltd NY Branch 4.33% 6/2/2025	4.33	191,381,000	191,381,000
Royal Bank of Canada Toronto 4.33% 6/2/2025	4.33	180,000,000	180,000,000
TOTAL TIME DEPOSITS (Cost $540,381,000)			540,381,000

U.S. Treasury Obligations - 18.0%
	Yield (%) (b)	Principal Amount (a)	Value ($)
US Treasury Bills 0% 6/10/2025	4.26 to 4.27	500,000,000	499,529,445
US Treasury Bills 0% 6/12/2025	4.26	129,000,000	128,847,684
US Treasury Bills 0% 6/17/2025	4.26 to 4.30	705,500,000	704,252,147
US Treasury Bills 0% 6/20/2025	4.26	500,000,000	498,941,250
US Treasury Bills 0% 6/26/2025	4.27	600,000,000	598,308,498
US Treasury Bills 0% 6/3/2025	4.27	300,000,000	299,964,774
US Treasury Bills 0% 6/5/2025	4.26	500,000,000	499,822,875
US Treasury Bills 0% 7/10/2025	4.26	650,000,000	647,101,182
US Treasury Bills 0% 7/15/2025	4.26	530,900,000	528,223,967
US Treasury Bills 0% 7/22/2025	4.26	600,000,000	596,483,022
US Treasury Bills 0% 7/3/2025	4.26	640,000,000	637,675,411
TOTAL U.S. TREASURY OBLIGATIONS (Cost $5,638,443,690)			5,639,150,255

TOTAL INVESTMENT IN SECURITIES - 98.3% (Cost $30,763,824,690)	30,764,531,255
NET OTHER ASSETS (LIABILITIES) - 1.7%	522,477,121
NET ASSETS - 100.0%	31,287,008,376

Legend

(a)	Amount is stated in United States dollars unless otherwise noted.

(b)	Yield represents either the annualized yield at the date of purchase, or the stated coupon rate, or, for floating and adjustable rate securities, the rate at period end.

* Repurchase Agreements
Counterparty	Lending Rate (%)	Settlement Date	Maturity Date	Repurchase Agreement Value ($)	Repurchase Agreement Proceeds ($)	Collateralized By	Collateral Coupon (%)	Collateral Maturity Date	Collateral Value Received ($)
Federal Reserve Bank of NY	4.25	5/30/2025	6/2/2025	24,585,000,000	24,593,707,187	U.S. Treasuries (including strips)	1.13 - 2.38	5/15/2029 - 5/15/2031	24,593,707,228
Total Repurchase Agreements				$ 24,585,000,000	24,593,707,187				24,593,707,228

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Repurchase Agreements	24,585,000,000	-	24,585,000,000	-

Time Deposits	540,381,000	-	540,381,000	-

U.S. Treasury Obligations	5,639,150,255	-	5,639,150,255	-
Total Investments in Securities:	30,764,531,255	-	30,764,531,255	-

Financial Statements

Statement of Assets and Liabilities
As of May 31, 2025
Assets
Investment in securities, at value (including repurchase agreements of $24,585,000,000) - See accompanying schedule: Unaffiliated issuers (cost $30,763,824,690)			$	30,764,531,255
Cash				628,067,845
Interest receivable				7,369,636
Other receivables				180,405
Total assets				31,400,149,141
Liabilities
Payable for fund shares redeemed	$	1
Distributions payable		112,946,881
Other payables and accrued expenses		193,883
Total liabilities				113,140,765
Net Assets			$	31,287,008,376
Net Assets consist of:
Paid in capital			$	31,286,244,136
Total accumulated earnings (loss)				764,240
Net Assets			$	31,287,008,376
Net Asset Value, offering price and redemption price per share ($31,287,008,376 ÷ 31,283,313,302 shares)			$	1.0001

Statement of Operations
Year ended May 31, 2025
Investment Income
Interest			$	1,202,095,512
Expenses
Custodian fees and expenses	$	55,574
Independent trustees' fees and expenses		67,757
Total expenses				123,331
Net Investment income (loss)				1,201,972,181
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		622
Total net realized gain (loss)				622
Change in net unrealized appreciation (depreciation) on investment securities				(1,342,125)
Net gain (loss)				(1,341,503)
Net increase in net assets resulting from operations			$	1,200,630,678

Statement of Changes in Net Assets

		Year ended May 31, 2025		Year ended May 31, 2024
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	1,201,972,181	$	1,485,967,655
Net realized gain (loss)		622		-
Change in net unrealized appreciation (depreciation)		(1,342,125)		2,048,690
Net increase in net assets resulting from operations		1,200,630,678		1,488,016,345
Distributions to shareholders		(1,201,971,138)		(1,485,969,269)

Affiliated share transactions
Proceeds from sales of shares		266,875,936,872		251,956,608,298
Cost of shares redeemed		(260,485,422,267)		(255,921,026,410)

Net increase (decrease) in net assets and shares resulting from share transactions		6,390,514,605		(3,964,418,112)
Total increase (decrease) in net assets		6,389,174,145		(3,962,371,036)

Net Assets
Beginning of period		24,897,834,231		28,860,205,267
End of period	$	31,287,008,376	$	24,897,834,231

Other Information
Shares
Sold		266,849,251,947		251,931,415,157
Redeemed		(260,459,376,329)		(255,895,436,867)
Net increase (decrease)		6,389,875,618		(3,964,021,710)

Financial Highlights

Fidelity® Securities Lending Cash Central Fund

Years ended May 31,		2025		2024		2023		2022		2021
Selected Per-Share Data
Net asset value, beginning of period	$	1.0002	$	1.0001	$	1.0001	$	1.0001	$	1.0001
Income from Investment Operations
Net investment income (loss) A		.0476		.0536		.0354		.0016		.0009
Net realized and unrealized gain (loss)		(.0001)		.0001		- B		- B		- B
Total from investment operations		.0475		.0537		.0354		.0016		.0009
Distributions from net investment income		(.0476)		(.0536)		(.0354)		(.0016)		(.0009)
Total distributions		(.0476)		(.0536)		(.0354)		(.0016)		(.0009)
Net asset value, end of period	$	1.0001	$	1.0002	$	1.0001	$	1.0001	$	1.0001
Total Return C		4.85 %		5.51%		3.59%		.15%		.09%
Ratios to Average Net Assets A,D,E
Expenses before reductions F		-%		-%		-%		-%		-%
Expenses net of fee waivers, if any F		- %		-%		-%		-%		-%
Expenses net of all reductions, if any F		-%		-%		-%		-%		-%
Net investment income (loss)		4.74%		5.36%		3.46%		.16%		.09%
Supplemental Data
Net assets, end of period (000 omitted)	$	31,287,008	$	24,897,834	$	28,860,205	$	37,572,025	$	36,244,909

BAmount represents less than $.00005 per share.

CTotal returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

DFees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses.

EExpense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

FAmount represents less than .005%.

Notes to Financial Statements

For the period ended May 31, 2025

1. Organization.

Fidelity Securities Lending Cash Central Fund (the Fund) is a fund of Fidelity Revere Street Trust (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Delaware statutory trust. Shares of the Fund are only offered to other investment companies and accounts (the Investing Funds) managed by Fidelity Management & Research Company LLC (FMR), or its affiliates. The Fund has been designated an institutional money market fund, and the value of the Fund's shares are calculated to four decimal places that fluctuates based upon changes in the value of the Fund's investments.

2. Significant Accounting Policies.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. U.S. government and government agency obligations, certificates of deposit and other short-term securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Short-term securities with remaining maturities of sixty days or less may be valued at amortized cost, which approximates fair value, and are categorized as Level 2 in the hierarchy.

The aggregate value of investments by input level as of May 31, 2025 is included at the end of the Fund's Schedule of Investments.

Investment Transactions and Income. Security transactions are accounted for as of trade date. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable.

Deferred Trustee Compensation. Under a Deferred Compensation Plan (the Plan) for certain Funds, certain independent Trustees have elected to defer receipt of a portion of their annual compensation. Deferred amounts are invested in affiliated mutual funds, are marked-to-market and remain in a fund until distributed in accordance with the Plan. The investment of deferred amounts and the offsetting payable to the Trustees presented below are included in the accompanying Statement of Assets and Liabilities in other receivables and other payables and accrued expenses, as applicable.

Fidelity Securities Lending Cash Central Fund

$180,405

As of period end, the cost and unrealized appreciation (depreciation) in securities for federal income tax purposes were as follows:

Gross unrealized appreciation	$706,565
Gross unrealized depreciation	-
Net unrealized appreciation (depreciation)	$706,565
Tax Cost	$30,763,824,690

The tax-based components of distributable earnings as of period end were as follows:

Undistributed ordinary income	$57,675
Net unrealized appreciation (depreciation) on securities and other investments	$706,565

The tax character of distributions paid was as follows:

	May 31, 2025	May 31, 2024
Ordinary Income	$1,201,971,138	$1,485,969,269

Repurchase Agreements. Pursuant to an Exemptive Order issued by the Securities and Exchange Commission, funds and other registered investment companies having management contracts with Fidelity Management and Research Company LLC, or its affiliates are permitted to transfer uninvested cash balances into joint trading accounts which are then invested in repurchase agreements. Funds may also invest directly with institutions in repurchase agreements. Repurchase agreements may be collateralized by government or non-government securities. Upon settlement date, collateral is held in segregated accounts with custodian banks and may be obtained in the event of a default of the counterparty. The collateral balance is monitored on a daily basis to ensure it is at least equal to the principal amount of the repurchase agreement (including accrued interest). In the event of a default by the counterparty, realization of the collateral proceeds could be delayed, during which time the value of the collateral may decline.

3. Fees and Other Transactions with Affiliates.

4. Other.

At the end of the period, mutual funds managed by the investment adviser or its affiliates were the owners of record of all of the outstanding shares of the Fund.

5. Risk and Uncertainties.

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity Revere Street Trust and Shareholders of Fidelity Securities Lending Cash Central Fund

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Fidelity Securities Lending Cash Central Fund (one of the funds constituting Fidelity Revere Street Trust, referred to hereafter as the "Fund") as of May 31, 2025, the related statement of operations for the year ended May 31, 2025, the statement of changes in net assets for each of the two years in the period ended May 31, 2025, including the related notes, and the financial highlights for each of the five years in the period ended May 31, 2025 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of May 31, 2025, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended May 31, 2025 and the financial highlights for each of the five years in the period ended May 31, 2025 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission.

We conducted our audits of these financial statements in accordance with the auditing standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of May 31, 2025 by correspondence with the custodian and brokers. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

July 15, 2025

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

Distributions

(Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

A total of 13.75% of the dividends distributed during the fiscal year was derived from interest on U.S. Government securities which is generally exempt from state income tax.

The fund designates $1,329,357,360 of distributions paid in the calendar year 2024 as qualifying to be taxed as interest-related dividends for nonresident alien shareholders.

The fund designates $1,201,971,138 of distributions paid during the fiscal year ended 2025 as qualifying to be taxed as section 163(j) interest dividends.

The fund will notify shareholders in January 2026 of amounts for use in preparing 2025 income tax returns.

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 9: Proxy Disclosures for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

(Unaudited)

Note: This information is disclosed as part of the financial statements for each Fund as part of Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

(Unaudited)

Note: This is not applicable for any fund included in this document.

1.734009.126

CCC-ANN-0725

Fidelity® Municipal Cash Central Fund

Annual Report

May 31, 2025

Contents

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Municipal Cash Central Fund

Notes to Financial Statements

Report of Independent Registered Public Accounting Firm

Distributions

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

Item 9: Proxy Disclosures for Open-End Management Investment Companies

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Municipal Cash Central Fund

Schedule of Investments May 31, 2025

Showing Percentage of Net Assets

Tender Option Bond - 28.9%
	Principal Amount (a)	Value ($)
Alabama - 1.2%
Alabama Infirmary Health Rev Participating VRDN Series 5065, 2% 2/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	6,400,000	6,400,000
Alabama Southeast Energy Participating VRDN Series 2025 XF1800, 3.15% 1/1/2056 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	9,920,000	9,920,000
Alabama Southeast Energy Participating VRDN Series 2025 XM1202, 3.15% 1/1/2056 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	8,330,000	8,330,000
Black Belt Energy Gas District Participating VRDN 2.02% 10/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,000,000	2,000,000
Black Belt Energy Gas District Participating VRDN Series 2023 XM1126, 3.15% 6/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	6,670,000	6,670,000
Black Belt Energy Gas District Participating VRDN Series 2023 XM1127, 3.15% 6/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,870,000	3,870,000
Black Belt Energy Gas District Participating VRDN Series 2023 XM1144, 2.02% 1/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	6,250,000	6,250,000
Black Belt Energy Gas District Participating VRDN Series 2024 XM1190, 2.02% 5/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	500,000	500,000
Black Belt Energy Gas District Participating VRDN Series 2025 XM1233, 2.02% 3/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	500,000	500,000
East Alabama Health Care Auth Participating VRDN Series 2025 BAML5061, 3.14% 9/1/2054 (Liquidity Facility Bank of America, N.A.) (b)(c)	4,600,000	4,600,000
Jefferson County Swr Rev Participating VRDN Series 2024 XL0531, 2.01% 10/1/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,400,000	2,400,000
TOTAL ALABAMA		51,440,000
Alaska - 0.1%
Anchorage AK Port Participating VRDN 2.03% 2/1/2060 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,725,000	2,725,000
Alaska,Illinois - 0.1%
Chicago O'Hare Int'l Arpt Rev Participating VRDN Series 2025 ZF1923, 2.02% 1/1/2059 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,500,000	2,500,000
Arizona - 0.2%
Arizona Health Facilities Auth Rev Participating VRDN Series 2022 MIZ9101, 2.17% 3/1/2029 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	1,552,000	1,552,000
Arizona Health Facs Auth Rev Participating VRDN Series 3384, 2% 1/1/2037 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	3,255,000	3,255,000
Arizona Indl Dev Auth Hosp Rev Participating VRDN Series 2022 XM1013, 3.17% 2/1/2050 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	1,270,000	1,270,000
Mesa AZ Util Sys Rev Participating VRDN 2.02% 7/1/2046 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	1,100,000	1,100,000
Phoenix Civic Impt Board Arpt Rev Participating VRDN 2.02% 7/1/2049 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	2,750,000	2,750,000
TOTAL ARIZONA		9,927,000
California - 0.6%
Los Angeles CA Dept Arpts Rev Participating VRDN Series 2022 XF1373, 2.02% 5/15/2044 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	800,000	800,000
San Diego Cnty CA Reg Arpt Auth Arpt Rev Participating VRDN Series 2025 XX1390, 3.05% 7/1/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	24,000,000	24,000,000
TOTAL CALIFORNIA		24,800,000
Colorado - 0.9%
Denver City & County Arpt Rev Participating VRDN Series 2018 XG0196, 2.05% 12/1/2048 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	10,680,000	10,680,000
Denver City & County Arpt Rev Participating VRDN Series 2023 XF1513, 2.05% 12/1/2048 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	7,420,000	7,420,000
Denver CO City & Cnty Arpt Participating VRDN 2.02% 11/15/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	7,075,000	7,075,000
Denver CO City & Cnty Arpt Participating VRDN Series 2023 ZF3204, 2.02% 11/15/2053 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)(d)	2,120,000	2,120,000
Denver CO Cty & Cnty Sch Dis 1 Participating VRDN Series 2025 XG0603, 2% 12/1/2049 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	5,000,000	5,000,000
Regional Transn Dist CO Sales Participating VRDN Series 2025 CF7024, 2% 11/1/2033 (Liquidity Facility Citibank NA) (b)(c)	3,600,000	3,600,000
TOTAL COLORADO		35,895,000
Connecticut - 0.3%
Connecticut Gen. Oblig. Participating VRDN Series 2017 016, 2.01% 6/1/2037 (Liquidity Facility Barclays Bank PLC) (b)(c)	3,300,000	3,300,000
Connecticut Gen. Oblig. Participating VRDN Series 2017 014, 2.01% 6/1/2037 (Liquidity Facility Barclays Bank PLC) (b)(c)	9,955,000	9,955,000
TOTAL CONNECTICUT		13,255,000
District Of Columbia - 0.2%
District Columbia Gen. Oblig. Participating VRDN 3.05% 1/1/2048 (Liquidity Facility UBS AG) (b)(c)	5,520,000	5,520,000
District Columbia Income Tax Rev Participating VRDN Series 2025 XF1919, 3.1% 5/1/2048 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,750,000	3,750,000
TOTAL DISTRICT OF COLUMBIA		9,270,000
Florida - 5.9%
Assured Guaranty Muni Corp Participating VRDN Series 2024 XM1183, 2.03% 10/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	3,100,000	3,100,000
Broward Cnty Fla Convention Ctr Hotel Rev Participating VRDN 3.17% 1/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,700,000	4,700,000
Broward Cnty Fla Convention Ctr Hotel Rev Participating VRDN Series 2023 XF1641, 2.07% 1/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,100,000	2,100,000
County of Broward FL Tourist Development Tax Revenue Participating VRDN Series 2023 XL0429, 2.08% 9/1/2051 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	700,000	700,000
Escambia County Health Facs Auth Participating VRDN 3.08% 8/15/2036 (Liquidity Facility Bank of America, N.A.) (b)(c)	43,150,000	43,150,000
Florida Dev Fin Corp Healthcare Facility Rev Participating VRDN 3.08% 2/1/2045 (Liquidity Facility Bank of America, N.A.) (b)(c)	34,615,000	34,615,000
Florida Dev Fin Corp Rev Participating VRDN 2.02% 7/1/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	4,500,000	4,500,000
Florida Dev Fin Corp Rev Participating VRDN Series 2024 XF1704, 2.02% 7/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	13,955,000	13,955,000
Greater Orlando Aviation Auth Arpt Facs Rev Participating VRDN Series 2023 XF1519, 2.05% 10/1/2052 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	3,750,000	3,750,000
Greater Orlando Aviation Auth Participating VRDN 2.05% 10/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	1,635,000	1,635,000
Greater Orlando Aviation Auth Participating VRDN 2.07% 10/1/2049 (Liquidity Facility Bank of America, N.A.) (b)(c)(d)	2,100,000	2,100,000
Greater Orlando Aviation Auth Participating VRDN 3.18% 10/1/2044 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	8,755,000	8,755,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN 2% 11/15/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	5,000,000	5,000,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN 2% 11/15/2054 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	1,700,000	1,700,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN Series 2024 XF3239, 2% 11/15/2054 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	3,185,000	3,185,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev Participating VRDN Series 2025 XM1229, 2% 11/15/2054 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	2,100,000	2,100,000
Hillsborough County Aviation Auth Rev Participating VRDN Series 2023 XF1610, 2.02% 10/1/2048 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	5,455,000	5,455,000
Hillsborough County Aviation Auth Rev Participating VRDN Series 2023 XF1637, 2.03% 10/1/2048 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	3,400,000	3,400,000
Jacksonville Fla Spl Rev Participating VRDN Series 2025 XL0618, 3.1% 10/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,700,000	4,700,000
JEA FL Wtr & Swr Sys Rev Participating VRDN 2% 10/1/2049 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	4,115,000	4,115,000
JEA FL Wtr & Swr Sys Rev Participating VRDN Series 2025 XF1845, 3.1% 10/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,540,000	4,540,000
JEA FL Wtr & Swr Sys Rev Participating VRDN Series 2025 XL0596, 3.1% 10/1/2055 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,400,000	3,400,000
Lee County Arpt Rev Participating VRDN Series 2021 XF1126, 2.05% 10/1/2051 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	3,195,000	3,195,000
Lee County Arpt Rev Participating VRDN Series 2023 XF1523, 2.03% 10/1/2051 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,440,000	2,440,000
Lee County Arpt Rev Participating VRDN Series 2025 XF1849, 2.01% 10/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	3,425,000	3,425,000
Miami-Dade Cnty FL Sch Dist Participating VRDN Series 2025 CF7023, 2.02% 3/15/2047 (Liquidity Facility Citibank NA) (b)(c)	3,600,000	3,600,000
Miami-Dade County Aviation Rev Participating VRDN Series 2025 XG0614, 2.01% 10/1/2049 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	1,360,000	1,360,000
Miami-Dade County Participating VRDN 2.05% 10/1/2052 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	2,815,000	2,815,000
Miami-Dade County Participating VRDN Series 2023 XF1159, 2.05% 10/1/2052 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	705,000	705,000
Miami-Dade FL The Villages Apts Participating VRDN Series 2024 MIZ9196, 3.17% 5/14/2036 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	13,690,000	13,690,000
North Broward Hosp District Rev Participating VRDN Series 2023 BAML5048, 3.08% 1/1/2038 (Liquidity Facility Bank of America, N.A.) (b)(c)	11,340,000	11,340,000
Palm Beach Cnty Fla Health Facs Auth Hosp Rev Participating VRDN Series 2022 XG0370, 2.07% 8/15/2049 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,300,000	1,300,000
South Miami FL Hlth Fcs Hsp Rv Participating VRDN 2.04% 8/15/2036 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,000,000	2,000,000
South Miami FL Hlth Fcs Hsp Rv Participating VRDN Series 2018 XG0173, 2.07% 8/15/2047 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	1,400,000	1,400,000
Volusia County FL Deltona Med Center Participating VRDN Series 5078, 3.1% 12/15/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	37,200,000	37,200,000
TOTAL FLORIDA		245,125,000
Georgia - 0.5%
Brookhaven Development Authority Participating VRDN Series 2023 XF1503, 3.1% 7/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	7,130,000	7,130,000
Burke County Indl Dev Auth Poll Cont Rev Participating VRDN 2.02% 11/1/2045 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	4,000,000	4,000,000
Columbia County Hosp Auth Rev Participating VRDN Series 2023 XF1640, 2.01% 4/1/2053 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	3,650,000	3,650,000
Georgia Muni Elec Auth Pwr Rev Participating VRDN Series 2023 XF1554, 2.01% 1/1/2059 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	2,080,000	2,080,000
Main Street Natural Gas Inc Participating VRDN 3.12% 12/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,750,000	3,750,000
Main Street Natural Gas Inc Participating VRDN Series 2024 XM1187, 2.02% 6/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	500,000	500,000
TOTAL GEORGIA		21,110,000
Hawaii - 0.2%
Hawaii Arpts Sys Rev Participating VRDN Series 2022 XX1217, 2.01% 7/1/2051 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	7,700,000	7,700,000
Hawaii Dpt Bg & Fin Spl Pur Rev Participating VRDN Series 2025 XM1242, 2.05% 7/1/2052 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	2,400,000	2,400,000
TOTAL HAWAII		10,100,000
Illinois - 1.1%
Chicago Board of Ed Participating VRDN Series 2023 XG0469, 2.03% 4/1/2048 (Liquidity Facility Bank of America, N.A.) (b)(c)	3,255,000	3,255,000
Chicago IL Gen. Oblig. Participating VRDN 2.01% 11/27/2028 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	10,700,000	10,700,000
Chicago O'Hare Int'l Arpt Rev Participating VRDN 2.03% 1/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,810,000	2,810,000
Chicago O'Hare Int'l Arpt Rev Participating VRDN Series 2018 XF0723, 2.01% 1/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	8,795,000	8,795,000
Chicago Transit Auth Participating VRDN Series 2020 XL0145, 2.01% 12/1/2057 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,830,000	1,830,000
Illinois Fin Auth Participating VRDN Series 2023 YX1326, 2.01% 11/15/2039 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,175,000	1,175,000
Illinois Gen. Oblig. Participating VRDN Series 2023 XF3111, 2% 5/1/2047 (Liquidity Facility Barclays Bank PLC) (b)(c)	5,700,000	5,700,000
Metropolitan Pier & Exposition Participating VRDN Series 2015 XF1045, 2.01% 6/15/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)	800,000	800,000
Pittsburg WTSW Participating VRDN 3.13% 11/15/2046 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	12,100,000	12,100,000
TOTAL ILLINOIS		47,165,000
Illinois,Utah - 0.1%
Chicago O'Hare Int'l Arpt Rev Participating VRDN Series 2023 XG0538, 2.03% 1/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,810,000	2,810,000
Indiana - 0.3%
Indian Fin Auth Univ Hlth Participating VRDN Series E 161, 2% 10/1/2064 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	10,700,000	10,700,000
Iowa - 0.0%
State of Iowa Board of Regents Participating VRDN 2% 9/1/2050 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,100,000	1,100,000
Kentucky - 0.0%
CommonSpirit Health Participating VRDN Series 2020 MIZ9021, 2.07% 5/1/2029 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	700,000	700,000
Kentucky Inc Pub Energy Participating VRDN Series 2024 XM1189, 2.02% 8/1/2052 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	500,000	500,000
Kentucky Inc Pub Energy Participating VRDN Series 2024 XM1188, 2.02% 5/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	500,000	500,000
TOTAL KENTUCKY		1,700,000
Louisiana - 2.8%
LA Calcasieu River Bridge Participating VRDN Series 2025 XF3348, 2.01% 9/1/2066 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	3,500,000	3,500,000
Louisiana Pub Facilities Auth Hosp Rev Participating VRDN Series 2023 BAML5041, 3.08% 12/1/2052 (Liquidity Facility Bank of America, N.A.) (b)(c)	108,655,000	108,655,000
New Orleans Aviation Board Rev Participating VRDN Series 2023 XF3148, 2.02% 1/1/2048 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	3,000,000	3,000,000
TOTAL LOUISIANA		115,155,000
Maryland - 0.0%
Tender Opt Bd Tr Rcpts / Ctfs Var Sts Participating VRDN Series 2025 XG0607, 2.01% 8/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,020,000	2,020,000
Massachusetts - 0.1%
Massachusetts St Gen. Oblig. Participating VRDN Series 2025 XF1904, 3.05% 5/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	5,330,000	5,330,000
Michigan - 1.2%
Eastern Michigan Univ Revs Participating VRDN 3.08% 3/1/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)	41,390,000	41,390,000
Gerald R Ford Intl Arpt Auth Mich Rev Participating VRDN 2.05% 1/1/2054 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	1,700,000	1,700,000
Michigan Fin Auth Act 38 Facs Participating VRDN Series 2024 XF1705, 2% 2/28/2057 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,400,000	4,400,000
Michigan Hsg Dev Auth Rent Hsg Rev Participating VRDN 3.08% 12/1/2045 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,600,000	4,600,000
TOTAL MICHIGAN		52,090,000
Minnesota - 0.1%
Duluth Econ Dev Auth Health Care Facs Rev Participating VRDN Series 2023 XG0523, 2.01% 2/15/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)	3,060,000	3,060,000
Missouri - 0.5%
Kansas City Indl Dev Auth Participating VRDN Series 2022 XG0396, 2.05% 3/1/2057 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	6,055,000	6,055,000
Kansas City Indl Dev Auth Participating VRDN Series 2023 XG0479, 2.05% 3/1/2055 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	2,945,000	2,945,000
Kansas City Spl Oblig Participating VRDN Series 2022 YX1193, 2.01% 9/1/2042 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,200,000	1,200,000
Missouri Health & Edl Facs Rev Participating VRDN Series C 23, 2.01% 6/1/2045 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	5,700,000	5,700,000
Missouri Hlth Facs Auth Rev Participating VRDN Series 5066, 2% 6/1/2045 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	5,500,000	5,500,000
Montana Hlth Facs Auth Rev Participating VRDN 2% 11/15/2043 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,100,000	1,100,000
TOTAL MISSOURI		22,500,000
Nebraska - 0.1%
Central Plains Energy Proj Rev Participating VRDN Series 2022 ZL0301, 2.02% 5/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	140,000	140,000
Nebraska Invt Fin Auth Sfh Rev Participating VRDN Series 2024 XL0563, 2% 9/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,000,000	2,000,000
Nebraska Invt Fin Auth Sfh Rev Participating VRDN Series 2024 YX1335, 2% 9/1/2054 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,910,000	1,910,000
TOTAL NEBRASKA		4,050,000
Nevada - 0.0%
Clark Cnty NV School Dist Participating VRDN Series 2023 XF1473, 2.09% 6/15/2042 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	1,490,000	1,490,000
New Jersey - 0.2%
New Jersey Trans Trust Fund Auth Participating VRDN 2% 6/15/2046 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,300,000	2,300,000
New Jersey Trans Trust Fund Auth Participating VRDN 2.01% 6/15/2050 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	2,170,000	2,170,000
New Jersey Turnpike Authority Participating VRDN 2.02% 1/1/2052 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,600,000	3,600,000
TOTAL NEW JERSEY		8,070,000
New Jersey,New York - 0.0%
Port Auth NY & NJ Participating VRDN Series 2022 023, 3.08% 11/15/2035 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	1,900,000	1,900,000
New York - 1.6%
City of New York NY Gen. Oblig. Participating VRDN Series 2025 XL0612, 3.1% 2/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,300,000	3,300,000
City of New York NY Gen. Oblig. Participating VRDN Series 2025 XL0620, 3.1% 2/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,750,000	3,750,000
Nassau Cnty NY Gen. Oblig. Participating VRDN Series 2024 XL0555, 3% 4/1/2054 (Liquidity Facility UBS AG) (b)(c)	6,970,000	6,970,000
New York City Gen. Oblig. Participating VRDN 3.1% 3/1/2048 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	9,850,000	9,850,000
New York City Muni Wtr Fin Auth Wtr & Swr Sys Rev Participating VRDN Series E 125, 3.1% 6/15/2048 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	8,600,000	8,600,000
New York City Transitional Finance Authority Participating VRDN 3% 5/1/2054 (Liquidity Facility UBS AG) (b)(c)	3,595,000	3,595,000
New York City Transitional Finance Authority Participating VRDN Series 2025 XX1380, 3.05% 2/1/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)	2,810,000	2,810,000
New York NY Cty Muni Wtr Fin Auth Participating VRDN Series 2025 XF1891, 3.1% 6/15/2051 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,000,000	4,000,000
New York NY Cty Muni Wtr Fin Auth Participating VRDN Series 2025 XF1894, 3.1% 6/15/2050 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,750,000	3,750,000
New York Trans Dev Corp Participating VRDN 2.07% 11/17/2029 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	6,750,000	6,750,000
New York Trans Dev Corp Participating VRDN Series 2024 XG0590, 3.08% 12/31/2054 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	5,095,000	5,095,000
Triborough Brdg & Tunl NY Revs Participating VRDN Series 2022 009, 3.05% 11/15/2042 (Liquidity Facility Barclays Bank PLC) (b)(c)	10,000,000	10,000,000
TOTAL NEW YORK		68,470,000
North Carolina - 0.1%
Charlotte NC Arpt Rev Participating VRDN 2.06% 7/1/2053 (Liquidity Facility Bank of America, N.A.) (b)(c)(d)	130,000	130,000
Charlotte NC Arpt Rev Participating VRDN Series 2023 XG0451, 2.05% 7/1/2051 (Liquidity Facility Wells Fargo Bank NA) (b)(c)(d)	2,000,000	2,000,000
Greater Asheville Reg'l Arpt Auth Participating VRDN Series 2022 XM1011, 2.03% 7/1/2052 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,700,000	2,700,000
TOTAL NORTH CAROLINA		4,830,000
North Dakota - 0.1%
Grand Forks Health Care Sys Rev Participating VRDN Series 2023 XF1602, 2.01% 12/1/2053 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	4,565,000	4,565,000
Ohio - 0.8%
Columbus OH Arpt Rev Participating VRDN 2.01% 1/1/2050 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	3,000,000	3,000,000
Columbus OH Arpt Rev Participating VRDN 2.01% 1/1/2055 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	535,000	535,000
Columbus OH Arpt Rev Participating VRDN 2.01% 1/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	3,700,000	3,700,000
Columbus OH Arpt Rev Participating VRDN Series 2025 YX1373, 2.01% 1/1/2045 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	4,125,000	4,125,000
Columbus OH Arpt Rev Participating VRDN Series 2025 ZF1835, 2.01% 1/1/2050 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	4,000,000	4,000,000
CommonSpirit Health Participating VRDN Series 2020 MIZ9020, 2.07% 5/1/2039 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	1,900,000	1,900,000
Middletown Hosp Facilities Rev Participating VRDN Series 2024 BAML5056, 3.08% 11/15/2054 (Liquidity Facility Bank of America, N.A.) (b)(c)	12,570,000	12,570,000
Montgomery County Hosp Rev Participating VRDN 2.01% 11/15/2045 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,300,000	1,300,000
Ohio Hosp Rev Participating VRDN Series C 18, 2.01% 1/15/2041 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,800,000	1,800,000
Ohio Housing Finance Agency Participating VRDN Series 2024 XF1762, 2% 9/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	1,585,000	1,585,000
TOTAL OHIO		34,515,000
Oregon - 0.5%
Multinomah OR Adventist Health Participating VRDN 2% 3/1/2040 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,200,000	2,200,000
Port of Portland Arpt Rev Participating VRDN 2.07% 7/1/2045 (Liquidity Facility Wells Fargo Bank NA) (b)(c)(d)	1,580,000	1,580,000
Port of Portland Arpt Rev Participating VRDN Series 2024 XF1741, 2.07% 7/1/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	1,330,000	1,330,000
Port of Portland Arpt Rev Participating VRDN Series 2024 ZF3262, 2.07% 7/1/2048 (Liquidity Facility Wells Fargo Bank NA) (b)(c)(d)	700,000	700,000
Port of Portland Arpt Rev Participating VRDN Series 2025 XF1869, 2.05% 7/1/2052 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	3,865,000	3,865,000
Port of Portland Arpt Rev Participating VRDN Series 2025 XF1873, 2.03% 7/1/2049 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	1,500,000	1,500,000
Port of Portland Arpt Rev Participating VRDN Series 2025 XF1896, 3.2% 7/1/2052 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	4,000,000	4,000,000
Portland OR Swr Sys Rev Participating VRDN Series 2025 XG0600, 2% 10/1/2054 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,535,000	1,535,000
Portland OR Swr Sys Rev Participating VRDN Series 2025 ZF3339, 2% 12/1/2047 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	4,015,000	4,015,000
TOTAL OREGON		20,725,000
Pennsylvania - 2.2%
Allegheny County Arpt Auth Rev Participating VRDN 2.03% 1/1/2056 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	6,190,000	6,190,000
Allegheny County Arpt Auth Rev Participating VRDN Series 2025 XF1911, 2.01% 1/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,275,000	2,275,000
Commonwealth Fing Auth Tobacco Participating VRDN Series 2018 XX1080, 2.01% 6/1/2035 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,530,000	4,530,000
Lehigh County Gen Purp Hosp Rev Participating VRDN 3.08% 7/1/2033 (Liquidity Facility Bank of America, N.A.) (b)(c)	1,640,000	1,640,000
Monroeville Fin Auth UPMC Rev Participating VRDN Series 2022 YX1185, 2% 2/15/2039 (Liquidity Facility Barclays Bank PLC) (b)(c)	3,500,000	3,500,000
Pennsylvania Econ Dev Fing Auth Participating VRDN 2.02% 12/31/2057 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	4,400,000	4,400,000
Pennsylvania Econ Dev Fing Auth Participating VRDN 2.05% 12/31/2062 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	3,900,000	3,900,000
Pennsylvania Econ Dev Fing Auth Participating VRDN Series 2022 YX1186, 2% 2/15/2040 (Liquidity Facility Barclays Bank PLC) (b)(c)	8,000,000	8,000,000
Pennsylvania Hsg Fin Agcy Multi Fam Hsg Dev Rev Participating VRDN 3.17% 9/19/2027 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	3,210,153	3,210,153
Pennsylvania Turnpike Commission Participating VRDN Series 2025 XM1217, 2% 12/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,750,000	3,750,000
Pennsylvania Turnpike Commission Participating VRDN Series 2025 XX1400, 2% 12/1/2054 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,640,000	1,640,000
Philadelphia Arpt Rev Participating VRDN Series 2024 ZF1782, 2.03% 7/1/2037 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,405,000	2,405,000
Philadelphia Arpt Rev Participating VRDN Series 2025 ZF1832, 2.01% 7/1/2051 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,220,000	2,220,000
Philadelphia PA Auth For Indl Dev Hosp Rev Participating VRDN Series 2025 XF1898, 3.1% 7/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	12,125,000	12,125,000
Philadelphia PA Auth For Indl Dev Hosp Rev Participating VRDN Series 2025 XL0621, 3.1% 7/1/2053 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	5,675,000	5,675,000
Philadelphia PA Gas Works Rev Participating VRDN Series 2024 ZF1772, 2% 8/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,585,000	3,585,000
Thomas Jefferson University Participating VRDN Series 2024 XF1769, 2% 11/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	1,300,000	1,300,000
Thomas Jefferson University Participating VRDN Series 5077, 2% 11/1/2064 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	17,400,000	17,400,000
TOTAL PENNSYLVANIA		87,745,153
South Carolina - 0.3%
Charelston SC Arpt Rev Participating VRDN Series 2025 XF1810, 2.01% 7/1/2054 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	3,150,000	3,150,000
South Carolina Pub Svc Auth Rev Participating VRDN 2% 12/1/2042 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,165,000	4,165,000
South Carolina Pub Svc Auth Rev Participating VRDN Series 2018 XG0209, 2.01% 12/1/2056 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	5,625,000	5,625,000
TOTAL SOUTH CAROLINA		12,940,000
Tennessee - 1.3%
Metropolitan Govt Nashville & Davidson Cnty TN Gen. Oblig. Participating VRDN Series 2025 CF7031, 2% 1/1/2042 (Liquidity Facility Citibank NA) (b)(c)	2,200,000	2,200,000
Metropolitan Nashville Arpt Auth Rev Participating VRDN 2.02% 7/1/2044 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	1,910,000	1,910,000
Metropolitan Nashville Arpt Auth Rev Participating VRDN 2.03% 7/1/2052 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	1,965,000	1,965,000
Sullivan County Health Ed and Hsg Board Participating VRDN 3.08% 9/1/2036 (Liquidity Facility Bank of America, N.A.) (b)(c)	49,760,000	49,760,000
TOTAL TENNESSEE		55,835,000
Texas - 1.5%
Austin Arpt Sys Rev Participating VRDN Series 2022 YX1199, 2.02% 11/15/2047 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	2,400,000	2,400,000
Ector Cnty TX Gen. Oblig. Participating VRDN 2.01% 2/15/2050 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)	3,885,000	3,885,000
Harris Cnty TX Flood Ctl Dist Gen. Oblig. Participating VRDN 2% 10/1/2046 (Liquidity Facility Citibank NA) (b)(c)	3,000,000	3,000,000
Houston Arpt Sys Rev Participating VRDN Series 2023 XF3126, 2.02% 7/1/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	2,480,000	2,480,000
Houston TX Gen. Oblig. Participating VRDN 2% 3/1/2051 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	1,800,000	1,800,000
Lamar TX Isd Participating VRDN 2.02% 2/15/2058 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	3,100,000	3,100,000
Lamar TX Isd Participating VRDN Series 2023 XM1103, 3.1% 2/15/2058 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,700,000	4,700,000
Lamar TX Isd Participating VRDN Series 2025 ZF3318, 2.02% 2/15/2058 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)	2,000,000	2,000,000
Las Varas TX Multi Fam Hsg Auth Participating VRDN Series 2024 MIZ9171, 3.17% 9/26/2027 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	4,400,000	4,400,000
Los Angeles CA Multi Fam Mtg Rev Participating VRDN Series 2024 MIZ9195, 2.07% 7/1/2063 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	5,300,000	5,300,000
North Ft Bend Wtr Auth Tex Wtrsys Rev Participating VRDN Series 2023 XL0422, 2.08% 12/15/2058 (Liquidity Facility Wells Fargo Bank NA) (b)(c)	600,000	600,000
Northwest Tex Indpt Sch Dist Participating VRDN Series 5079, 2% 2/15/2046 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	1,780,000	1,780,000
Rockwall Tex Indpt Sch Dist Participating VRDN Series 2025 XM1252, 3.1% 2/15/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	1,580,000	1,580,000
San Antonio TX Elec & Gas Rev Participating VRDN 3.1% 2/1/2046 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,660,000	3,660,000
Texas Gas Acq & Sply Rev Participating VRDN Series 2025 XM1232, 2.02% 1/1/2055 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	500,000	500,000
Texas Muni Gas Acquisition & Supply Corp Participating VRDN Series 2023 XM1154, 2.02% 1/1/2054 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	2,175,000	2,175,000
Texas Private Activity Bond Surface Trans Corp Participating VRDN 2.03% 12/31/2058 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	3,300,000	3,300,000
Travis TX Hog Eye Apts Participating VRDN Series 2024 MIZ9197, 3.17% 2/1/2068 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	8,200,000	8,200,000
Tuloso Midway TX Indpt Sch Dst Participating VRDN 3.1% 8/15/2050 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	4,500,000	4,500,000
Ysleta Independent School District Participating VRDN Series 2022 XF1395, 3.1% 8/15/2056 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	2,335,000	2,335,000
TOTAL TEXAS		61,695,000
Utah - 0.4%
Salt Lake City Arpt Rev Participating VRDN 2.02% 7/1/2051 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	1,000,000	1,000,000
Salt Lake City Arpt Rev Participating VRDN Series 2023 XF1550, 2.05% 7/1/2047 (Liquidity Facility Toronto Dominion Bank NA) (b)(c)(d)	3,975,000	3,975,000
Salt Lake City Arpt Rev Participating VRDN Series 2023 XL0457, 2.02% 7/1/2051 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	2,615,000	2,615,000
Salt Lake City Arpt Rev Participating VRDN Series 2023 XL0459, 2.02% 7/1/2053 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	3,490,000	3,490,000
Salt Lake City Arpt Rev Participating VRDN Series 2023 XM1146, 2.02% 7/1/2047 (Liquidity Facility UBS AG) (b)(c)(d)	2,500,000	2,500,000
Salt Lake City Arpt. Rev Participating VRDN Series 2025 XL0577, 2.02% 7/1/2053 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	1,700,000	1,700,000
TOTAL UTAH		15,280,000
Virginia - 1.2%
Chesapeake Bay Bridge and Tunnel District Gen Rev Participating VRDN 2.01% 7/1/2051 (Liquidity Facility Barclays Bank PLC) (b)(c)	3,500,000	3,500,000
Norfolk Econ Dev Health Care Facs Participating VRDN 2.01% 11/1/2043 (Liquidity Facility Royal Bank of Canada NY) (b)(c)	3,000,000	3,000,000
Suffolk Econ Dev Auth Hosp Facs Rev Participating VRDN Series 2020 MIZ9025, 2.07% 11/1/2035 (Liquidity Facility Mizuho Capital Markets LLC) (b)(c)	35,110,000	35,110,000
Virginia Small Bus Fing Auth Participating VRDN Series 2024 XF3217, 2.02% 12/31/2056 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	5,225,000	5,225,000
Virginia Small Business Fing Auth Healthcare Facs Rev Participating VRDN 3.15% 12/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	3,700,000	3,700,000
TOTAL VIRGINIA		50,535,000
Washington - 0.8%
Port Seattle WA Rev Participating VRDN 2.02% 8/1/2047 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)(d)	2,635,000	2,635,000
Port Seattle WA Rev Participating VRDN 2.05% 5/1/2043 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	2,585,000	2,585,000
Port Seattle WA Rev Participating VRDN 2.05% 7/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	3,500,000	3,500,000
Port Seattle WA Rev Participating VRDN Series 2020 XM0875, 2.07% 4/1/2044 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	2,970,000	2,970,000
Port Seattle WA Rev Participating VRDN Series 2022 XM1027, 2.05% 8/1/2046 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	4,500,000	4,500,000
Port Seattle WA Rev Participating VRDN Series 2022 YX1241, 2.04% 8/1/2040 (Liquidity Facility Barclays Bank PLC) (b)(c)(d)	1,430,000	1,430,000
Port Seattle WA Rev Participating VRDN Series 2023 XF1599, 2.03% 5/1/2043 (Liquidity Facility Royal Bank of Canada NY) (b)(c)(d)	2,605,000	2,605,000
Port Seattle WA Rev Participating VRDN Series 2024 XF1730, 2.07% 7/1/2049 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)(d)	1,260,000	1,260,000
Port Seattle WA Rev Participating VRDN Series 2025 XL0647, 0% 7/1/2049 (Liquidity Facility Bank of America, N.A.) (b)(c)(d)	3,495,000	3,495,000
Port Seattle WA Rev Participating VRDN Series 2025 XL0648, 0% 8/1/2046 (Liquidity Facility Bank of America, N.A.) (b)(c)(d)	2,300,000	2,300,000
Port Seattle WA Rev Participating VRDN Series 2025 ZF3364, 2.02% 8/1/2046 (Liquidity Facility Morgan Stanley Bank NA) (b)(c)(d)	2,070,000	2,070,000
Washington Convention Ctr Pub Facs Participating VRDN Series 2020 XG0287, 2.01% 7/1/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)	4,185,000	4,185,000
Washington Convention Ctr Pub Facs Participating VRDN Series 2022 XX1238, 2.01% 7/1/2058 (Liquidity Facility Barclays Bank PLC) (b)(c)	1,500,000	1,500,000
TOTAL WASHINGTON		35,035,000
Wisconsin - 1.4%
Wisconsin Health & Edl Facilities Auth Rev Participating VRDN 3.14% 2/15/2040 (Liquidity Facility Bank of America, N.A.) (b)(c)	30,675,000	30,675,000
Wisconsin Health & Educational Facilities Authority Participating VRDN Series 2018 XF2541, 3.1% 11/15/2034 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	10,000,000	10,000,000
Wisconsin Health & Educational Facilities Authority Participating VRDN Series 5082, 3.1% 8/15/2054 (Liquidity Facility JP Morgan Chase Bank NA) (b)(c)	18,980,000	18,980,000
TOTAL WISCONSIN		59,655,000
TOTAL TENDER OPTION BOND (Cost $1,217,112,153)		1,217,112,153

Variable Rate Demand Note - 69.2%
	Principal Amount (a)	Value ($)
Alabama - 3.0%
Decatur AL Indl Dev Brd Exempt (Nucor Corp Proj.) 2.25% 8/1/2036 VRDN (c)(d)	1,900,000	1,900,000
Mobile AL Indl Dev Brd Rev (Alabama Power & Light Proj.) 3.1% 4/1/2031 VRDN (c)(d)	6,800,000	6,800,000
Walker Cnty AL Economic & Indl Dev Auth Solid Waste Disp Rev (Alabama Power & Light Proj.) 3.1% 12/1/2036 VRDN (c)(d)	5,300,000	5,300,000
Walker Cnty AL Economic & Indl Dev Auth Solid Waste Disp Rev (Alabama Power & Light Proj.) Series FIRST 2023, 3.15% 8/1/2063 VRDN (c)(d)	45,910,000	45,910,000
Walker Cnty AL Economic & Indl Dev Auth Solid Waste Disp Rev (Alabama Power & Light Proj.) Series SECOND 2023, 3.15% 8/1/2063 VRDN (c)(d)	19,150,000	19,150,000
West Jefferson Ala Indl Dev Brd Solid Waste Disp Rev (Alabama Power & Light Proj.) 3.1% 12/1/2038 VRDN (c)(d)	7,590,000	7,590,000
West Jefferson Ala Indl Dev Brd Solid Waste Disp Rev (Alabama Power & Light Proj.) Series 2023, 2.6% 8/1/2063 VRDN (c)(d)	8,900,000	8,900,000
Wilsonville AL Indl Dev Brd Pollutn Ctl Rev (Alabama Power & Light Proj.) 3.1% 12/1/2030 VRDN (c)(d)	28,790,000	28,790,000
TOTAL ALABAMA		124,340,000
Alaska - 0.0%
Valdez Alaska Marine Term Rev (Conocophillips Company Proj.) 1.93% 5/1/2031 (ConocoPhillips Guaranteed) VRDN (c)	1,200,000	1,200,000
Arizona - 1.5%
Arizona Brd Regents AZ St Univ Sys Rev (Arizona St Univ Revs Proj.) Series 2025C, 2.12% 7/1/2055 VRDN (c)	7,800,000	7,800,000
Arizona Indl Dev Auth Hosp Rev (Phoenix Childrens Hospital Proj.) Series 2019 A, 3% 2/1/2048, LOC TD Bank NA VRDN (c)	1,285,000	1,285,000
Arizona Indl Dev Auth Hosp Rev (Phoenix Childrens Hospital Proj.) Series 2019B, 3% 2/1/2048, LOC TD Bank NA VRDN (c)	20,155,000	20,155,000
Maricopa Cnty Ariz Indl Dev Auth Hosp Rev (Honorhealth Proj.) Series 2024B, 3% 12/1/2048, LOC JPMorgan Chase Bank NA VRDN (c)	22,305,000	22,305,000
Maricopa Cnty AZ Ida ID Rev (Clayton Homes Inc Proj.) 2.11% 8/1/2028, LOC US Bank NA/Cincinnati OH VRDN (c)(d)	1,900,000	1,900,000
Maricopa Cnty AZ Pollution Ctl (Arizona Public Service Co Proj.) 2.2% 5/1/2029 VRDN (c)	4,900,000	4,900,000
Maricopa Cnty AZ Pollution Ctl (Arizona Public Service Co Proj.) Series 2009 A, 2.25% 5/1/2029 VRDN (c)	2,700,000	2,700,000
TOTAL ARIZONA		61,045,000
Arkansas - 0.0%
Blytheville AR Indl Dev Rev (Nucor Corp Proj.) 2.25% 6/1/2028 VRDN (c)(d)	200,000	200,000
Blytheville AR Indl Dev Rev (Nucor Corp Proj.) 2.65% 1/2/2033 VRDN (c)(d)	1,000,000	1,000,000
TOTAL ARKANSAS		1,200,000
Colorado - 1.6%
Colorado Health Facilities Authority (Childrens Hospital Assoc, Co Proj.) Series 2020A, 3% 12/1/2052, LOC TD Bank NA VRDN (c)	11,800,000	11,800,000
Colorado Health Facilities Authority (Ihc Health Services Inc Proj.) 3% 5/15/2064 VRDN (c)	25,500,000	25,500,000
University of Colorado Hospital Authority Series 2018B, 3% 11/15/2035 VRDN (c)	29,420,000	29,420,000
TOTAL COLORADO		66,720,000
Connecticut - 0.9%
Conn St Hsg Fin Auth (Ct Hsg Mortgage Proj.) Series 2017 C 3, 1.98% 11/15/2035 (Liquidity Facility TD Bank NA) VRDN (c)(d)	25,065,000	25,065,000
Conn St Hsg Fin Auth (Ct Hsg Mortgage Proj.) Series 2019 B 2, 1.98% 11/15/2039 (Liquidity Facility Bank of America NA) VRDN (c)(d)	5,350,000	5,350,000
Conn St Hsg Fin Auth (Ct Hsg Mortgage Proj.) Series 2019 B 3, 1.95% 11/15/2044 (Liquidity Facility Bank of America NA) VRDN (c)	2,085,000	2,085,000
Connecticut St Gen. Oblig. Series 2016 C, 1.96% 5/15/2034 (Liquidity Facility Bank of America NA) VRDN (c)	900,000	900,000
Connecticut State Health & Educational Facilities Authority (Yale-New Haven Hospital Inc Proj.) Series D, 1.85% 7/1/2048 VRDN (c)	6,325,000	6,325,000
TOTAL CONNECTICUT		39,725,000
Delaware - 0.7%
Delaware St Econ Dev Auth Rev (Delmarva Power & Light Proj.) 3.32% 10/1/2029 VRDN (c)(d)	28,200,000	28,200,000
Florida - 4.2%
Bay Cny Fla Pcr (Florida Pwr & Lt Co Proj.) Series 2020, 2.5% 6/1/2050 VRDN (c)(d)	22,300,000	22,300,000
Broward Cnty FL Idr (Florida Pwr & Lt Co Proj.) Series 2015, 2.05% 6/1/2045 VRDN (c)(d)	13,500,000	13,500,000
Broward Cnty FL Idr (Florida Pwr & Lt Co Proj.) Series 2018 A, 2.43% 12/1/2048 VRDN (c)(d)	2,800,000	2,800,000
Broward Cnty FL Idr (Florida Pwr & Lt Co Proj.) Series 2018 B, 2.35% 12/1/2048 VRDN (c)(d)	3,100,000	3,100,000
Escambia Cnty FL Solid Wste (Florida Pwr & Lt Co Proj.) Series FIRST 2009, 2.4% 4/1/2039 VRDN (c)	9,200,000	9,200,000
FL Pcr Power And Light (Florida Pwr & Lt Co Proj.) 2.45% 5/1/2029 VRDN (c)	5,600,000	5,600,000
Florida Hsg Fin Corp Mltfmy Rv (Hunters Run Partners Ii, Ltd Lp Proj.) 1.98% 6/15/2036, LOC Fannie Mae VRDN (c)(d)	4,425,000	4,425,000
Hillsborough Cnty FL Hfa Rev (Claymore Housing Ltd Proj.) 2.11% 12/15/2038, LOC Citibank NA VRDN (c)(d)	8,425,000	8,425,000
Hillsborough Cnty FL Hfa Rev (Grande Oaks Llc Proj.) 2.05% 2/15/2037, LOC Fannie Mae VRDN (c)(d)	830,000	830,000
Hillsborough Cnty Fla Indl Dev Auth Health Sys Rev (Baycare Health System Proj.) 3% 11/15/2054 (Liquidity Facility Royal Bank of Canada/New York NY) VRDN (c)	37,605,000	37,605,000
Lee Cnty FL Indl DevAuth Rev (Florida Pwr & Lt Co Proj.) Series 2016 A, 2.05% 12/1/2046 VRDN (c)(d)	5,100,000	5,100,000
Lee Cnty FL Indl DevAuth Rev (Florida Pwr & Lt Co Proj.) Series 2016 B, 2.55% 12/1/2046 VRDN (c)(d)	4,100,000	4,100,000
Miami-Dade Cnty FL Indl Dev Au (Florida Pwr & Lt Co Proj.) Series 2021, 2.3% 5/1/2046 VRDN (c)(d)	5,700,000	5,700,000
Miami-Dade Cnty FL Indl Dev Au (Florida Pwr & Lt Co Proj.) Series 2024A, 2.45% 5/1/2054 VRDN (c)(d)	13,700,000	13,700,000
Miami-Dade Cnty FL Indl Dev Au (Florida Pwr & Lt Co Proj.) Series 2024B, 2.15% 5/1/2054 VRDN (c)(d)	16,350,000	16,350,000
Mississippi Bus Fin Corp MI Po (Florida Pwr & Lt Co Proj.) Series 2014, 2.45% 4/1/2044 VRDN (c)	2,100,000	2,100,000
Orange Cnty FL Health Facs (Nemours Foundation Proj.) Series 2009B, 1.95% 1/1/2039, LOC TD Bank NA VRDN (c)	23,350,000	23,350,000
TOTAL FLORIDA		178,185,000
Georgia - 2.2%
Bartow Cnty GA Dev Auth Solid Waste Disp Fac Rev (Georgia Power Co Proj.) 3.1% 11/1/2062 VRDN (c)(d)	12,650,000	12,650,000
Bartow Cnty GA Dev Auth Solid Waste Disp Fac Rev (Georgia Power Co Proj.) 3.15% 11/1/2062 VRDN (c)(d)	16,955,000	16,955,000
Burke Cnty GA Dev Auth Pcr (Georgia Power Co Proj.) 3.1% 7/1/2049 VRDN (c)	7,830,000	7,830,000
Burke Cnty GA Dev Auth Pcr (Georgia Power Co Proj.) Series 1997, 3.15% 11/1/2052 VRDN (c)(d)	21,170,000	21,170,000
Heard Cnty GA Dev Auth Poll Cont Rev (Georgia Power Co Proj.) 2.75% 12/1/2037 VRDN (c)(d)	14,500,000	14,500,000
Monroe Cnty GA Dev Auth Rev (Florida Pwr & Lt Co Proj.) Series 2017, 2.17% 11/1/2047 VRDN (c)(d)	6,200,000	6,200,000
Monroe Cnty GA Dev Auth Rev (Florida Pwr & Lt Co Proj.) Series 2019, 2.45% 6/1/2049 VRDN (c)(d)	13,040,000	13,040,000
TOTAL GEORGIA		92,345,000
Illinois - 1.4%
Chicago IL Midway Arpt Rev Series 2014 C, 2.02% 1/1/2044, LOC PNC Bank NA VRDN (c)(d)	4,300,000	4,300,000
Chicago IL O'Hare Intl Arpt Rev Spl (Deutsche Lufthansa A G Proj.) 2.12% 5/1/2035, LOC Bayerische Landesbank VRDN (c)(d)	6,000,000	6,000,000
Illinois Dev Fin Auth Rev (Glenwood School For Boys, Il Proj.) 2.17% 2/1/2033, LOC Northern Trust CO Chicago VRDN (c)	1,900,000	1,900,000
Illinois Fin Auth Rev (University Of Chicago Hosps,Il Proj.) 2.85% 8/1/2043, LOC TD Bank NA VRDN (c)	1,100,000	1,100,000
Illinois Finance Authority Rev (Northwestern Memorial Hosp,Il Proj.) Series 2021 B, 3% 7/15/2055 (Liquidity Facility Royal Bank of Canada) VRDN (c)	6,305,000	6,305,000
Illinois Finance Authority Rev (Northwestern Memorial Hosp,Il Proj.) Series 2021 C, 3% 7/15/2055 (Liquidity Facility Barclays Bank PLC) VRDN (c)	11,730,000	11,730,000
Will Cnty IL Exempt Facs Rev (Exxon Capital Ventures Inc Proj.) 3.04% 4/1/2026 (Exxon Mobil Corp Guaranteed) VRDN (c)(d)	26,815,000	26,815,000
TOTAL ILLINOIS		58,150,000
Indiana - 2.1%
Hammond Ind Sew&Sd Wst Dsp Rev (Cargill Inc Proj.) 1.98% 12/1/2029 VRDN (c)(d)	33,700,000	33,700,000
Indiana Fin Auth Health Sys Rev (Franciscan Alliance Proj.) 1.9% 9/1/2048, LOC Barclays Bank PLC VRDN (c)	7,750,000	7,750,000
Indiana Fin Auth Hosp Rev (Parkview Health System Proj.) 3% 11/1/2039, LOC TD Bank NA VRDN (c)	33,620,000	33,620,000
Indiana Mun Pwr Agy Pwr Supply Series 2019 B, 3% 1/1/2042, LOC Truist Bank VRDN (c)	13,750,000	13,750,000
Indiana St Dev Fin Auth Envr Rev (Duke Energy Ind Inc Proj.) 2.16% 12/1/2038 VRDN (c)(d)	1,050,000	1,050,000
TOTAL INDIANA		89,870,000
Iowa - 2.2%
Iowa Fin Auth Health Facs Rev (Unitypoint Health Proj.) Series 2013B 1, 2.8% 2/15/2039, LOC TD Bank NA VRDN (c)	9,420,000	9,420,000
Iowa Fin Auth Midwestern Disaster Area Rev (Archer Daniels Midland Co Proj.) 2% 12/1/2051 VRDN (c)	5,000,000	5,000,000
Iowa Fin Auth Pollutn Ctl Fac Rev (Midamerican Energy Co Proj.) Series 2016A, 2.1% 9/1/2036 VRDN (c)	1,200,000	1,200,000
Iowa Fin Auth Rev (Unitypoint Health Proj.) Series 2018 F, 2.8% 7/1/2041, LOC TD Bank NA VRDN (c)	6,405,000	6,405,000
Iowa Fin Auth Sld Disp Wst Rev (Chevron Usa Inc Proj.) 3% 8/1/2054 (Chevron Corp Guaranteed) VRDN (c)(d)	36,050,000	36,050,000
Iowa Fin Auth Solid Waste Facs Rev (Midamerican Energy Co Proj.) 2.25% 12/1/2047 VRDN (c)(d)	36,530,000	36,530,000
TOTAL IOWA		94,605,000
Kansas - 0.3%
Burlington Kans Envr Imprv Rev (Evergy Kansas Metro Proj.) 2.4% 9/1/2035 VRDN (c)	3,300,000	3,300,000
Burlington Kans Envr Imprv Rev (Evergy Kansas Metro Proj.) 2.4% 9/1/2035 VRDN (c)	1,000,000	1,000,000
LA Cygne KS Pollution Ctl Rev (Evergy Kansas South Proj.) 2.5% 4/15/2027 VRDN (c)	400,000	400,000
St Marys Kans Pollutn Ctl Rev (Evergy Kansas South Proj.) 2.5% 4/15/2032 VRDN (c)	4,100,000	4,100,000
University Kansas Hosp Auth Hlth Fac Rev 3% 9/1/2034, LOC US Bank NA/Cincinnati OH VRDN (c)	3,700,000	3,700,000
Wamego Kansas Pcr (Evergy Kansas Central Proj.) 2.5% 4/15/2032 VRDN (c)	600,000	600,000
Wamego Kansas Pcr (Evergy Kansas South Proj.) 2.5% 4/15/2032 VRDN (c)	200,000	200,000
TOTAL KANSAS		13,300,000
Kentucky - 5.2%
Kentucky Bond Development Corp (Baptist Health Obligated Group Proj.) Series 2025 B, 3.1% 8/15/2055, LOC Truist Bank VRDN (c)	105,620,000	105,620,000
Louisville & Jefferson Cnty KY Metro Govt Health Sys Rev (Norton Healthcare Inc Proj.) Series 2023C, 3.1% 10/1/2053, LOC Truist Bank VRDN (c)	5,900,000	5,900,000
Louisville & Jefferson Cnty KY Metro Govt Health Sys Rev (Norton Healthcare Inc Proj.) Series 2023D, 3.1% 10/1/2053, LOC Truist Bank VRDN (c)	41,365,000	41,365,000
Louisville KY Regl Arpt Auth Spl Facs Rev (United Parcel Service Inc Proj.) 3.05% 11/1/2036 VRDN (c)(d)	42,600,000	42,600,000
Meade Cnty KY Indl Bldg Rev (Nucor Corp Proj.) Series 2020 A 1, 3.55% 7/1/2060 VRDN (c)(d)	10,560,000	10,560,000
Meade Cnty KY Indl Bldg Rev (Nucor Corp Proj.) Series 2020 B 1, 3.55% 7/1/2060 VRDN (c)(d)	4,500,000	4,500,000
Meade Cnty KY Indl Bldg Rev (Nucor Corp Proj.) Series 2021 A 1, 3.55% 8/1/2061 VRDN (c)(d)	6,775,000	6,775,000
Meade Cnty KY Indl Bldg Rev (Nucor Corp Proj.) Series 2021B 1, 3.5% 8/1/2061 VRDN (c)(d)	200,000	200,000
TOTAL KENTUCKY		217,520,000
Louisiana - 3.1%
Louisiana Pub Facs Auth Recycling Fac Rev (Chevron Usa Inc Proj.) Series 2024, 3% 5/1/2054 (Chevron Corp Guaranteed) VRDN (c)(d)	36,785,000	36,785,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 2.2% 12/1/2037 VRDN (c)(d)	14,000,000	14,000,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 2.2% 12/1/2038 VRDN (c)(d)	18,650,000	18,650,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 3% 12/1/2043 VRDN (c)	12,400,000	12,400,000
Louisiana Pub Facs Auth Rev (Air Products & Chemicals Inc Proj.) 3% 5/1/2042 VRDN (c)	25,000,000	25,000,000
Louisiana St Gas & Fuel Tax Rv 3% 5/1/2043, LOC Toronto-Dominion Bank/NY VRDN (c)	4,700,000	4,700,000
Louisiana St Gas & Fuel Tax Rv 3% 5/1/2043, LOC Toronto-Dominion Bank/NY VRDN (c)	3,975,000	3,975,000
St Bernard Parish LA Exempt Fa C Rev (Exxon Mobil Corp Proj.) 3.04% 11/1/2026 VRDN (c)(d)	15,500,000	15,500,000
TOTAL LOUISIANA		131,010,000
Maryland - 0.3%
Maryland Health & Higher Educational Facilities Authority (Johns Hopkins Health Sys Corp Proj.) 2.95% 6/1/2048, LOC TD Bank NA VRDN (c)	8,225,000	8,225,000
Maryland Health & Higher Educational Facilities Authority (Johns Hopkins Health Sys Corp Proj.) 2.95% 6/1/2048, LOC TD Bank NA VRDN (c)	4,970,000	4,970,000
TOTAL MARYLAND		13,195,000
Michigan - 1.7%
Grand Traverse Cnty MI Hosp (Munson Healthcare Proj.) Series 2019C, 3% 7/1/2041, LOC PNC Bank NA VRDN (c)	6,275,000	6,275,000
Michigan St Strategic Fd Ltd Oblig Rev (Air Products & Chemicals Inc Proj.) 2.97% 12/1/2042 VRDN (c)	29,915,000	29,915,000
Michigan St Strategic Fd Ltd Oblig Rev (Kroger Co Proj.) 2.01% 1/1/2026, LOC Bank of Nova Scotia NY Brh VRDN (c)	2,100,000	2,100,000
Michigan Strategic Fund (Chevron Usa Inc Proj.) Series 2024, 3% 11/1/2054 (Chevron Corp Guaranteed) VRDN (c)(d)	35,000,000	35,000,000
TOTAL MICHIGAN		73,290,000
Minnesota - 1.8%
Minneapolis MN Health Care Sys Rev (Fairview Hsp & Hltcare Srv Sys Proj.) Series 2018 C, 3% 11/15/2048, LOC Bank of America NA VRDN (c)	73,615,000	73,615,000
Mississippi - 0.9%
Mississippi Bus Fin Corp Rev (Florida Pwr & Lt Co Proj.) 2.55% 12/1/2049 VRDN (c)(d)	14,300,000	14,300,000
Mississippi Bus Fin Corp Rev (Mississippi Power Co Proj.) Series 1999, 2.8% 12/1/2027 VRDN (c)(d)	2,700,000	2,700,000
Mississippi Bus Fin Corp Sld Wst Disp Rev (Waste Management Inc Del Proj.) 1.93% 7/1/2028, LOC Bank of America NA VRDN (c)(d)	10,000,000	10,000,000
Mississippi Business Fin Corp Miss Solid Waste Disp Fac & Wastewater Fac Rev (Mississippi Power Co Proj.) 2.8% 11/1/2052 VRDN (c)(d)	9,820,000	9,820,000
TOTAL MISSISSIPPI		36,820,000
Nebraska - 1.2%
Nebraska Invt Fin Auth Sfh Rev (Ne Single Family Hsg Proj.) Series 2016B, 1.85% 9/1/2032 (Liquidity Facility Federal Home Loan Bank of Topeka) VRDN (c)(d)	7,115,000	7,115,000
Nebraska Invt Fin Auth Sfh Rev (Ne Single Family Hsg Proj.) Series 2016D, 1.85% 9/1/2032 (Liquidity Facility Federal Home Loan Bank of Topeka) VRDN (c)(d)	7,170,000	7,170,000
Nebraska Invt Fin Auth Sfh Rev (Ne Single Family Hsg Proj.) Series 2018 B, 1.85% 3/1/2048 (Liquidity Facility Federal Home Loan Bank of Topeka) VRDN (c)(d)	12,000,000	12,000,000
Nebraska Invt Fin Auth Sfh Rev (Ne Single Family Hsg Proj.) Series 2018 D, 1.85% 9/1/2048 (Liquidity Facility Federal Home Loan Bank of Topeka) VRDN (c)(d)	1,950,000	1,950,000
Nebraska Invt Fin Auth Sfh Rev (Ne Single Family Hsg Proj.) Series 2021 B, 1.85% 9/1/2050 (Liquidity Facility Federal Home Loan Bank of Topeka) VRDN (c)(d)	20,000,000	20,000,000
Stanton Cnty NE Indl Dev Rev (Nucor Corp Proj.) 2.25% 11/1/2026 VRDN (c)(d)	1,200,000	1,200,000
Stanton Cnty NE Indl Dev Rev (Nucor Corp Proj.) 2.25% 6/1/2028 VRDN (c)(d)	100,000	100,000
TOTAL NEBRASKA		49,535,000
Nevada - 0.4%
Clark Cnty NV Indl Dev Rev (Southwest Gas Corp Proj.) Series 2008 A, 2.2% 3/1/2038, LOC MUFG Bank Ltd/New York NY VRDN (c)(d)	15,000,000	15,000,000
New Hampshire - 0.8%
National Fin Auth NH Health Care Facs Rev (Novant Health Inc Proj.) Series 2024 B, 3% 11/1/2064, LOC Truist Bank VRDN (c)	30,000,000	30,000,000
National Fin Auth NH Health Care Facs Rev (Novant Health Inc Proj.) Series 2024 C, 2.07% 11/1/2064, LOC Truist Bank VRDN (c)	4,200,000	4,200,000
TOTAL NEW HAMPSHIRE		34,200,000
New York - 14.3%
Battery Pk City Auth NY Rev Series 2019D 2, 3% 11/1/2038 (Liquidity Facility TD Bank NA) VRDN (c)	1,500,000	1,500,000
City of New York NY Gen. Oblig. Series 2013 A 3, 3% 10/1/2040 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (c)	22,945,000	22,945,000
City of New York NY Gen. Oblig. Series 2013 SUB A 2, 3% 10/1/2038 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (c)	7,300,000	7,300,000
City of New York NY Gen. Oblig. Series 2014 D 4, 3% 8/1/2040, LOC TD Bank NA VRDN (c)	7,845,000	7,845,000
City of New York NY Gen. Oblig. Series 2014 I 2, 3% 3/1/2040 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	4,990,000	4,990,000
City of New York NY Gen. Oblig. Series FISCAL 2019 D 4, 3.05% 12/1/2047 (Liquidity Facility State Street Bank & Trust Co) VRDN (c)	4,300,000	4,300,000
City of New York NY Gen. Oblig. Series FISCAL 2023A SUB A 3, 3% 9/1/2049 (Liquidity Facility Bank of Montreal/Chicago IL) VRDN (c)	31,490,000	31,490,000
City of New York NY Gen. Oblig. Series FISCAL 2023A SUB A 4, 3% 9/1/2049 (Liquidity Facility Toronto Dominion Bank) VRDN (c)	10,595,000	10,595,000
City of New York NY Gen. Oblig. Series G 3, 3% 2/1/2055 (Liquidity Facility TD Bank NA) VRDN (c)	15,500,000	15,500,000
City of New York NY Series FISCAL 2017A SUB A4, 3% 8/1/2044 (Liquidity Facility State Street Bank & Trust Co) VRDN (c)	31,165,000	31,165,000
Metropolitan Transn Auth NY Rv Series 2015 E 1, 3.05% 11/15/2045, LOC Barclays Bank PLC VRDN (c)	13,325,000	13,325,000
Metropolitan Transn Auth NY Rv Series SUB 2002D 2A 1, 3% 11/1/2032, LOC Truist Bank VRDN (c)	9,435,000	9,435,000
Metropolitan Transn Auth NY Rv Series SUB 2002D 2B, 3% 11/1/2032, LOC Truist Bank VRDN (c)	12,160,000	12,160,000
Metropolitan Transn Auth NY Rv Series SUB 2005D 1, 3% 11/1/2035, LOC Truist Bank VRDN (c)	12,915,000	12,915,000
Metropolitan Transn Auth NY Rv Series SUB 2012G 3, 3% 11/1/2031, LOC Royal Bank of Canada/New York NY VRDN (c)	25,135,000	25,135,000
New York NY City Transitional Fin Auth Rev 3% 8/1/2045 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	15,005,000	15,005,000
New York NY City Transitional Fin Auth Rev Series 2011 A 4, 3.05% 8/1/2039 (Liquidity Facility Barclays Bank PLC) VRDN (c)	33,250,000	33,250,000
New York NY City Transitional Fin Auth Rev Series 2013 FISCAL A 4, 3% 8/1/2039 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	1,900,000	1,900,000
New York NY City Transitional Fin Auth Rev Series 2013C 4, 3% 11/1/2036 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	10,690,000	10,690,000
New York NY City Transitional Fin Auth Rev Series 2015 E 3, 3% 2/1/2045 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	30,250,000	30,250,000
New York NY City Transitional Fin Auth Rev Series A 4, 3% 8/1/2043 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (c)	5,030,000	5,030,000
New York NY City Transitional Fin Auth Rev Series B 4, 3% 8/1/2042 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	18,385,000	18,385,000
New York NY City Transitional Fin Auth Rev Series FISCAL 2019 C 4, 3.05% 11/1/2044 (Liquidity Facility Barclays Bank PLC) VRDN (c)	16,285,000	16,285,000
New York NY Cty Hsg Dev Corp Multifamily Rev (Glenwood Management Proj.) 2.15% 6/15/2029, LOC Fannie Mae VRDN (c)(d)	14,800,000	14,800,000
New York NY Cty Muni Wtr Fin Auth 3% 6/15/2039 (Liquidity Facility UBS AG/Stamford CT) VRDN (c)	61,385,000	61,385,000
New York NY Cty Muni Wtr Fin Auth 3% 6/15/2043 (Liquidity Facility TD Bank NA) VRDN (c)	6,300,000	6,300,000
New York NY Cty Muni Wtr Fin Auth 3.02% 6/15/2039 (Liquidity Facility UBS AG/Stamford CT) VRDN (c)	4,160,000	4,160,000
New York NY Cty Muni Wtr Fin Auth Series 2014 AA 3, 3% 6/15/2049 (Liquidity Facility TD Bank NA) VRDN (c)	6,555,000	6,555,000
New York NY Cty Muni Wtr Fin Auth Series 2014AA 4, 3% 6/15/2049 (Liquidity Facility State Street Bank & Trust Co) VRDN (c)	2,800,000	2,800,000
New York NY Cty Muni Wtr Fin Auth Series 2015 BB 2, 3.02% 6/15/2049 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (c)	18,095,000	18,095,000
New York NY Cty Muni Wtr Fin Auth Series AA 1, 3% 6/15/2050 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	9,390,000	9,390,000
New York NY Cty Muni Wtr Fin Auth Series AA 5, 3% 6/15/2048 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (c)	8,695,000	8,695,000
New York NY Cty Muni Wtr Fin Auth Series AA 6, 3% 6/15/2048 (Liquidity Facility Mizuho Bank Ltd/New York NY) VRDN (c)	18,935,000	18,935,000
New York NY Cty Muni Wtr Fin Auth Series BB 1A, 3% 6/15/2049 (Liquidity Facility State Street Bank & Trust Co) VRDN (c)	7,500,000	7,500,000
New York NY Cty Muni Wtr Fin Auth Series BB 1B, 3% 6/15/2049 (Liquidity Facility State Street Bank & Trust Co) VRDN (c)	10,830,000	10,830,000
New York NY Cty Muni Wtr Fin Auth Series DD 2, 3% 6/15/2043 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	1,570,000	1,570,000
New York NY Hsg Dev Multi Rev (119 Manhattan Equities Llc Proj.) 1.95% 6/1/2036, LOC Citibank NA VRDN (c)(d)	5,000,000	5,000,000
New York St Hsg Fin Agy Rev (Durst Organization Proj.) 2.05% 5/15/2036, LOC Fannie Mae VRDN (c)(d)	19,700,000	19,700,000
New York St Hsg Fin Agy Rev (Penmark Realty Corp Proj.) 3.1% 11/1/2034, LOC Landesbank Hessen-Thueringen Girozentrale VRDN (c)(d)	50,100,000	50,100,000
New York St Hsg Fin Agy Rev (Various Capital Projects) Series 2014A, 3% 11/1/2046, LOC Landesbank Hess-Thurngn (Ungtd) NY Br VRDN (c)	5,615,000	5,615,000
Triborough Brdg & Tunl NY Revs 3.05% 1/1/2032, LOC Barclays Bank PLC VRDN (c)	2,050,000	2,050,000
Triborough Brdg & Tunl NY Revs Series 2005B 4A, 3% 1/1/2032, LOC TD Bank NA VRDN (c)	4,390,000	4,390,000
TOTAL NEW YORK		599,265,000
North Carolina - 0.8%
Atrium Health (Carolinas Healthcare System Proj.) 3% 1/15/2044, LOC TD Bank NA VRDN (c)	4,855,000	4,855,000
Cumberland Cnty NC Indl Facs & Pollution Ctl Fing Auth Exempt Facs Rev (Cargill Inc Proj.) Series 2022, 2.01% 8/1/2052 VRDN (c)(d)	2,900,000	2,900,000
Lower Cape Fear N C Wtr & Swr Auth Spl Fac Rev (Smithfield Foods Proj.) 2.06% 12/1/2034, LOC Cooperatieve Rabobank UA/NY VRDN (c)	1,400,000	1,400,000
North Carolina Housing Finance Agency (Nc Homeownership Proj.) Series 55 B, 3% 1/1/2050 (Liquidity Facility TD Bank NA) VRDN (c)	25,500,000	25,500,000
TOTAL NORTH CAROLINA		34,655,000
Ohio - 1.6%
Allen Cnty OH Hosp Facs Rev (Mercy Healthcare System Proj.) 3.05% 6/1/2034, LOC Truist Bank VRDN (c)	5,900,000	5,900,000
Cuyahoga Cnty OH Hlth Care Fac (The A.M. Mcgregor Home Proj.) Series 2014, 2.01% 5/1/2049, LOC Northern Trust CO Chicago VRDN (c)	1,800,000	1,800,000
Franklin Cnty OH Hosp Facs Rev (Nationwide Children'S Hospital Proj.) 3% 11/1/2042 (Liquidity Facility JPMorgan Chase Bank NA) VRDN (c)	1,600,000	1,600,000
Franklin Cnty OH Hosp Facs Rev (Ohiohealth Corporation Proj.) Series 2011C, 1.85% 11/15/2033 VRDN (c)	3,300,000	3,300,000
Franklin Cnty OH Hosp Facs Rev (Ohiohealth Corporation Proj.) Series 2011D, 1.85% 11/15/2033 VRDN (c)	8,000,000	8,000,000
Franklin Cnty Ohio Hosp Rev (Ohiohealth Corporation Proj.) 1.9% 12/1/2028, LOC Northern Trust CO Chicago VRDN (c)	3,945,000	3,945,000
Hamilton Cnty OH Hosp Facs Rev (Childrens Hosp Med Ctr Cinn,Oh Proj.) Series 2018 Z, 2% 5/15/2037 VRDN (c)	3,980,000	3,980,000
Montgomery Cnty OH Hosp Rev (Premier Health Partners Proj.) Series 2019 C, 3.05% 11/15/2045, LOC PNC Bank NA VRDN (c)	4,200,000	4,200,000
Ohio St Higher Ed Fac Comm (Cleveland Clinic Foundtn (The) Proj.) 3% 1/1/2043 (Liquidity Facility Barclays Bank PLC) VRDN (c)	14,550,000	14,550,000
Ohio St Higher Ed Fac Comm (Cleveland Clinic Foundtn (The) Proj.) Series 2013 B 1, 1.85% 1/1/2039 VRDN (c)	16,525,000	16,525,000
Ohio St Hsg Fin Agy Residential Mtg Rev (Oh Residential Mortgage Proj.) Series F, 2.2% 3/1/2036 (Liquidity Facility TD Bank NA) VRDN (c)(d)	3,765,000	3,765,000
TOTAL OHIO		67,565,000
Oregon - 0.7%
Oregon St Facs Auth Rev (Peacehealth (Hlth Sys),Wa Proj.) Series 2018 B, 2.9% 8/1/2034, LOC TD Bank NA VRDN (c)	27,450,000	27,450,000
Pennsylvania - 1.5%
Allegheny Cnty PA Ida Rev (Watson Institute Proj.) 2.05% 8/1/2040, LOC PNC Bank NA VRDN (c)	2,245,000	2,245,000
Lancaster PA Indl Dev Auth Rev (Willow Valley Retirement Communities Proj.) 2.05% 12/1/2039, LOC PNC Bank NA VRDN (c)	5,270,000	5,270,000
Pennsylvania Higher Educational Facilities Authority (Thomas Jefferson Univ-Abiington Proj.) Series 2024 D3, 3% 11/1/2061, LOC Truist Bank VRDN (c)	46,850,000	46,850,000
Philadelphia PA Gen. Oblig. 2.07% 8/1/2031, LOC Truist Bank VRDN (c)	10,100,000	10,100,000
TOTAL PENNSYLVANIA		64,465,000
South Carolina - 1.0%
Berkeley Cnty SC Indl Dev Rev (Nucor Corp Proj.) 2.25% 4/1/2030 VRDN (c)(d)	2,700,000	2,700,000
Berkeley Cnty SC Indl Dev Rev (Nucor Corp Proj.) 2.25% 9/1/2028 VRDN (c)(d)	200,000	200,000
Berkeley Cnty SC Indl Dev Rev (Nucor Corp Proj.) 2.75% 3/1/2029 VRDN (c)(d)	1,925,000	1,925,000
Darlington Cnty SC Indl Dev Re (Nucor Corp Proj.) 2.75% 8/1/2029 VRDN (c)(d)	1,200,000	1,200,000
South Carolina Jobs-Economic Dev Auth Hosp Rev (Prisma Health Proj.) Series 2018B, 3% 5/1/2048, LOC TD Bank NA VRDN (c)	5,400,000	5,400,000
South Carolina Jobs-Economic Dev Auth Hosp Rev (Prisma Health Proj.) Series 2018C, 3% 5/1/2048, LOC TD Bank NA VRDN (c)	31,805,000	31,805,000
TOTAL SOUTH CAROLINA		43,230,000
Tennessee - 0.6%
Clarksville TN Public Bldg Ath (Tennessee Muni Bond Fund Proj.) 3.03% 11/1/2035, LOC Bank of America NA VRDN (c)	11,565,000	11,565,000
Clarksville TN Public Bldg Ath (Tennessee Muni Bond Fund Proj.) 3.03% 2/1/2038, LOC Bank of America NA VRDN (c)	11,390,000	11,390,000
Industrial Dev Brd Blount Cnty & Cities Alcoa & Maryville Tenn (Alcoa Tn Proj.) 2.3% 6/1/2036, LOC Truist Bank VRDN (c)	2,150,000	2,150,000
Loudon CO TN Idb Exmpt Fac Rv (Kimberly-Clark Corp Proj.) 2.5% 11/1/2034 VRDN (c)(d)	1,000,000	1,000,000
TOTAL TENNESSEE		26,105,000
Texas - 9.0%
Calhoun Cnty Tex Nav Dist Environmental Facs Rev (Formosa Plastics Corp Proj.) 2% 5/1/2034, LOC Citibank NA VRDN (c)(d)	5,000,000	5,000,000
Calhoun Cnty TX Nav Dist Pol (Formosa Plastics Corp Texas Proj.) 2% 9/1/2032, LOC Citibank NA VRDN (c)(d)	10,000,000	10,000,000
Calhoun Port Auth TX Environmental Facs Rev (Formosa Plastics Corp Texas Proj.) 2.01% 11/1/2037, LOC PNC Bank NA VRDN (c)(d)	11,330,000	11,330,000
Calhoun Port Auth TX Environmental Facs Rev (Formosa Plastics Corp Texas Proj.) 2.01% 11/1/2038, LOC Bank of America NA VRDN (c)(d)	4,400,000	4,400,000
Dallas-Fort Worth Intl Arpt TX (United Parcel Service Inc Proj.) 2.98% 5/1/2032 VRDN (c)(d)	29,050,000	29,050,000
Gulf Coast Industrial Development Authority (Exxon Capital Ventures Inc Proj.) Series 2012, 3% 11/1/2041 (Exxon Mobil Corp Guaranteed) VRDN (c)	5,400,000	5,400,000
Gulf Coast Wst Disp Auth TX En (Exxon Capital Ventures Inc Proj.) 3.04% 9/1/2025 (Exxon Mobil Corp Guaranteed) VRDN (c)(d)	24,485,000	24,485,000
Harris Cnty TX Cultural Ed Facs Fin Corp Rev (Methodist Healthcare Sys, Tx Proj.) Series 2020B, 3% 12/1/2059 VRDN (c)	63,170,000	63,170,000
Harris Cnty TX Health Facs Rev (Methodist Healthcare Sys, Tx Proj.) 3% 12/1/2041 VRDN (c)	16,550,000	16,550,000
Harris Cnty TX Health Facs Rev (Methodist Healthcare Sys, Tx Proj.) 3% 12/1/2041 VRDN (c)	12,630,000	12,630,000
Harris Cnty TX Hfc Mfhr (Louetta Village Apartments 45 Lp Proj.) 2.04% 1/15/2038, LOC Fannie Mae VRDN (c)(d)	4,480,000	4,480,000
Harris Cnty TX Hosp Dist Rev 2.02% 2/15/2042, LOC JPMorgan Chase Bank NA VRDN (c)	3,800,000	3,800,000
Harris Cnty TX Idc Pcr (Exxon Capital Ventures Inc Proj.) 3.04% 8/15/2027 (Exxon Mobil Corp Guaranteed) VRDN (c)(d)	7,300,000	7,300,000
Houston TX Util Sys Rev 2% 5/15/2034, LOC Sumitomo Mitsui Banking Corp/New York VRDN (c)	5,800,000	5,800,000
Jewett Economic Dev Corp Tex I (Nucor Corp Proj.) 2.25% 8/1/2038 VRDN (c)(d)	4,950,000	4,950,000
Lower Nchs Vly Ath TX Idcrp Re (Exxon Capital Ventures Inc Proj.) 3% 11/1/2029 (Exxon Mobil Corp Guaranteed) VRDN (c)	9,990,000	9,990,000
Lower Nchs Vly Ath TX Idcrp Re (Exxon Capital Ventures Inc Proj.) 3.04% 11/1/2029 (Exxon Mobil Corp Guaranteed) VRDN (c)(d)	1,155,000	1,155,000
Lower Nchs Vly Ath TX Idcrp Re (Exxon Capital Ventures Inc Proj.) 3.04% 12/1/2039 (Exxon Mobil Corp Guaranteed) VRDN (c)(d)	1,180,000	1,180,000
Lower Nchs Vly Ath TX Idcrp Re (Exxon Capital Ventures Inc Proj.) 3.04% 3/1/2033 (Exxon Mobil Corp Guaranteed) VRDN (c)(d)	2,505,000	2,505,000
Lower Nchs Vly Ath TX Idcrp Re (Exxon Mobil Corp Proj.) 3.04% 4/1/2029 VRDN (c)(d)	16,100,000	16,100,000
Lower Nchs Vly Ath TX Idcrp Re (Onyx Environmental Svcs Llc Proj.) Series 2003, 2.07% 5/1/2028, LOC Bank of America NA VRDN (c)(d)	10,250,000	10,250,000
Lower Neches Valley Auth Tex (Exxon Capital Ventures Inc Proj.) 3% 11/1/2038 (Exxon Mobil Corp Guaranteed) VRDN (c)	19,930,000	19,930,000
Lower Neches Valley Auth Tex (Exxon Capital Ventures Inc Proj.) 3% 5/1/2046 (Exxon Mobil Corp Guaranteed) VRDN (c)	8,630,000	8,630,000
Port Arthur TX Navigation District (Air Products & Chemicals Inc Proj.) 2.2% 4/1/2035 VRDN (c)(d)	25,000,000	25,000,000
Port Arthur TX Navigation District (Air Products & Chemicals Inc Proj.) 2.2% 4/1/2036 VRDN (c)(d)	25,000,000	25,000,000
Port Arthur TX Navigation District (Air Products & Chemicals Inc Proj.) 2.2% 4/1/2037 VRDN (c)(d)	22,500,000	22,500,000
Port Arthur TX Navigation District (Air Products Lp Proj.) 2.97% 5/1/2040 (Air Products and Chemicals Inc Guaranteed) VRDN (c)	1,800,000	1,800,000
Port Port Arthur TX Nav Dist R (Total Petrochemicals &Refining Sa/Nv Proj.) 2.07% 4/1/2027 (TotalEnergies SE Guaranteed) VRDN (c)(d)	10,000,000	10,000,000
Port Port Arthur TX Nav Dist R (Total Petrochemicals &Refining Sa/Nv Proj.) 2.07% 5/1/2035 (TotalEnergies SE Guaranteed) VRDN (c)(d)	10,000,000	10,000,000
Tarrant Cnty TX Cultural Ed Facs Fin Corp Hosp Rev (Methodist Hospitals Of Dallas Proj.) 2.95% 10/1/2041, LOC TD Bank NA VRDN (c)	1,185,000	1,185,000
Texas State Gen. Oblig. 2.25% 12/1/2042 (Liquidity Facility State Street Bank & Trust Co) VRDN (c)	500,000	500,000
Texas State Gen. Oblig. 2.25% 6/1/2043 (Liquidity Facility State Street Bank & Trust Co) VRDN (c)	940,000	940,000
TOTAL TEXAS		375,010,000
Virginia - 1.8%
Harrisonburg VA Economic Dev Auth Health Care Facs Rev (Sentara Healthcare Proj.) Series 2023, 2.25% 8/15/2046, LOC US Bank NA/Cincinnati OH VRDN (c)	840,000	840,000
Norfolk VA Economic Dev Auth Hosp Facs Rev (Sentara Hlth Sys Obl Group Proj.) 1.95% 11/1/2034 VRDN (c)	1,450,000	1,450,000
Roanoke VA Economic Dev Auth Hosp Rev (Carilion Health System Proj.) Series 2020C, 2.9% 7/1/2052, LOC TD Bank NA VRDN (c)	26,200,000	26,200,000
VA Small Business Fing Auth Hosp Rev (Carilion Health System Proj.) Series 2008 A, 3% 7/1/2042, LOC Truist Bank VRDN (c)	7,350,000	7,350,000
VA Small Business Fing Auth Hosp Rev (Carilion Health System Proj.) Series 2008 B, 3% 7/1/2042, LOC TD Bank NA VRDN (c)	12,825,000	12,825,000
Winchester VA Economic Dev Auth Rev (Valley Health Proj.) Series 2024B 1, 3.1% 1/1/2054, LOC Truist Bank VRDN (c)	18,700,000	18,700,000
Winchester VA Economic Dev Auth Rev (Valley Health Proj.) Series 2024B 2, 3.1% 1/1/2054, LOC Truist Bank VRDN (c)	8,740,000	8,740,000
TOTAL VIRGINIA		76,105,000
Washington - 0.5%
Washington St Hsg Fin Comm Mf (Redm Llc Proj.) 2.06% 7/1/2041, LOC Federal Home Loan Bank of San Francisco VRDN (c)(d)	19,250,000	19,250,000
West Virginia - 1.2%
West Virginia Economic Dev Auth Sold Waste Disp Facs Rev (Appalachian Power Co Proj.) 2.13% 2/1/2036 VRDN (c)(d)	22,400,000	22,400,000
West Virginia Economic Dev Auth Sold Waste Disp Facs Rev (Appalachian Power Co Proj.) Series 2008 A, 2.01% 2/1/2036 VRDN (c)(d)	27,800,000	27,800,000
TOTAL WEST VIRGINIA		50,200,000
Wisconsin - 0.6%
Green Bay Wis Redev Auth Exempt Fac Redev Rev (Green Bay Wis Pkg Sys Rev Proj.) Series 2019, 2.02% 7/1/2047, LOC Wells Fargo Bank NA VRDN (c)(d)(e)	21,500,000	21,500,000
Wisconsin Health & Educational Facilities Authority (Marshfield Clinic Proj.) Series 2018 A, 3.05% 2/15/2050, LOC Barclays Bank PLC VRDN (c)	3,900,000	3,900,000
TOTAL WISCONSIN		25,400,000
Wyoming - 0.1%
Converse Cnty Wyo Environmenta Impt Rev (Pacificorp Proj.) Series 1995, 2.25% 11/1/2025 VRDN (c)(d)	1,300,000	1,300,000
Sweetwater Cnty WY Env Imp Rev (Pacificorp Proj.) 3.25% 11/1/2025 VRDN (c)(d)	4,400,000	4,400,000
TOTAL WYOMING		5,700,000
TOTAL VARIABLE RATE DEMAND NOTE (Cost $2,907,470,000)		2,907,470,000

TOTAL INVESTMENT IN SECURITIES - 98.1% (Cost $4,124,582,153)	4,124,582,153
NET OTHER ASSETS (LIABILITIES) - 1.9%	81,057,549
NET ASSETS - 100.0%	4,205,639,702

Security Type Abbreviations

VRDN

VARIABLE RATE DEMAND NOTE (A debt instrument that is payable upon demand, either daily, weekly or monthly)

Legend

(a)	Amount is stated in United States dollars unless otherwise noted.

(b)	Provides evidence of ownership in one or more underlying municipal bonds. Coupon rates are determined by re-marketing agents based on current market conditions.

(c)	Coupon rates for floating and adjustable rate securities reflect the rates in effect at period end.

(d)	Private activity obligations whose interest is subject to the federal alternative minimum tax for individuals.

(e)

Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $21,500,000 or 0.5% of net assets.

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Tender Option Bond	1,217,112,153	-	1,217,112,153	-

Variable Rate Demand Note	2,907,470,000	-	2,907,470,000	-
Total Investments in Securities:	4,124,582,153	-	4,124,582,153	-

Financial Statements

Statement of Assets and Liabilities
As of May 31, 2025
Assets
Investment in securities, at value - See accompanying schedule: Unaffiliated issuers (cost $4,124,582,153)			$	4,124,582,153
Cash				56,381,741
Receivable for investments sold				80,090,000
Interest receivable				15,557,810
Other receivables				14,204
Total assets				4,276,625,908
Liabilities
Payable for investments purchased	$	62,175,687
Distributions payable		8,796,728
Other payables and accrued expenses		13,791
Total liabilities				70,986,206
Net Assets			$	4,205,639,702
Net Assets consist of:
Paid in capital			$	4,205,635,906
Total accumulated earnings (loss)				3,796
Net Assets			$	4,205,639,702
Net Asset Value, offering price and redemption price per share ($4,205,639,702 ÷ 4,204,734,127 shares)			$	1.0002

Statement of Operations
Year ended May 31, 2025
Investment Income
Interest			$	90,136,608
Expenses
Custodian fees and expenses	$	37,287
Independent trustees' fees and expenses		7,766
Miscellaneous		33
Total expenses before reductions		45,086
Expense reductions		(37,697)
Total expenses after reductions				7,389
Net Investment income (loss)				90,129,219
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		8,735
Total net realized gain (loss)				8,735
Change in net unrealized appreciation (depreciation) on investment securities				(1,198)
Net gain (loss)				7,537
Net increase in net assets resulting from operations			$	90,136,756

Statement of Changes in Net Assets

		Year ended May 31, 2025		Year ended May 31, 2024
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	90,129,219	$	85,507,521
Net realized gain (loss)		8,735		36,209
Change in net unrealized appreciation (depreciation)		(1,198)		1,198
Net increase in net assets resulting from operations		90,136,756		85,544,928
Distributions to shareholders		(90,128,941)		(85,507,794)

Affiliated share transactions
Proceeds from sales of shares		17,208,561,163		14,061,391,161
Cost of shares redeemed		(14,994,689,974)		(14,066,332,327)

Net increase (decrease) in net assets and shares resulting from share transactions		2,213,871,189		(4,941,166)
Total increase (decrease) in net assets		2,213,879,004		(4,904,032)

Net Assets
Beginning of period		1,991,760,698		1,996,664,730
End of period	$	4,205,639,702	$	1,991,760,698

Other Information
Shares
Sold		17,205,120,139		14,086,164,542
Redeemed		(14,991,691,636)		(14,091,079,010)
Net increase (decrease)		2,213,428,503		(4,914,468)

Financial Highlights

Fidelity® Municipal Cash Central Fund

Years ended May 31,		2025		2024		2023		2022		2021
Selected Per-Share Data
Net asset value, beginning of period	$	1.0002	$	1.0002	$	1.0002	$	1.0002	$	1.0001
Income from Investment Operations
Net investment income (loss) A		.0302		.0349		.0220		.0016		.0011
Net realized and unrealized gain (loss)		- B		- B		- B		.0001		.0001
Total from investment operations		.0302		.0349		.0220		.0017		.0012
Distributions from net investment income		(.0302)		(.0349)		(.0220)		(.0016)		(.0011)
Distributions from net realized gain		-		-		- B		- B		- B
Total distributions		(.0302)		(.0349)		(.0220)		(.0017) C		(.0011)
Net asset value, end of period	$	1.0002	$	1.0002	$	1.0002	$	1.0002	$	1.0002
Total Return D		3.07 %		3.54%		2.22%		.17%		.12%
Ratios to Average Net Assets A,E,F
Expenses before reductions G		-%		-%		-%		-%		-%
Expenses net of fee waivers, if any G		- %		-%		-%		-%		-%
Expenses net of all reductions, if any G		-%		-%		-%		-%		-%
Net investment income (loss)		2.92%		3.46%		2.25%		.17%		.10%
Supplemental Data
Net assets, end of period (000 omitted)	$	4,205,640	$	1,991,761	$	1,996,665	$	1,856,209	$	1,342,909

BAmount represents less than $.00005 per share.

CTotal distributions per share do not sum due to rounding.

DTotal returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

FFees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses.

GAmount represents less than .005%.

Notes to Financial Statements

For the period ended May 31, 2025

1. Organization.

Fidelity Municipal Cash Central Fund (the Fund) is a fund of Fidelity Revere Street Trust (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Delaware statutory trust. Shares of the Fund are only offered to other investment companies and accounts (the Investing Funds) managed by Fidelity Management & Research Company LLC (FMR), or its affiliates. The Fund has been designated an institutional money market fund, and the value of the Fund's shares are calculated to four decimal places that fluctuates based upon changes in the value of the Fund's investments.

2. Significant Accounting Policies.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Municipal securities and other short-term securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

The aggregate value of investments by input level as of May 31, 2025 is included at the end of the Fund's Schedule of Investments.

Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. During the period, the Fund incurred an excise tax liability on undistributed short-term capital gain and undistributed long-term capital gain which is included in Miscellaneous expense on the Statement of Operations. As of May 31, 2025, the Fund did not have any unrecognized tax benefits in the financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction.

As of period end, the cost and unrealized appreciation (depreciation) in securities for federal income tax purposes were as follows:

Gross unrealized appreciation	$-
Gross unrealized depreciation	-
Net unrealized appreciation (depreciation)	$-
Tax Cost	$4,124,582,153

The tax-based components of distributable earnings as of period end were as follows:

Undistributed tax-exempt income	$290
Undistributed long-term capital gain	$3,506
Net unrealized appreciation (depreciation) on securities and other investments	$-

The tax character of distributions paid was as follows:

	May 31, 2025	May 31, 2024
Tax-exempt Income	$90,128,941	$85,507,794
Total	$90,128,941	$85,507,794

Restricted Securities (including Private Placements). Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities held at period end is included at the end of the Schedule of Investments, if applicable.

3. Fees and Other Transactions with Affiliates.

	Purchases ($)	Sales ($)	Realized Gain (Loss) ($)
Fidelity Municipal Cash Central Fund	1,414,665,000	1,070,938,000	-

4. Expense Reductions.

Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $37,697.

5. Other.

At the end of the period, mutual funds and accounts managed by the investment adviser or its affiliates were the owners of record of all of the outstanding shares of the Fund.

6. Risk and Uncertainties.

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity Revere Street Trust and Shareholders of Fidelity Municipal Cash Central Fund

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Fidelity Municipal Cash Central Fund (one of the funds constituting Fidelity Revere Street Trust, referred to hereafter as the "Fund") as of May 31, 2025, the related statement of operations for the year ended May 31, 2025, the statement of changes in net assets for each of the two years in the period ended May 31, 2025, including the related notes, and the financial highlights for each of the five years in the period ended May 31, 2025 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of May 31, 2025, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended May 31, 2025 and the financial highlights for each of the five years in the period ended May 31, 2025 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of May 31, 2025 by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

July 15, 2025

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

Distributions

(Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

The fund hereby designates as a capital gain dividend with respect to the taxable year ended May 31, 2025, $8,691, or, if subsequently determined to be different, the net capital gain of such year.

During fiscal year ended 2025, 100% of the fund's income dividends was free from federal income tax, and 42.76% of the fund's income dividends was subject to the federal alternative minimum tax.

The fund will notify shareholders in January 2026 of amounts for use in preparing 2025 income tax returns.

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 9: Proxy Disclosures for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

(Unaudited)

Note: This information is disclosed as part of the financial statements for each Fund as part of Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

(Unaudited)

Note: This is not applicable for any fund included in this document.

1.743117.125

MCC-ANN-0725

Fidelity® Cash Central Fund

Annual Report

May 31, 2025

Contents

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Cash Central Fund

Notes to Financial Statements

Report of Independent Registered Public Accounting Firm

Distributions

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

Item 9: Proxy Disclosures for Open-End Management Investment Companies

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Annual Report)

Fidelity® Cash Central Fund

Schedule of Investments May 31, 2025

Showing Percentage of Net Assets

Repurchase Agreements - 78.2%
	Maturity Amount ($)	Value ($)
Repurchase Agreements* (Cost $43,049,000,000)	43,064,246,521	43,049,000,000

Time Deposits - 1.7%
	Yield (%) (b)	Principal Amount (a)	Value ($)
Canadian Imperial Bank of Commerce 4.33% 6/2/2025	4.33	205,000,000	205,000,000
Credit Agricole CIB 4.33% 6/2/2025	4.33	96,000,000	96,000,000
Mizuho Bank Ltd NY Branch 4.33% 6/2/2025	4.33	341,000,000	341,000,000
Royal Bank of Canada Toronto 4.33% 6/2/2025	4.33	320,000,000	320,000,000
TOTAL TIME DEPOSITS (Cost $962,000,000)			962,000,000

U.S. Treasury Obligations - 18.6%
	Yield (%) (b)	Principal Amount (a)	Value ($)
US Treasury Bills 0% 6/10/2025	4.26 to 4.27	1,050,000,000	1,049,011,835
US Treasury Bills 0% 6/12/2025	4.26	232,000,000	231,726,067
US Treasury Bills 0% 6/17/2025	4.26 to 4.30	1,407,800,000	1,405,309,954
US Treasury Bills 0% 6/20/2025	4.26	800,000,000	798,306,000
US Treasury Bills 0% 6/26/2025	4.27	1,075,000,000	1,071,969,392
US Treasury Bills 0% 6/3/2025	4.27	550,000,000	549,935,419
US Treasury Bills 0% 6/5/2025	4.26	1,025,000,000	1,024,636,894
US Treasury Bills 0% 7/10/2025	4.26	1,050,000,000	1,045,317,294
US Treasury Bills 0% 7/15/2025	4.26	884,800,000	880,340,113
US Treasury Bills 0% 7/22/2025	4.26	1,075,000,000	1,068,698,748
US Treasury Bills 0% 7/3/2025	4.26	1,050,000,000	1,046,186,222
US Treasury Notes 0.25% 7/31/2025	4.32	55,000,000	54,636,914
TOTAL U.S. TREASURY OBLIGATIONS (Cost $10,224,802,767)			10,226,074,852

TOTAL INVESTMENT IN SECURITIES - 98.5% (Cost $54,235,802,767)	54,237,074,852
NET OTHER ASSETS (LIABILITIES) - 1.5%	832,655,224
NET ASSETS - 100.0%	55,069,730,076

Legend

(a)	Amount is stated in United States dollars unless otherwise noted.

(b)	Yield represents either the annualized yield at the date of purchase, or the stated coupon rate, or, for floating and adjustable rate securities, the rate at period end.

* Repurchase Agreements
Counterparty	Lending Rate (%)	Settlement Date	Maturity Date	Repurchase Agreement Value ($)	Repurchase Agreement Proceeds ($)	Collateralized By	Collateral Coupon (%)	Collateral Maturity Date	Collateral Value Received ($)
Federal Reserve Bank of NY	4.25	5/30/2025	6/2/2025	43,049,000,000	43,064,246,521	U.S. Treasuries (including strips)	1.13 - 2.88	5/15/2029 - 5/15/2032	43,064,246,596
Total Repurchase Agreements				$ 43,049,000,000	43,064,246,521				43,064,246,596

Investment Valuation

Valuation Inputs at Reporting Date:
Description	Total ($)	Level 1 ($)	Level 2 ($)	Level 3 ($)
Investments in Securities:

Repurchase Agreements	43,049,000,000	-	43,049,000,000	-

Time Deposits	962,000,000	-	962,000,000	-

U.S. Treasury Obligations	10,226,074,852	-	10,226,074,852	-
Total Investments in Securities:	54,237,074,852	-	54,237,074,852	-

Financial Statements

Statement of Assets and Liabilities
As of May 31, 2025
Assets
Investment in securities, at value (including repurchase agreements of $43,049,000,000) - See accompanying schedule: Unaffiliated issuers (cost $54,235,802,767)			$	54,237,074,852
Cash				966,412,697
Interest receivable				11,969,701
Receivable for interfund loans				50,845,000
Other affiliated receivables				15,206
Other receivables				157,826
Total assets				55,266,475,282
Liabilities
Distributions payable	$	196,560,451
Other payables and accrued expenses		184,755
Total liabilities				196,745,206
Net Assets			$	55,069,730,076
Net Assets consist of:
Paid in capital			$	55,068,381,863
Total accumulated earnings (loss)				1,348,213
Net Assets			$	55,069,730,076
Net Asset Value, offering price and redemption price per share ($55,069,730,076 ÷ 55,057,829,559 shares)			$	1.0002

Statement of Operations
Year ended May 31, 2025
Investment Income
Interest (including $1,852,587 from affiliated interfund lending)			$	2,380,314,086
Expenses
Custodian fees and expenses	$	91,808
Independent trustees' fees and expenses		132,886
Total expenses				224,694
Net Investment income (loss)				2,380,089,392
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers		77,799
Total net realized gain (loss)				77,799
Change in net unrealized appreciation (depreciation) on investment securities				(2,499,920)
Net gain (loss)				(2,422,121)
Net increase in net assets resulting from operations			$	2,377,667,271

Statement of Changes in Net Assets

		Year ended May 31, 2025		Year ended May 31, 2024
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)	$	2,380,089,392	$	2,435,342,680
Net realized gain (loss)		77,799		11
Change in net unrealized appreciation (depreciation)		(2,499,920)		3,772,005
Net increase in net assets resulting from operations		2,377,667,271		2,439,114,696
Distributions to shareholders		(2,380,094,739)		(2,435,345,654)

Affiliated share transactions
Proceeds from sales of shares		589,077,444,580		515,597,423,520
Reinvestment of distributions		71,933		77,024
Cost of shares redeemed		(582,416,954,869)		(508,253,475,743)

Net increase (decrease) in net assets and shares resulting from share transactions		6,660,561,644		7,344,024,801
Total increase (decrease) in net assets		6,658,134,176		7,347,793,843

Net Assets
Beginning of period		48,411,595,900		41,063,802,057
End of period	$	55,069,730,076	$	48,411,595,900

Other Information
Shares
Sold		588,959,174,271		515,494,098,703
Issued in reinvestment of distributions		71,919		77,009
Redeemed		(582,299,777,527)		(508,151,529,440)
Net increase (decrease)		6,659,468,663		7,342,646,272

Financial Highlights

Fidelity® Cash Central Fund

Years ended May 31,		2025		2024		2023		2022		2021
Selected Per-Share Data
Net asset value, beginning of period	$	1.0003	$	1.0002	$	1.0002	$	1.0002	$	1.0002
Income from Investment Operations
Net investment income (loss) A		.0476		.0536		.0354		.0016		.0010
Net realized and unrealized gain (loss)		(.0001)		.0001		- B		- B		- B
Total from investment operations		.0475		.0537		.0354		.0016		.0010
Distributions from net investment income		(.0476)		(.0536)		(.0354)		(.0016)		(.0010)
Total distributions		(.0476)		(.0536)		(.0354)		(.0016)		(.0010)
Net asset value, end of period	$	1.0002	$	1.0003	$	1.0002	$	1.0002	$	1.0002
Total Return C		4.85 %		5.51%		3.59%		.15%		.10%
Ratios to Average Net Assets A,D,E
Expenses before reductions F		-%		-%		-%		-%		-%
Expenses net of fee waivers, if any F		- %		-%		-%		-%		-%
Expenses net of all reductions, if any F		-%		-%		-%		-%		-%
Net investment income (loss)		4.74%		5.37%		3.42%		.14%		.09%
Supplemental Data
Net assets, end of period (000 omitted)	$	55,069,730	$	48,411,596	$	41,063,802	$	52,890,259	$	58,295,494

BAmount represents less than $.00005 per share.

CTotal returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

DFees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses.

FAmount represents less than .005%.

Notes to Financial Statements

For the period ended May 31, 2025

1. Organization.

Fidelity Cash Central Fund (the Fund) is a fund of Fidelity Revere Street Trust (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Delaware statutory trust. Shares of the Fund are only offered to other investment companies and accounts (the Investing Funds) managed by Fidelity Management & Research Company LLC (FMR), or its affiliates. The Fund has been designated an institutional money market fund, and the value of the Fund's shares are calculated to four decimal places that fluctuates based upon changes in the value of the Fund's investments.

2. Significant Accounting Policies.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. U.S. government and government agency obligations and other short-term securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Short-term securities with remaining maturities of sixty days or less may be valued at amortized cost, which approximates fair value, and are categorized as Level 2 in the hierarchy.

The aggregate value of investments by input level as of May 31, 2025 is included at the end of the Fund's Schedule of Investments.

Investment Transactions and Income. Security transactions are accounted for as of trade date. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable.

Fidelity Cash Central Fund

$157,826

As of period end, the cost and unrealized appreciation (depreciation) in securities for federal income tax purposes were as follows:

Gross unrealized appreciation	$1,272,085
Gross unrealized depreciation	-
Net unrealized appreciation (depreciation)	$1,272,085
Tax Cost	$54,235,802,767

The tax-based components of distributable earnings as of period end were as follows:

Net unrealized appreciation (depreciation) on securities and other investments

$1,272,085

The tax character of distributions paid was as follows:

	May 31, 2025	May 31, 2024
Ordinary Income	$2,380,094,739	$2,435,345,654

3. Fees and Other Transactions with Affiliates.

Interfund Lending Program. Pursuant to an Exemptive Order issued by the Securities and Exchange Commission (the SEC), the Fund, along with other registered investment companies having management contracts with FMR, or other affiliated entities of FMR, may participate in an interfund lending program. This program provides an alternative credit facility allowing the Fund to borrow from, or lend money to, other participating affiliated funds at rates that are beneficial to both the borrowing and lending fund. Borrowings under the program are generally for temporary or emergency purposes, including meeting fund shareholder redemptions. The interfund loan rate is determined, as specified in the Exemptive Order, by averaging, (1) the higher of the overnight time deposit rate and the current overnight repurchase agreement rate, and (2) a benchmark rate representing the lowest bank loan rate available to the funds. Any open loans at period end are presented as Receivable for interfund loans in the Statement of Assets and Liabilities, and any accrued interest is included in Other affiliated receivables. Activity in this program during the period for which loans were outstanding was as follows:

		Average Loan Balance ($)	Weighted Average Interest Rate
Fidelity Cash Central Fund	Lender	$21,729,864	4.89%

4. Other.

At the end of the period, mutual funds managed by the investment adviser or its affiliates were the owners of record of all of the outstanding shares of the Fund.

5. Risk and Uncertainties.

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity Revere Street Trust and Shareholders of Fidelity Cash Central Fund

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Fidelity Cash Central Fund (one of the funds constituting Fidelity Revere Street Trust, referred to hereafter as the "Fund") as of May 31, 2025, the related statement of operations for the year ended May 31, 2025, the statement of changes in net assets for each of the two years in the period ended May 31, 2025, including the related notes, and the financial highlights for each of the five years in the period ended May 31, 2025 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of May 31, 2025, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended May 31, 2025 and the financial highlights for each of the five years in the period ended May 31, 2025 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

July 15, 2025

We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

Distributions

(Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

A total of 13.56% of the dividends distributed during the fiscal year was derived from interest on U.S. Government securities which is generally exempt from state income tax.

The fund designates $2,523,449,785 of distributions paid in the calendar year 2024 as qualifying to be taxed as interest-related dividends for nonresident alien shareholders.

The fund designates $2,380,094,739 of distributions paid during the fiscal year ended 2025 as qualifying to be taxed as section 163(j) interest dividends.

The fund will notify shareholders in January 2026 of amounts for use in preparing 2025 income tax returns.

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 9: Proxy Disclosures for Open-End Management Investment Companies

(Unaudited)

Note: This is not applicable for any fund included in this document.

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

(Unaudited)

Note: This information is disclosed as part of the financial statements for each Fund as part of Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

(Unaudited)

Note: This is not applicable for any fund included in this document.

1.743118.125

TCC-ANN-0725

Item 8.

Changes in and Disagreements with Accountants for Open-End Management Investment Companies

See Item 7.

Item 9.

Proxy Disclosures for Open-End Management Investment Companies

See Item 7.

Item 10.

Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies

See Item 7.

Item 11.

Statement Regarding Basis for Approval of Investment Advisory Contract

See Item 7.

Item 12.

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies

Not applicable.

Item 13.

Portfolio Managers of Closed-End Management Investment Companies

Not applicable.

Item 14.

Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers

Not applicable.

Item 15.

Submission of Matters to a Vote of Security Holders

There were no material changes to the procedures by which shareholders may recommend nominees to the trust’s Board of Trustees.

Item 16.

Controls and Procedures

(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the trust’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.

(a)(ii) There was no change in the trust’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the trust’s internal control over financial reporting.

Item 17.

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies

Not applicable.

Item 18.

Recovery of Erroneously Awarded Compensation

(a)

Not applicable.

(b)

Not applicable.

Item 19.

Exhibits


(a)	(1)	Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH.
(a)	(2)	Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.
(a)	(3)	Not applicable.
(b)		Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Fidelity Revere Street Trust


By:	/s/Laura M. Del Prato
	Laura M. Del Prato
	President and Treasurer (Principal Executive Officer)

Date:	July 23, 2025

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


By:	/s/Laura M. Del Prato
	Laura M. Del Prato
	President and Treasurer (Principal Executive Officer)

Date:	July 23, 2025


By:	/s/Stephanie Caron
	Stephanie Caron
	Chief Financial Officer (Principal Financial Officer)

Date:	July 23, 2025

Fidelity Investments

FIDELITY FUNDS’

CODE OF ETHICS

FOR PRESIDENT, TREASURER

AND PRINCIPAL ACCOUNTING OFFICER

2023

FIDELITY FUNDS’ CODE OF ETHICS FOR

PRESIDENT, TREASURER AND PRINCIPAL ACCOUNTING OFFICER

I. Purposes of the Code/Covered Officers

This document constitutes the Code of Ethics (Code) adopted by the Fidelity Funds (Funds) pursuant to Section 406 of the Sarbanes-Oxley Act of 2002. The Code applies to the Fidelity Funds’ President and Treasurer, and Chief Financial Officer (Covered Officers). Fidelity’s Ethics Office, within Enterprise Compliance, administers the Code.

The purposes of the Code are to deter wrongdoing and to promote, on the part of the Covered Officers:

honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

full, fair, accurate, timely and understandable disclosure in reports and documents that the Fidelity Funds submit to the Securities and Exchange Commission (SEC), and in other public communications by a Fidelity Fund;

compliance with applicable laws and governmental rules and regulations;

the prompt internal reporting to an appropriate person or persons identified in the Code of violations of the Code; and

accountability for adherence to the Code.

Each Covered Officer should adhere to a high standard of business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.

II.

Covered Officers Should Handle Ethically

Actual and Apparent Conflicts of Interest

Overview. A “conflict of interest” occurs when a Covered Officer’s private interest interferes with the interests of, or their service to, the Fidelity Funds. For example, a conflict of interest would arise if a Covered Officer, or a member of their family, receives improper personal benefits as a result of their position with the Fidelity Funds.

Certain conflicts of interest arise out of the relationships between Covered Officers and the Fidelity Funds and already are subject to conflict of interest provisions in the Investment Company Act of 1940 (Investment Company Act) and the Investment Advisers Act of 1940 (Investment Advisers Act). For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with a Fidelity Fund because of their status as “affiliated persons” of the Fund. Separate compliance programs and procedures of the Fidelity Funds, Fidelity Management & Research Company (FMR) and the other Fidelity companies are designed to prevent, or identify and correct, violations of these provisions. This Code does not, and is not intended to, repeat or replace these programs and procedures, and such conflicts fall outside of the parameters of this Code.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Fidelity Funds and FMR (or another Fidelity company) of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Fidelity Funds, FMR or another Fidelity company), be involved in establishing policies and implementing decisions that have different effects on the Fidelity Funds, FMR and other Fidelity companies. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Fidelity Funds and FMR (or another Fidelity company) and is consistent with the performance by the Covered Officers of their duties as officers of the Fidelity Funds. Thus, if performed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, such activities will be deemed to have been handled ethically. In addition, it is recognized by the Funds’ Board of Trustees (Board) that the Covered Officers also may be officers or employees of one or more other Fidelity Funds covered by this Code.

Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act and the Investment Advisers Act. The following list provides examples of conflicts of interest under the Code, but Covered Officers should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Officer should not be placed improperly before the interest of a Fidelity Fund.

* * *

Each Covered Officer must:

not use their personal influence or personal relationships improperly to influence investment decisions or financial reporting by any Fidelity Fund whereby the Covered Officer would benefit personally to the detriment of any Fidelity Fund;

not cause a Fidelity Fund to take action, or fail to take action, for the individual personal benefit of the Covered Officer rather than the benefit of the Fidelity Fund;

not engage in any outside business activity, including serving as a director or trustee, that prevents the Covered Officer from devoting appropriate time and attention to the Covered Officer’s responsibilities with the Fidelity Funds;

not have a consulting or employment relationship with any of the Fidelity Funds’ service providers that are not affiliated with Fidelity; and

not retaliate against any employee or Covered Officer for reports of actual or potential misconduct, which are made in good faith.

With respect to other fact patterns, if a Covered Officer is in doubt, other potential conflict of interest situations should be described immediately to the Fidelity Ethics Office for resolution. Similarly, any questions a Covered Officer has generally regarding the application or interpretation of the Code should be directed to the Fidelity Ethics Office immediately.

III. Disclosure and Compliance

Each Covered Officer should familiarize themself with the disclosure requirements generally applicable to the Fidelity Funds.

Each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about any Fidelity Fund to others, whether within or outside Fidelity, including to the Board and auditors, and to governmental regulators and self-regulatory organizations;

Each Covered Officer should, to the extent appropriate within their area of responsibility, consult with other officers and employees of the Fidelity Funds, FMR and the Fidelity service providers, and with the Board’s Compliance Committee, with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Fidelity Funds file with, or submit to, the SEC and in other public communications made by the Fidelity Funds; and

It is the responsibility of each Covered Officer to promote compliance with the standards and restrictions imposed by applicable laws, rules and regulations.

IV. Reporting and Accountability

Each Covered Officer must:

upon receipt of the Code, and annually thereafter, submit to the Fidelity Ethics Office an acknowledgement stating that they have received, read, and understand the Code; and

notify the Fidelity Ethics Office promptly if they know of any violation of the Code. Failure to do so is itself a violation of this Code.

The Fidelity Ethics Office shall take all action it considers appropriate to investigate any actual or potential violations reported to it. Upon completion of the investigation, if necessary, the matter will be reviewed with senior management or other appropriate parties, and a determination will be made as to whether any action should be taken as detailed below. The Covered Officer will be informed of any action determined to be appropriate. The Fidelity Ethics Office will inform the Personal Trading Committee of all Code violations and actions taken in response. Without implied limitation, appropriate remedial, disciplinary or preventive action may include a written warning, a letter of censure, suspension, dismissal or, in the event of criminal or other serious violations of law, notification of the SEC or other appropriate law enforcement authorities. Additionally, other legal remedies may be pursued.

The policies and procedures described in the Code do not create any obligations to any person or entity other than the Fidelity Funds. The Code is intended solely for the internal use by the Fidelity Funds and does not constitute a promise, contract or an admission by or on behalf of any Fidelity Fund as to any fact, circumstance, or legal conclusion. The Fidelity Funds, the Fidelity companies and the Fidelity Head of Ethics retain the discretion to decide whether the Code applies to a specific situation, and how it should be interpreted.

V. Oversight

Material violations of this Code will be reported promptly by FMR (or another Fidelity company) to the Board’s Compliance Committee. In addition, at least once each year, FMR (or another Fidelity company) will provide a written report to the Board, which describes any issues arising under the Code since the last report to the Board, including, but not limited to, information about material violations of the Code and action taken in response to the material violations.

VI. Other Policies and Procedures

This Code shall be the sole code of ethics adopted by the Fidelity Funds for purposes of Section 406 of the Sarbanes-Oxley Act. Other Fidelity policies or procedures that cover the behavior or activities of Covered Officers are separate requirements applying to the Covered Officers (and others) and are not part of this Code.

VII. Amendments

Any material amendments or changes to this Code must be approved or ratified by a majority vote of the Board, including a majority of the Trustees who are not interested persons of the Fidelity Funds.

VIII. Records and Confidentiality

Records of any violation of the Code and of the actions taken as a result of such violations will be kept by the Fidelity Ethics Office. All reports and records prepared or maintained pursuant to this Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters shall not be disclosed to anyone other than the Fidelity Ethics Office, the Personal Trading Committee, the Board, appropriate personnel at the relevant Fidelity company or companies and the legal counsel of any or all of the foregoing.

2023

Exhibit EX-99.CERT

I, Laura M. Del Prato, certify that:

I have reviewed this report on Form N-CSR of Fidelity Revere Street Trust;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based upon such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:

July 23, 2025

/s/Laura M. Del Prato

Laura M. Del Prato

President and Treasurer (Principal Executive Officer)

I, Stephanie Caron, certify that:

I have reviewed this report on Form N-CSR of Fidelity Revere Street Trust;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:

July 23, 2025

/s/Stephanie Caron

Stephanie Caron

Chief Financial Officer (Principal Financial Officer)

Exhibit EX-99.906CERT

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code)

In connection with the attached Report of Fidelity Revere Street Trust (the “Trust”) on Form N-CSR to be filed with the Securities and Exchange Commission (the “Report”), each of the undersigned officers of the Trust does hereby certify that, to the best of such officer’s knowledge:

The Report fully complies with the requirements of 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust as of, and for, the periods presented in the Report.

Dated: July 23, 2025

/s/Laura M. Del Prato

Laura M. Del Prato

President and Treasurer (Principal Executive Officer)

Dated: July 23, 2025

/s/Stephanie Caron

Stephanie Caron

Chief Financial Officer (Principal Financial Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Trust and will be retained by the Trust and furnished to the Securities and Exchange Commission or its staff upon request.

v3.25.2

Form N-CSR Cover
12 Months Ended

May 31, 2025

Shareholder Report [Line Items]

Document Type N-CSR

Amendment Flag false

Registrant Name Fidelity Revere Street Trust

Entity Central Index Key 0001022695

Entity Investment Company Type N-1A

Document Period End Date May 31, 2025

v3.25.2

Shareholder Report
12 Months Ended

May 31, 2025

USD ($)

shares

Shareholder Report [Line Items]

Document Type N-CSR

Amendment Flag false

Registrant Name Fidelity Revere Street Trust

Entity Central Index Key 0001022695

Entity Investment Company Type N-1A

Document Period End Date May 31, 2025

Fidelity Securities Lending Cash Central Fund

Shareholder Report [Line Items]

Fund Name Fidelity® Securities Lending Cash Central Fund

Class Name Fidelity® Securities Lending Cash Central Fund

No Trading Symbol Flag true

Annual or Semi-Annual Statement [Text Block] This annual shareholder report contains information about Fidelity® Securities Lending Cash Central Fund for the period June 1, 2024 to May 31, 2025.

Shareholder Report Annual or Semi-Annual annual shareholder report

Additional Information [Text Block] You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

Material Fund Change Notice [Text Block] This report describes changes to the Fund that occurred during the reporting period.

Additional Information Phone Number 1-800-544-8544

Additional Information Website fundresearch.fidelity.com/prospectus/sec

Expenses [Text Block] What were your Fund costs for the last year?
(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

Costs of a $10,000 investment

Costs paid as a percentage of a $10,000 investment

Fidelity® Securities Lending Cash Central Fund

$ 0 A

0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Expenses Paid, Amount $ 0

Expense Ratio, Percent 0.00%

Net Assets $ 31,287,008,376

Holdings Count | shares 16

Advisory Fees Paid, Amount $ 0

Additional Fund Statistics [Text Block] Key Fund Statistics

(as of May 31, 2025)

KEY FACTS

Fund Size

$31,287,008,376

Number of Holdings

16

Total Advisory Fee

$0

Holdings [Text Block] EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets) Days 1-7 82.9 8-30 7.7 31-60 7.7 Repurchase Agreements 78.6 U.S. Treasury Obligations 18.0 Non-Negotiable Time Deposit 1.7 Net Other Assets (Liabilities) 1.7 ASSET ALLOCATION (% of Fund's net assets) Repurchase Agreements - 78.6 U.S. Treasury Obligations - 18.0 Non-Negotiable Time Deposit - 1.7 Net Other Assets (Liabilities) - 1.7

Material Fund Change [Text Block]
How has the Fund changed?

This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Material Fund Change Risks Change [Text Block] The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Summary of Change Legend [Text Block] This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

Updated Prospectus Phone Number 1-800-544-8544

Updated Prospectus Web Address fundresearch.fidelity.com/prospectus/sec

Fidelity Municipal Cash Central Fund

Shareholder Report [Line Items]

Fund Name Fidelity® Municipal Cash Central Fund

Class Name Fidelity® Municipal Cash Central Fund

No Trading Symbol Flag true

Annual or Semi-Annual Statement [Text Block] This annual shareholder report contains information about Fidelity® Municipal Cash Central Fund for the period June 1, 2024 to May 31, 2025.

Shareholder Report Annual or Semi-Annual annual shareholder report

Additional Information [Text Block] You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

Material Fund Change Notice [Text Block] This report describes changes to the Fund that occurred during the reporting period.

Additional Information Phone Number 1-800-544-8544

Additional Information Website fundresearch.fidelity.com/prospectus/sec

Expenses [Text Block] What were your Fund costs for the last year?
(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

Costs of a $10,000 investment

Costs paid as a percentage of a $10,000 investment

Fidelity® Municipal Cash Central Fund

$ 0 A

0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Expenses Paid, Amount $ 0

Expense Ratio, Percent 0.00%

Net Assets $ 4,205,639,702

Holdings Count | shares 450

Advisory Fees Paid, Amount $ 0

Additional Fund Statistics [Text Block] Key Fund Statistics

(as of May 31, 2025)

KEY FACTS

Fund Size

$4,205,639,702

Number of Holdings

450

Total Advisory Fee

$0

Holdings [Text Block] EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets) Days 1-7 98.1 Variable Rate Demand Notes (VRDNs) 69.2 Tender Option Bond 28.9 Net Other Assets (Liabilities) 1.9 ASSET ALLOCATION (% of Fund's net assets) Variable Rate Demand Notes (VRDNs) - 69.2 Tender Option Bond - 28.9 Net Other Assets (Liabilities) - 1.9

Material Fund Change [Text Block]
How has the Fund changed?

This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Material Fund Change Risks Change [Text Block] The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Summary of Change Legend [Text Block] This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

Updated Prospectus Phone Number 1-800-544-8544

Updated Prospectus Web Address fundresearch.fidelity.com/prospectus/sec

Fidelity Cash Central Fund

Shareholder Report [Line Items]

Fund Name Fidelity® Cash Central Fund

Class Name Fidelity® Cash Central Fund

No Trading Symbol Flag true

Annual or Semi-Annual Statement [Text Block] This annual shareholder report contains information about Fidelity® Cash Central Fund for the period June 1, 2024 to May 31, 2025.

Shareholder Report Annual or Semi-Annual annual shareholder report

Additional Information [Text Block] You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

Material Fund Change Notice [Text Block] This report describes changes to the Fund that occurred during the reporting period.

Additional Information Phone Number 1-800-544-8544

Additional Information Website fundresearch.fidelity.com/prospectus/sec

Expenses [Text Block] What were your Fund costs for the last year?
(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

Costs of a $10,000 investment

Costs paid as a percentage of a $10,000 investment

Fidelity® Cash Central Fund

$ 0 A

0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Expenses Paid, Amount $ 0

Expense Ratio, Percent 0.00%

Net Assets $ 55,069,730,076

Holdings Count | shares 17

Advisory Fees Paid, Amount $ 0

Additional Fund Statistics [Text Block] Key Fund Statistics

(as of May 31, 2025)

KEY FACTS

Fund Size

$55,069,730,076

Number of Holdings

17

Total Advisory Fee

$0

Holdings [Text Block] EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets) Days 1-7 82.8 8-30 8.3 31-60 7.3 61-90 0.1 Repurchase Agreements 78.2 U.S. Treasury Obligations 18.6 Non-Negotiable Time Deposit 1.7 Net Other Assets (Liabilities) 1.5 ASSET ALLOCATION (% of Fund's net assets) Repurchase Agreements - 78.2 U.S. Treasury Obligations - 18.6 Non-Negotiable Time Deposit - 1.7 Net Other Assets (Liabilities) - 1.5

Material Fund Change [Text Block]
How has the Fund changed?

This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Material Fund Change Risks Change [Text Block] The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Summary of Change Legend [Text Block] This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

Updated Prospectus Phone Number 1-800-544-8544

Updated Prospectus Web Address fundresearch.fidelity.com/prospectus/sec

Fidelity Tax-Free Cash Central Fund

Shareholder Report [Line Items]

Fund Name Fidelity® Tax-Free Cash Central Fund

Class Name Fidelity® Tax-Free Cash Central Fund

No Trading Symbol Flag true

Annual or Semi-Annual Statement [Text Block] This annual shareholder report contains information about Fidelity® Tax-Free Cash Central Fund for the period June 1, 2024 to May 31, 2025.

Shareholder Report Annual or Semi-Annual annual shareholder report

Additional Information [Text Block] You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544.

Material Fund Change Notice [Text Block] This report describes changes to the Fund that occurred during the reporting period.

Additional Information Phone Number 1-800-544-8544

Additional Information Website fundresearch.fidelity.com/prospectus/sec

Expenses [Text Block] What were your Fund costs for the last year?
(based on hypothetical $10,000 investment)

FUND COST (PREVIOUS YEAR)

Costs of a $10,000 investment

Costs paid as a percentage of a $10,000 investment

Fidelity® Tax-Free Cash Central Fund

$ 0 A

0.00%B

A Amount represents less than $.50

B Amount represents less than 0.005%

Expenses Paid, Amount $ 0

Expense Ratio, Percent 0.00%

Net Assets $ 2,412,130,368

Holdings Count | shares 336

Advisory Fees Paid, Amount $ 0

Additional Fund Statistics [Text Block] Key Fund Statistics

(as of May 31, 2025)

KEY FACTS

Fund Size

$2,412,130,368

Number of Holdings

336

Total Advisory Fee

$0

Holdings [Text Block] EFFECTIVE MATURITY DIVERSIFICATION (% of Fund's net assets) Days 1-7 96.5 Variable Rate Demand Notes (VRDNs) 69.1 Tender Option Bond 27.4 Net Other Assets (Liabilities) 3.5 ASSET ALLOCATION (% of Fund's net assets) Variable Rate Demand Notes (VRDNs) - 69.1 Tender Option Bond - 27.4 Net Other Assets (Liabilities) - 3.5

Material Fund Change [Text Block]
How has the Fund changed?

This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Material Fund Change Risks Change [Text Block] The fund's principal investment risks were updated in connection with the implementation of recent rule amendments related to money market funds adopted by the SEC.

Summary of Change Legend [Text Block] This is a summary of certain changes to the Fund since June 1, 2024. For more complete information, you may review the Fund's next prospectus, which we expect to be available by July 30, 2025 at fundresearch.fidelity.com/prospectus/sec or upon request at 1-800-544-8544 .

Updated Prospectus Phone Number 1-800-544-8544

Updated Prospectus Web Address fundresearch.fidelity.com/prospectus/sec

{
 "version": "2.2",
 "instance": {
  "filing8964.htm": {
   "nsprefix": "fmr",
   "nsuri": "http://www.fidelity.com/20250730",
   "dts": {
    "inline": {
     "local": [
      "filing8964.htm"
     ]
    },
    "schema": {
     "local": [
      "fmr-20250730.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/oef/2024q3/oef-2024q3.xsd",
      "https://xbrl.sec.gov/oef/2024q3/oef-2024q3_cal.xsd",
      "https://xbrl.sec.gov/oef/2024q3/oef-2024q3_lab.xsd",
      "https://xbrl.sec.gov/oef/2024q3/oef-sr-2024q3.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 29,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 14,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2024": 5
   },
   "contextCount": 32,
   "entityCount": 1,
   "segmentCount": 14,
   "elementCount": 146,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/oef/2024q3": 103,
    "http://xbrl.sec.gov/dei/2024": 13,
    "http://fasb.org/us-gaap/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/oef/role/NcsrCover",
     "longName": "030000 - Disclosure - Form N-CSR Cover",
     "shortName": "Form N-CSR Cover",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Trust",
      "name": "dei:DocumentPeriodEndDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "filing8964.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/oef/role/ShareholderReport",
     "longName": "030001 - Disclosure - Shareholder Report",
     "shortName": "Shareholder Report",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "Trust",
      "name": "dei:DocumentPeriodEndDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "filing8964.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C000019656_ClassMember",
      "name": "oef:FundName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "filing8964.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails",
     "longName": "040020 - Disclosure - Shareholder Report, Holdings (Details)",
     "shortName": "Shareholder Report, Holdings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C000019656_EMD_0_Member",
      "name": "oef:PctOfNav",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "oef:HoldingsTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "filing8964.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C000019656_EMD_0_Member",
      "name": "oef:PctOfNav",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "oef:HoldingsTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "filing8964.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "fmr_AANetOtherAssetsLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "AANetOtherAssetsLiabilitiesMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AANetOtherAssetsLiabilitiesMember [Member]",
        "verboseLabel": "AANetOtherAssetsLiabilitiesMember",
        "terseLabel": "AANetOtherAssetsLiabilitiesMember"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_AANonNegotiableTimeDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "AANonNegotiableTimeDepositMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AANonNegotiableTimeDepositMember [Member]",
        "verboseLabel": "AANonNegotiableTimeDepositMember",
        "terseLabel": "AANonNegotiableTimeDepositMember"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_AARepurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "AARepurchaseAgreementsMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AARepurchaseAgreementsMember [Member]",
        "verboseLabel": "AARepurchaseAgreementsMember",
        "terseLabel": "AARepurchaseAgreementsMember"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_AATenderOptionBondMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "AATenderOptionBondMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AATenderOptionBondMember [Member]",
        "verboseLabel": "AATenderOptionBondMember",
        "terseLabel": "AATenderOptionBondMember"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_AAUSTreasuryObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "AAUSTreasuryObligationsMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AAUSTreasuryObligationsMember [Member]",
        "verboseLabel": "AAUSTreasuryObligationsMember",
        "terseLabel": "AAUSTreasuryObligationsMember"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_AAVariableRateDemandNotesVRDNsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "AAVariableRateDemandNotesVRDNsMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AAVariableRateDemandNotesVRDNsMember [Member]",
        "verboseLabel": "AAVariableRateDemandNotesVRDNsMember",
        "terseLabel": "AAVariableRateDemandNotesVRDNsMember"
       }
      }
     },
     "auth_ref": []
    },
    "oef_AccmVal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AccmVal",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Value"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "oef_AccountValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AccountValueLineItems",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Account Value [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "oef_AccountValueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AccountValueTable",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Account Value [Table]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "oef_AccountValueTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AccountValueTableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Account Value Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "oef_AccountantChngDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AccountantChngDate",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accountant Change Date"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "oef_AccountantChngDisagreementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AccountantChngDisagreementsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accountant Change Disagreements [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "oef_AccountantChngStatementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AccountantChngStatementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accountant Change Statement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "oef_AcctVal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AcctVal",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/Deprecated"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Account Value (Deprecated 2024-07-31)"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "oef_AcquiredFundFeesAndExpensesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AcquiredFundFeesAndExpensesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_ExpensesOverAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "oef_AdditionalIndexAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AdditionalIndexAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Index [Axis]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "oef_AdditionalIndexDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AdditionalIndexDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Index [Domain]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "oef_AddlFundStatisticsSignificanceOrLimitsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AddlFundStatisticsSignificanceOrLimitsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Fund Statistics Significance or Limits [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "oef_AddlFundStatisticsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AddlFundStatisticsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Fund Statistics [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "oef_AddlInfoEmail": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AddlInfoEmail",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Information Email"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "oef_AddlInfoPhoneNumber": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AddlInfoPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Information Phone Number"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "oef_AddlInfoTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AddlInfoTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Information [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "oef_AddlInfoWebsite": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AddlInfoWebsite",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Information Website"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "oef_AdvisoryFeesPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AdvisoryFeesPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advisory Fees Paid, Amount"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "oef_AnnlOrSemiAnnlStatementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AnnlOrSemiAnnlStatementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual or Semi-Annual Statement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_AssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "oef_AverageAnnualReturnAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AverageAnnualReturnAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Annual Return:"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "oef_AverageAnnualReturnLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AverageAnnualReturnLineItems",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Annual Return [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "oef_AverageAnnualReturnTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AverageAnnualReturnTable",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Annual Return [Table]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "oef_AvgAnnlRtrPct": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AvgAnnlRtrPct",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Annual Return, Percent"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "oef_AvgAnnlRtrTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "AvgAnnlRtrTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Annual Return [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "oef_BroadBasedIndexAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "BroadBasedIndexAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Broad Based Index [Axis]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "oef_BroadBasedIndexDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "BroadBasedIndexDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Broad Based Index [Domain]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "fmr_C000019654Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "C000019654Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport",
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C000019654 [Member]",
        "verboseLabel": "Fidelity Cash Central Fund",
        "terseLabel": "Fidelity Cash Central Fund"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_C000019655Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "C000019655Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport",
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C000019655 [Member]",
        "verboseLabel": "Fidelity Municipal Cash Central Fund",
        "terseLabel": "Fidelity Municipal Cash Central Fund"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_C000019656Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "C000019656Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport",
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C000019656 [Member]",
        "verboseLabel": "Fidelity Securities Lending Cash Central Fund",
        "terseLabel": "Fidelity Securities Lending Cash Central Fund"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_C000019657Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "C000019657Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport",
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C000019657 [Member]",
        "verboseLabel": "Fidelity Tax-Free Cash Central Fund",
        "terseLabel": "Fidelity Tax-Free Cash Central Fund"
       }
      }
     },
     "auth_ref": []
    },
    "oef_ClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ClassAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport",
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class [Axis]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "oef_ClassName": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ClassName",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Name"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "oef_Component1OtherExpensesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "Component1OtherExpensesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_OtherExpensesOverAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Component1 Other Expenses"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "oef_Component2OtherExpensesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "Component2OtherExpensesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_OtherExpensesOverAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Component2 Other Expenses"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "oef_Component3OtherExpensesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "Component3OtherExpensesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_OtherExpensesOverAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Component3 Other Expenses"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "oef_CreditQualityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "CreditQualityAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Quality [Axis]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_CreditQualityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "CreditQualityDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Quality [Domain]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_CreditQualityExplanationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "CreditQualityExplanationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Quality Explanation [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_CreditRatingsSelectionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "CreditRatingsSelectionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Ratings Selection [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_DistOfCapitalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "DistOfCapitalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution of Capital [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "oef_DistributionAndService12b1FeesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "DistributionAndService12b1FeesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_ExpensesOverAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution and Service (12b-1) Fees"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "oef_DistributionOrSimilarNon12b1FeesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "DistributionOrSimilarNon12b1FeesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_ExpensesOverAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution or Similar (Non 12b-1) Fees"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "fmr_EMD0Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "EMD0Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EMD0Member [Member]",
        "verboseLabel": "EMD0Member",
        "terseLabel": "EMD0Member"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_EMD1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "EMD1Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EMD1Member [Member]",
        "verboseLabel": "EMD1Member",
        "terseLabel": "EMD1Member"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_EMD2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "EMD2Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EMD2Member [Member]",
        "verboseLabel": "EMD2Member",
        "terseLabel": "EMD2Member"
       }
      }
     },
     "auth_ref": []
    },
    "fmr_EMD3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.fidelity.com/20250730",
     "localname": "EMD3Member",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EMD3Member [Member]",
        "verboseLabel": "EMD3Member",
        "terseLabel": "EMD3Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Investment Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "oef_EtfDiscountNumDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "EtfDiscountNumDays",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ETF Discount, Number of Days"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "oef_EtfPastPerfTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "EtfPastPerfTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ETF Past Performance [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "oef_EtfPremiumDiscountTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "EtfPremiumDiscountTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ETF Premium Discount [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "oef_EtfPremiumNumDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "EtfPremiumNumDays",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ETF Premium, Number of Days"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "oef_EtfPurchaseExplanationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "EtfPurchaseExplanationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ETF Purchase Explanation [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "oef_ExpenseRatioPct": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExpenseRatioPct",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Ratio, Percent"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "oef_ExpensesExclExtraordinaryExpensesPct": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExpensesExclExtraordinaryExpensesPct",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Excluding Extraordinary Expenses, Percent"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "oef_ExpensesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExpensesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_NetExpensesOverAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses (as a percentage of Assets)",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "oef_ExpensesPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExpensesPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Paid, Amount"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "oef_ExpensesRepresentBothMasterAndFeeder": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExpensesRepresentBothMasterAndFeeder",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Represent Both Master and Feeder [Text]"
       }
      }
     },
     "auth_ref": [
      "r29",
      "r59"
     ]
    },
    "oef_ExpensesShortPeriodFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExpensesShortPeriodFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Short Period Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "oef_ExpensesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExpensesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "oef_ExposureBasisExplanationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExposureBasisExplanationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exposure Basis Explanation [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_ExtraordinaryExpensesFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ExtraordinaryExpensesFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extraordinary Expenses Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "oef_FactorsAffectingPerfTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "FactorsAffectingPerfTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Factors Affecting Performance [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "oef_FeeWaiverOrReimbursementOverAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "FeeWaiverOrReimbursementOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_NetExpensesOverAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Waiver or Reimbursement",
        "negatedLabel": "Fee Waiver or Reimbursement"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "oef_FundName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "FundName",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fund Name"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "oef_GeographicRegionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "GeographicRegionAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Region [Axis]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_GeographicRegionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "GeographicRegionDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Region [Domain]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_HoldingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "HoldingsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Holdings [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_HoldingsCount": {
     "xbrltype": "integerItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "HoldingsCount",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Holdings Count"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "oef_HoldingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "HoldingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Holdings [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_HoldingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "HoldingsTable",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Holdings [Table]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_HoldingsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "HoldingsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Holdings [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_InabilityToMeetDistLevelTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "InabilityToMeetDistLevelTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inability to Meet Distribution Level [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "oef_IndustrySectorAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "IndustrySectorAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Industry Sector [Axis]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_IndustrySectorDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "IndustrySectorDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Industry Sector [Domain]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_InvestmentCompanyPortfolioTurnover": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentCompanyPortfolioTurnover",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of lesser of purchase or sale of portfolio securities to average value of portfolio securities owned.",
        "label": "Investment Company Portfolio Turnover"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investment Type Categorization [Member]"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17"
     ]
    },
    "oef_LargestHoldingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "LargestHoldingAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Largest Holding [Axis]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_LargestHoldingsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "LargestHoldingsDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Largest Holdings [Domain]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_LargestHoldingsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "LargestHoldingsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Largest Holdings [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "oef_LineGraphAndTableMeasureName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "LineGraphAndTableMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line Graph and Table Measure Name"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "oef_LineGraphTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "LineGraphTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line Graph [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "oef_ManagementFeesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ManagementFeesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_ExpensesOverAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees (as a percentage of Assets)"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "oef_MaterialChngDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialChngDate",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Change Date"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "oef_MaterialChngDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialChngDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Change Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "oef_MaterialFundChngAdviserTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngAdviserTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change Adviser [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "oef_MaterialFundChngExpensesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngExpensesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change Expenses [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "oef_MaterialFundChngNameTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngNameTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change Name [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "oef_MaterialFundChngNoticeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngNoticeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change Notice [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "oef_MaterialFundChngObjectivesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngObjectivesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change Objectives [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "oef_MaterialFundChngRisksChngTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngRisksChngTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change Risks Change [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "oef_MaterialFundChngStrategiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngStrategiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change Strategies [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "oef_MaterialFundChngTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaterialFundChngTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Fund Change [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "oef_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaturityAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [Axis]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "MaturityDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [Domain]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_NetExpensesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "NetExpensesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expenses (as a percentage of Assets)",
        "totalLabel": "Net Expenses"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "oef_NoDeductionOfTaxesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "NoDeductionOfTaxesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Deduction of Taxes [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "oef_OefDeprecatedConceptsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "OefDeprecatedConceptsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deprecated OEF Concepts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "oef_OtherCategory1Axis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "OtherCategory1Axis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Category 1 [Axis]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_OtherCategory1Domain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "OtherCategory1Domain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Category 1 [Domain]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_OtherCategory2Axis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "OtherCategory2Axis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Category 2 [Axis]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_OtherCategory2Domain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "OtherCategory2Domain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Category 2 [Domain]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_OtherExpensesOverAssets": {
     "xbrltype": "nonNegativePure4ItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "OtherExpensesOverAssets",
     "calculation": {
      "http://xbrl.sec.gov/rr/role/OperatingExpensesData": {
       "parentTag": "oef_ExpensesOverAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses (as a percentage of Assets):",
        "totalLabel": "Other Expenses"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "oef_PctOfNav": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PctOfNav",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percent of Net Asset Value"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_PctOfNetLongExposure": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PctOfNetLongExposure",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percent of Net Long Exposure"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_PctOfNetShortExposure": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PctOfNetShortExposure",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percent of Net Short Exposure"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_PctOfTotalInv": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PctOfTotalInv",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percent of Total Investments"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_PctOfTotalLongExposure": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PctOfTotalLongExposure",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percent of Total Long Exposure"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_PctOfTotalShortExposure": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PctOfTotalShortExposure",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percent of Total Short Exposure"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "oef_PerfInceptionDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PerfInceptionDate",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Inception Date"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "oef_PerfTableMarketIndexChngdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PerfTableMarketIndexChngdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Table Market Index Changed [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "oef_PerformancePastDoesNotIndicateFuture": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PerformancePastDoesNotIndicateFuture",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Past Does Not Indicate Future [Text]"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r68"
     ]
    },
    "oef_PreviousInvestmentAdviserTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PreviousInvestmentAdviserTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previous Investment Adviser [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "oef_PriorMarketIndexComparisonTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "PriorMarketIndexComparisonTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Market Index Comparison [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "oef_SalesLoadAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "SalesLoadAxis",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Axis]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Exchange",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "oef_ShareClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ShareClassDomain",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport",
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportHoldingsDetails",
      "http://xbrl.sec.gov/oef/role/ShareholderReportLineGraphDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Classes"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "oef_ShareholderReportAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ShareholderReportAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Report [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "oef_ShareholderReportAnnualOrSemiAnnual": {
     "xbrltype": "shareholderReportTypeItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ShareholderReportAnnualOrSemiAnnual",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Report Annual or Semi-Annual"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "oef_ShareholderReportLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ShareholderReportLineItems",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Report [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "oef_ShareholderReportTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "ShareholderReportTable",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/NcsrCover",
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Report [Table]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "oef_SummaryOfChngLegendTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "SummaryOfChngLegendTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Change Legend [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Ticker",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "oef_UpdPerfInfoLocationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "UpdPerfInfoLocationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Updated Performance Information Location [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "oef_UpdProspectusEmailAddress": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "UpdProspectusEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Updated Prospectus Email Address"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "oef_UpdProspectusPhoneNumber": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "UpdProspectusPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Updated Prospectus Phone Number"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "oef_UpdProspectusWebAddress": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "UpdProspectusWebAddress",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReport"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Updated Prospectus Web Address"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "oef_WithSalesLoadMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "WithSalesLoadMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "With Sales Load [Member]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "oef_WithoutSalesLoadMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/oef/2024q3",
     "localname": "WithoutSalesLoadMember",
     "presentation": [
      "http://xbrl.sec.gov/oef/role/ShareholderReportAverageAnnualReturnDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Without Sales Load [Member]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479910/205-30-50-1"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "1",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "b",
   "Paragraph": "3"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "b",
   "Paragraph": "4"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "b",
   "Paragraph": "5"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "b",
   "Paragraph": "instruction",
   "Subparagraph": "2"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "c"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "c",
   "Paragraph": "ii"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "c",
   "Paragraph": "iii"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "c",
   "Paragraph": "instruction",
   "Sentence": "1",
   "Clause": "b"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "c",
   "Paragraph": "instruction",
   "Subparagraph": "1",
   "Clause": "c"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "c",
   "Paragraph": "instruction",
   "Subparagraph": "1",
   "Clause": "d"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "1"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Clause": "B"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "iiii",
   "Clause": "A"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "instruction",
   "Clause": "12"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "instruction",
   "Clause": "14"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "instruction",
   "Clause": "15"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "instruction",
   "Clause": "7"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "2",
   "Subparagraph": "instruction",
   "Clause": "8"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "3"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "4"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "4",
   "Subparagraph": "instruction",
   "Clause": "3"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "d",
   "Paragraph": "4",
   "Subparagraph": "instruction",
   "Clause": "4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "e"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "e",
   "Paragraph": "instruction",
   "Subparagraph": "6"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "f"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g",
   "Paragraph": "1"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g",
   "Paragraph": "2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g",
   "Paragraph": "3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g",
   "Paragraph": "4"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g",
   "Paragraph": "5"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g",
   "Paragraph": "6"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "g",
   "Paragraph": "instruction",
   "Subparagraph": "2"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "h",
   "Paragraph": "1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "27A",
   "Subsection": "h",
   "Paragraph": "2"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "1",
   "Subparagraph": "d",
   "Sentence": "i"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3",
   "Subparagraph": "a"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3",
   "Subparagraph": "b"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3",
   "Subparagraph": "c",
   "Sentence": "i"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3",
   "Subparagraph": "c",
   "Sentence": "iii"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3",
   "Subparagraph": "d"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3",
   "Subparagraph": "e"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "3",
   "Subsection": "instruction",
   "Paragraph": "3",
   "Subparagraph": "f",
   "Sentence": "i"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "4",
   "Subsection": "b",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-1A",
   "Section": "4",
   "Subsection": "b",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r71": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  }
 }
}

Repurchase Agreements	78.6
U.S. Treasury Obligations	18.0
Non-Negotiable Time Deposit	1.7
Net Other Assets (Liabilities)	1.7

Variable Rate Demand Notes (VRDNs)	69.2
Tender Option Bond	28.9
Net Other Assets (Liabilities)	1.9

Repurchase Agreements	78.2
U.S. Treasury Obligations	18.6
Non-Negotiable Time Deposit	1.7
Net Other Assets (Liabilities)	1.5

Variable Rate Demand Notes (VRDNs)	69.1
Tender Option Bond	27.4
Net Other Assets (Liabilities)	3.5

Form N-CSR Cover	12 Months Ended
Form N-CSR Cover	May 31, 2025
Shareholder Report [Line Items]
Document Type	N-CSR
Amendment Flag	false
Registrant Name	Fidelity Revere Street Trust
Entity Central Index Key	0001022695
Entity Investment Company Type	N-1A
Document Period End Date	May 31, 2025

Shareholder Report, Holdings (Details)	May 31, 2025
Fidelity Securities Lending Cash Central Fund \| EMD0Member
Holdings [Line Items]
Percent of Net Asset Value	82.90%
Fidelity Securities Lending Cash Central Fund \| EMD1Member
Holdings [Line Items]
Percent of Net Asset Value	7.70%
Fidelity Securities Lending Cash Central Fund \| EMD2Member
Holdings [Line Items]
Percent of Net Asset Value	7.70%
Fidelity Securities Lending Cash Central Fund \| AARepurchaseAgreementsMember
Holdings [Line Items]
Percent of Net Asset Value	78.60%
Fidelity Securities Lending Cash Central Fund \| AAUSTreasuryObligationsMember
Holdings [Line Items]
Percent of Net Asset Value	18.00%
Fidelity Securities Lending Cash Central Fund \| AANonNegotiableTimeDepositMember
Holdings [Line Items]
Percent of Net Asset Value	1.70%
Fidelity Securities Lending Cash Central Fund \| AANetOtherAssetsLiabilitiesMember
Holdings [Line Items]
Percent of Net Asset Value	1.70%
Fidelity Municipal Cash Central Fund \| EMD0Member
Holdings [Line Items]
Percent of Net Asset Value	98.10%
Fidelity Municipal Cash Central Fund \| AANetOtherAssetsLiabilitiesMember
Holdings [Line Items]
Percent of Net Asset Value	1.90%
Fidelity Municipal Cash Central Fund \| AAVariableRateDemandNotesVRDNsMember
Holdings [Line Items]
Percent of Net Asset Value	69.20%
Fidelity Municipal Cash Central Fund \| AATenderOptionBondMember
Holdings [Line Items]
Percent of Net Asset Value	28.90%
Fidelity Cash Central Fund \| EMD0Member
Holdings [Line Items]
Percent of Net Asset Value	82.80%
Fidelity Cash Central Fund \| EMD1Member
Holdings [Line Items]
Percent of Net Asset Value	8.30%
Fidelity Cash Central Fund \| EMD2Member
Holdings [Line Items]
Percent of Net Asset Value	7.30%
Fidelity Cash Central Fund \| EMD3Member
Holdings [Line Items]
Percent of Net Asset Value	0.10%
Fidelity Cash Central Fund \| AARepurchaseAgreementsMember
Holdings [Line Items]
Percent of Net Asset Value	78.20%
Fidelity Cash Central Fund \| AAUSTreasuryObligationsMember
Holdings [Line Items]
Percent of Net Asset Value	18.60%
Fidelity Cash Central Fund \| AANonNegotiableTimeDepositMember
Holdings [Line Items]
Percent of Net Asset Value	1.70%
Fidelity Cash Central Fund \| AANetOtherAssetsLiabilitiesMember
Holdings [Line Items]
Percent of Net Asset Value	1.50%
Fidelity Tax-Free Cash Central Fund \| EMD0Member
Holdings [Line Items]
Percent of Net Asset Value	96.50%
Fidelity Tax-Free Cash Central Fund \| AANetOtherAssetsLiabilitiesMember
Holdings [Line Items]
Percent of Net Asset Value	3.50%
Fidelity Tax-Free Cash Central Fund \| AAVariableRateDemandNotesVRDNsMember
Holdings [Line Items]
Percent of Net Asset Value	69.10%
Fidelity Tax-Free Cash Central Fund \| AATenderOptionBondMember
Holdings [Line Items]
Percent of Net Asset Value	27.40%